Logo Reference Ranges Report
Sorted by refranges    {click on appropriate heading to sort}
Test NameBilling CodeTest CodeMethodReference Ranges
HCV RNA QUANTITATION (PCR)HCVRQTHCVRQTPCR: Ampliprep/TaqMan HCV Test
TitleRangesUnits
Hepatitis C Viral RNA Viral Load ResultNot detectedLog IU/mL
Hepatitis C Viral RNA Viral Load ResultNot detectedIU/mL
Reportable range HCV RNA 1.2 to 8.0 Log IU/mL (15-100,000,000 IU/mL)
The test is intended for use as an aid in the management of HCV-infected individuals undergoing anti-viral therapy. The COBAS Ampliprep/COBAS Taqman test is not intended for use as a screening test for the presence of HCV in blood or blood products.
1,3 BETA D GLUCAN13BGA13BGASemi-Quantitative Colorimetry
TitleDescriptorRangesUnits
1,3 Beta-D-GlucanNegative< 31pg/mL
Negative31-59
Indeterminate60-79
Positive> = 80
1,3 Beta-D-Glucan
Interpretation
PAIN MANAGEMENT COMPREHENSIVEPM5PM5Tandem Mass Spectrometry/Gas Chromatography
TitleDescriptorRangesUnits
2-Hydroxyethylflurazepam ScreenNegative< 25ng/mL
2-Hydroxyethylflurazepam Confirmation LCMSMSNot Detected< 25
6-MAM ScreenNegative< 10
6-MAM Confirmation LCMSMSNot Detected< 10
7-Aminoclonazepam ScreenNegative< 10
7-Aminoclonazepam Confirmation LCMSMSNot Detected< 10
Clonazepam Confirmation LCSMSMNot Detected< 10
7-Aminoflunitrazepam ScreenNegative< 10
7-Aminoflunitrazepam Confirmation LCMSMSNot Detected< 10
Flunitrazepam Confirmation LCMSMSNot Detected< 10
alpha-Hydroxyalprazolam ScreenNegative< 25
alpha-Hydroxyalprazolam Confirmation LCMSMSNot Detected< 25
Alprazolam Confirmation LCMSMSNot Detected< 10
alpha-Hydroxymidazolam ScreenNegative< 25
alpha-Hydroxymidazolam Confirmation LCMSMSNot Detected< 25
alpha-Hydroxytriazolam ScreenNegative< 25
alpha-Hydroxytriazolam Confirmation LCMSMSNot Detected< 25
Amitriptyline ScreenNegative< 100
Amitriptyline Confirmation LCMSMSNot Detected< 100
Amphetamine ScreenNegative< 250
Amphetamine Confirmation GCMSNot Detected< 40
Benzoylecgonine ScreenNegative< 100
Benzoylecgonine Confirmation GCMSNot Detected< 30
Barbituates ScreenNegative< 200
Amobarbital Confirmation GCMSNot Detected< 30
Butalbital Confirmation GCMSNot Detected< 80
Phenobarbital Confirmation GCMSNot Detected< 50
Secobarbital Confirmation GCMSNot Detected< 80
Pentobarbital Confirmation GCMSNot Detected< 50
Buprenorphine ScreenNegative< 50
Buprenorphine Confirmation GCMSNot Detected< 5
Norbuprenorphine Confirmation GCMSNot Detected< 5
Butorphanol ScreenNegative< 50
Butorphanol Confirmation LCMSMSNot Detected< 50
Cannabinoid ScreenNegative< 20
Carboxy THC Confirmation GCMSNot Detected< 4
Citalopram ScreenNegative< 100
Citalopram Confirmation LCMSMSNot Detected< 100
Codeine ScreenNegative< 50
Codeine Confirmation LCMSMSNot Detected< 50
Cyclobenzaprine ScreenNegative< 100
Cyclobenzaprine Confirmation LCMSMSNot Detected< 100
Desipramine ScreenNegative< 100
Desipramine Confirmation LCMSMSNot Detected< 100
Diazepam ScreenNegative< 10
Diazepam Confirmation LCMSMSNot Detected< 10
Doxepin ScreenNegative< 100
Doxepin Confirmation LCMSMSNot Detected< 100
EDDP ScreenNegative< 150
EDDP Confirmation GCMSNot Detected< 90
Fentanyl ScreenNegative< 5
Fentanyl Confirmation LCMSMSNot Detected< 5
Gabapentin ScreenNegative< 50
Gabapentin Confirmation LCMSMSNot Detected< 50
Hydrocodone ScreenNegative< 50
Hydrocodone Confirmation LCMSMSNot Detected< 50
Norhydrocodone Confirmation LCMSMSNot Detected< 50
Hydromorphone ScreenNegative< 50
Hydromorphone Confirmation LCMSMSNot Detected< 50
Hydroxybupropion ScreenNegative< 100
Hydroxybupropion Confirmation LCMSMSNot Detected< 100
Imipramine ScreenNegative< 100
Imipramine Confirmation LCMSMSNot Detected< 100
Lorazepam ScreenNegative< 25
Lorazepam Confirmation LCMSMSNot Detected< 25
Maprotiline ScreenNegative< 100
Maprotiline Confirmation LCMSMSNot Detected< 100
MDA ScreenNegative< 250
MDA Confirmation GCMSNot Detected< 40
MDEA ScreenNegative< 250
MDEA Confirmation GCMSNot Detected< 40
MDMA ScreenNegative< 250
MDMA Confirmation GCMSNot Detected< 40
Meprobamate ScreenNegative< 1000
Meprobamate Confirmation GCMSNot Detected< 500
Methadone ScreenNegative< 150
EDDP Confirmation GCMSNot Detected< 90
Methamphetamine ScreenNegative< 250
Methamphetamine Confirmation GCMSNot Detected< 40
Methylphenidate ScreenNegative< 50
Methylphenidate Confirmation LCMSMSNot Detected< 50
Morphine ScreenNegative< 50
Morphine Confirmation LCMSMSNot Detected< 50
Nalbuphine ScreenNegative< 50
Nalbuphine Confirmation LCMSMSNot Detected< 50
Naloxone ScreenNegative< 50
Naloxone Confirmation LCMSMSNot Detected< 50
Naltrexone ScreenNegative< 50
Naltrexone Confirmation LCMSMSNot Detected< 50
Nefazodone ScreenNegative< 100
Nefazodone Confirmation LCMSMSNot Detected< 100
Nordiazepam ScreenNegative< 25
Nordiazepam Confirmation LCMSMSNot Detected< 25
Norfentanyl ScreenNegative< 5
Norfentanyl Confirmation LCMSMSNot Detected< 5
Norketamine ScreenNegative< 50
Norketamine Confirmation GCMSNot Detected< 7
Normeperidine ScreenNegative< 200
Normeperidine Confirmation GCMSNot Detected< 40
Nortriptyline ScreenNegative< 100
Nortriptyline Confirmation LCMSMSNot Detected< 100
Norvenlafaxine ScreenNegative< 100
Norvenlafaxine Confirmation LCMSMSNot Detected< 100
Oxazepam ScreenNegative< 25
Oxazepam Confirmation LCMSMSNot Detected< 25
Oxycodone ScreenNegative< 50
Oxycodone Confirmation LCMSMSNot Detected< 50
Noroxycodone Confirmation LCMSMSNot Detected< 50
Oxymorphone ScreenNegative< 50
Oxymorphone Confirmation LCMSMSNot Detected< 50
PCP ScreenNegative< 25
PCP Confirmation GCMSNot Detected< 6
Pentazocine ScreenNegative< 50
Pentazocine Confirmation LCMSMSNot Detected< 50
Pregabalin ScreenNegative< 50
Pregabalin Confirmation LCMSMSNot Detected< 50
Propoxyphene ScreenNegative< 300
NorPropoxyphene Confirmation GCMSNot Detected< 80
Ritalinic Acid ScreenNegative< 50
Ritalinic Acid Confirmation LCMSMSNot Detected< 50
Sertraline ScreenNegative< 100
Sertraline Confirmation LCMSMSNot Detected< 100
Tapentadol ScreenNegative< 50
Tapentadol Confirmation LCMSMSNot Detected< 50
Temazepam ScreenNegative< 25
Temazepam Confirmation LCMSMSNot Detected< 25
Tramadol ScreenNegative< 200
Tramadol Confirmation LCMSMSNot Detected< 80
Trazodone ScreenNegative< 100
Trazodone Confirmation LCMSMSNot Detected< 100
Zolpidem ScreenNegative< 50
Zolpidem Confirmation LCMSMSNot Detected< 50
Carisoprodol ScreenNegative< 100
Carisoprodol Confirmation GCMSNot Detected< 2.5ug/mL
Creatinine< or = 20mg/dL
VIT D, 25 HYDROXY D23 (LCMSMS)VITD23VITD23Liquid Chromatography-Tandem Mass Spectrometry LCMSMS
TitleDescriptorRangesUnits
25-OH Vitamin D2ng/mL
25-OH Vitamin D3ng/mL
25-OH Vitamin D, TotalSevere DeficiencyLT 10.0ng/mL
Mild to Moderate Deficiency10.0-23.9
Optimum Levels24.0-80.0
Toxicity Possible, Pediatrics (0-18 yrs)80.0 or greater
Toxicity Possible, Adults (19+ yrs)150.0 or greater
BLASTOMYCES DERMATITIDIS AGBLAGD.LCABLAGDQuantitative sandwich enzyme immunoassay (EIA)
TitleDescriptorRangesUnits
316 MVista® Blastomyces AgNone Detectedng/mL
Reference intervalNone Detected
Results reported as ng/mL in 0.2-14.7 ng/mL range
Results above the limit of detection but below 0.2 ng/mL are reported as 'Positive, Below the Limit of Quantification.'
Results above 14.7 ng/mL are reported as 'Positive Above the Limit of Quantification.'
6 MAM SCREEN RFLX6MAM6MAMEnzyme Immunoassay
TitleDescriptorRangesUnits
6MAM ScreenNegative< 10ng/mL
ABO, NON-CROSSMATCHABOM1ABOHemagglutination
ABO
OBSTETRIC PANEL NO CBC RFLXOBPAN2OBPAN2Hemagglutination, Electrochemiluminescent Immunoassay, Solid Phase
TitleDescriptorRangesUnits
ABO
RH
Antibody ScreenNegative
Hepatitis B Surface AntigenNonreactive
Hepatitis B Surface Antigen
Confirmation
Treponema pallidum Ab by CLIANegative
RPRNonreactive
RPR Titer< 1:1
Treponema pallidum Ab by TP-PANonreactive
Rubella, Ab IgGPresumed Immune> 9IU/mL
Presumed Non-Immune< 10
Result flagging is based on presumed immune status
FDA DONOR PANELFDADOFDADO
ABRH
CHAG
CRIP
CHOL
CMV
CMVM
HBC
AHBS
HBS
HBSN
HCV
HCVC
HIV
IFHI
H12C
HTLV
HTIL
ULTR
DHIV
DHCV
DHBV
STS
SYPG
WNV
WNVA
MALE DONORFDAMAOFDAMAO
ABRH
CHAG
CRIP
CMV
CMVM
HBC
AHBS
HBS
HBSN
HCV
HCVC
HIV
IFHI
H12C
HTLV
HTIL
ULTR
DHIV
DHCV
DHBV
STS
SYPG
WNV
WNVA
FEMALE DONORFDAFEOFDAFEO
ABRH
CHAG
CRIP
HBC
AHBS
HBS
HBSN
HCV
HCVC
HIV
IFHI
H12C
ULTR
DHIV
DHCV
DHBV
STS
SYPG
WNV
WNVA
ABO GROUP AND RH TYPEABOOBIABOOBIBeckman Coulter PK 7200
ABRH
PAIN MANAGEMENT ACETAMINOPHENPMACETPMACETEnzyme Immunoassay
TitleDescriptorRangesUnits
Acetaminophen ScreenNegative< 2.5ug/mL
Acetaminophen by GC/MSug/mL
ACETAMINOPHEN, URINEACETAMACETAMGas Chromatography Mass Spectrometry
TitleDescriptorRangesUnits
Acetaminophen, UrineNot Detected< 2.5ug/mL
ACETAMINOPHENTYLENTYLEnzyme Immunoassay
TitleDescriptorRangesUnits
AcetaminophenTherapeutic10-25ug/mL
Toxic> 150
ACETONEACETACETGas Chromatography/FID
TitleDescriptorRangesUnits
AcetoneNot Detected< 8mg/dL
ACETYLCHOLINE REC BINDING ABACRBDA.LCAACRBDARadioimmunoassay
TitleDescriptorRangesUnits
Acetylcholine Receptor Binding AntibodyNegative0.00-0.24nmol/L
Borderline0.25-0.40
Positive> 0.40
PLT AGGREGATN, WHOLE BLD RFLXWBPAGGWBPAGGLumi-Aggregation, Whole Blood
TitleDescriptorRangesUnits
ADP AggregationPatient5.1-27.3Ohms
Control5.1-27.3Ohms
ADP SecretionPatient0.2-1.9nM
Control0.2-1.9nM
Collagen Low AggregationPatient14.6-39.8Ohms
Control14.6-39.8Ohms
Collagen Low SecretionPatient0.5-2.2nM
Control0.5-2.2nM
Thrombin SecretionPatient0.8-2.5nM
Control0.8-2.5nM
Ristocetin High AggregationPatient5.1-14.9Ohms
Control5.1-14.9Ohms
Ristocetin Low AggregationPatient0Ohms
Control0Ohms
Type 1 VWD Mixing StudyRistocentinHighOhms
Type 2 VWD Mixing StudyRistocentinLowOhms
Collagen High AggregationPatient18.5-41.0Ohms
Control18.5-41.0Ohms
Collagen High SecretionPatient0.7-2.4nM
Control0.7-2.4nM
Arachidonic Acid AggregationPatient7.0-25.8Ohms
Control7.0-25.8Ohms
Arachidonic Acid SecretionPatient0.4-1.9nM
Control0.4-1.9nM
Platelet CountPatientk/uL
0-3 days250-450
3-9 days200-400
9-30 days250-450
1-6 months300-750
6 months-2 years250-600
2-8 years250-550
8-12 years200-450
12-18 years150-250
18+ years150-400
Reviewed by
Interpretation
Note
ALBUMINALBALBColorimetric (BCP)
TitleDescriptorRangesUnits
Albumin0-4 days2.8-4.4g/dL
4 days-14 years3.8-5.4
14-18 years3.2-4.5
18+ years3.5-5.2
PAIN MANAGEMENT ALCOHOL RFLXPMALCPMALCEnzyme Immunoassay
TitleDescriptorRangesUnits
Alcohol ScreenNegative< 20mg/dL
Alcohol by GC/FIDmg/dL
ALCOHOL SCREEN RFLXALCOHOL,UALC20Enzyme Immunoassay
TitleDescriptorRangesUnits
Alcohol ScreenNegative< 20mg/dL
ALCOHOL, ETHYL SERUM OR PLASMAALCOHOL,EALCGas Chromatography/FID
TitleDescriptorRangesUnits
Alcohol, EthylNot Detected< 8mg/dL
ALDOLASEALDOALDOEnzymatic
TitleDescriptorRangesUnits
Aldolase0-30 days5.7-34.3U/L
1-5 months2.4-12.3
6-35 months3.0-10.1
3-6 years2.1-8.8
7-17 years2.8-9.8
18+ years1.2-7.6
ALPHA 2 ANTIPLASMIN ACTIVITYALP2A.LCAALP2AChromogenic Assay
TitleDescriptorRangesUnits
Alpha 2 Antiplasmin Activity1-4 days55-115%
5-29 days70-130
30-89 days76-124
90-179 days76-140
180-364 days83-139
1-5 years93-117
6 years89-110
7-9 years88-147
10-11 years90-144
12-13 years87-142
14-15 years83-136
16-17 years77-134
18+ years82-133
AFP, TUMOR MARKERAFP-NMAFPTMICMA
TitleDescriptorRangesUnits
Alpha FetoproteinMales and non-pregnant females0.6-6.6ng/mL
ALPHA SUBUNITALPSUB.LCAALPSUBImmunochemiluminometric Assay (ICMA)
TitleDescriptorRangesUnits
Alpha SubunitMales0.1-0.5ng/mL
Premenopausal Females0.1-0.6
Postmenopausal Females0.1-1.5
Pregnancy (1st and 2nd trimesters)35.0-186.0
Hypothyroidism0.2-3.2
This test measures the alpha subunit that is common to LH, FSH, TSH and hCG. These hormones are comprised of identical alpha subunits and unique beta subunits that confer biological specificity.
ALPRAZOLAMALPRAZ.LCAALPRAZQuantitative Liquid Chromatography/Tandem Mass Spectrometry
TitleDescriptorRangesUnits
AlprazolamAnxiety10-40 (Dose 1-4 mg/d)ng/mL
Phobia and Panic50-100 (Dose 6-9 mg/d)
Toxic> 100
S CENTRAL STATES ALLERGENS 18SOCN18SOCN18ImmunoCap FEIA
TitleDescriptorRangesUnits
Alternaria tenuis IgELT 0.35kU/L
Aspergillus fumigatus IgELT 0.35kU/L
Bermuda Grass IgELT 0.35kU/L
Cat dander IgELT 0.35kU/L
Cockroach IgELT 0.35kU/L
Short (Common) Ragweed IgELT 0.35kU/L
D. farinae (mite) IgELT 0.35kU/L
D. pteronyssinus (mite) IgELT 0.35kU/L
Dog dander IgELT 0.35kU/L
Elm Tree IgELT 0.35kU/L
Cladosporium herbarum IgELT 0.35kU/L
Johnson Grass IgELT 0.35kU/L
Meadow (Ktky Blue) Grass IgELT 0.35kU/L
Oak Tree IgELT 0.35kU/L
Pecan (Hickory) Tree IgELT 0.35kU/L
Penicillium chrysogenum IgELT 0.35kU/L
Rough Marsh Elder IgELT 0.35kU/L
Walnut Tree IgELT 0.35kU/L
PEDIATRIC MARCH PROFILEPEDMARPEDMARImmunoCap FEIA
TitleDescriptorRangesUnits
Alternaria tenuis IgE< 0.35kU/L
Cat Dander IgE< 0.35
Cockroach IgE< 0.35
Cod Fish (Whitefish) IgE< 0.35
D. farinae (mite) IgE< 0.35
D. pteronyssinus (mite) IgE< 0.35
Dog dander IgE< 0.35
Egg white IgE< 0.35
Cows Milk IgE< 0.35
Peanut IgE< 0.10
Soybean IgE< 0.35
Wheat IgE< 0.35
Immunoglobulin E TotalkU/L
0-11 months1.4-52.3
1-4 years0.4-351.6
5-10 years0.5-393.0
11-15 years1.9-170.0
16+ years0.0-158.0
Minimum detectable concentration is 2.0 kU/L
ALTERNATE AMPHETAMINES SCREEN RFLXALTAMPALTAMPEnzyme Immunoassay
TitleDescriptorRangesUnits
Alternate Amphetamines ScreenNegative< 500ng/mL
PAIN MANAGEMENT ALT AMP RFLXPMAAMPPMAAMPEnzyme Immunoassay
TitleDescriptorRangesUnits
Alternate Amphetamines ScreenNot Detected< 500ng/mL
MDMA by GC/MSng/mL
MDA by GC/MSng/mL
MDEA by GC/MSng/mL
ALUMINUMALUMINUMALInductively Coupled Plasma/Mass Spectrometry
TitleDescriptorRangesUnits
Aluminum, SerumNormal< 10.0ug/L
Normal for dialysis patients< 40.0
Toxic> 100.0
AMIKACIN, PEAKAMIK.PKAMIKPKEnzyme Immunoassay
TitleDescriptorRangesUnits
Amikacin, Peakug/mL
Peak10.0-30.0
Toxic> 35.0
AMIKACIN, TROUGHAMIK.TRAMIKTREnzyme Immunoassay
TitleDescriptorRangesUnits
AmikacinTrough4.0-8.0ug/mL
ToxicGT 8.0
AMIKACIN, RANDOMAMIKAMIKREnzyme Immunoassay
TitleDescriptorRangesUnits
Amikacinug/mL
Trough4.0-8.0
Toxic> 8.0
Peak10.0-30.0
Toxic> 35.0
AMIODARONE AND METABOLITE AMIO.LCAAMIOQuantitative Liquid Chromatography-Tandem Mass Spectrometry
TitleDescriptorRangesUnits
AmiodaroneTherapeutic1.0-2.5ug/mL
NoramiodaroneTherapeutic1.0-2.5ug/mL
AMITRIPTYLINELCAMILCAMILiquid Chromatography Tandem Mass Spectrometry
TitleDescriptorRangesUnits
AmitriptylineNot Detected< 350ng/mL
NortriptylineNot Detected< 350ng/mL
AMITRIPTYLINE AND METABOLITEAMIAMITRTandem Mass Spectrometry
TitleDescriptorRangesUnits
AmitriptylineNo reference range established for parent drug. See Total for reference range, which takes into account all metabolites.ng/mL
NortriptylineTherapeutic50-150ng/mL
Toxic> 500
Total (Amitriptline + Nortriptline)Therapeutic95-250ng/mL
Toxic> 500
Studies have determined that Norpace will interfere with the measurement of the Amitriptyline metabolite, Nortriptyline. Nortriptyline results and total tricyclic results are not valid for patients on Norpace.
PAIN MANAGEMENT BARB CONFIRMPBARPBARGas Chromatography Mass Spectrometry
TitleDescriptorRangesUnits
Amobarbital Confirmation by GC/MSNot Detected< 50ng/mL
Butalbital Confirmation by GC/MSNot Detected< 80ng/mL
Phenobarbital Confirmation by GC/MSNot Detected< 50ng/mL
Secobarbital Confirmation by GC/MSNot Detected< 80ng/mL
Pentobarbital Confirmation by GC/MSNot Detected< 50ng/mL
BARBITURATES (GCMS)MSBARMSBARGas Chromatography Mass Spectrometry
TitleDescriptorRangesUnits
Amobarbital Confirmation by GC/MSNot Detected< 50ng/mL
Butalbital Confirmation by GC/MSNot Detected< 80ng/mL
Phenobarbital Confirmation by GC/MSNot Detected< 50ng/mL
Secobarbital Confirmation by GC/MSNot Detected< 80ng/mL
Pentobarbital Confirmation by GC/MSNot Detected< 50ng/mL
EXTENDED AMPHETAMINE CONFMSAPXMSAPXGas Chromatography Mass Spectrometry
TitleDescriptorRangesUnits
Amphetamine Confirmation by GC/MSNot Detected< 40ng/mL
Methamphetamine Confirmation by GC/MSNot Detected< 40ng/mL
Methylenedioxymethamphetamine (MDMA) Confirmation by GC/MSNot Detected< 40ng/mL
Methylenedioxyethylamphetamine (MDEA) Confirmation by GC/MSNot Detected< 40ng/mL
Methylenedioxyamphetamine (MDA) Confirmation by GC/MSNot Detected< 40ng/mL
PAIN MGMT AMPHETAMINE CONFIRMPAMPPAMPGas Chromatography Mass Spectrometry
TitleDescriptorRangesUnits
Amphetamine Confirmation by GC/MSNot Detected< 40ng/mL
Methamphetamine Confirmation by GC/MSNot Detected< 40ng/mL
PAIN MGMT AMP/METHAMPHETAMINE RFLXPMAMPPMAMPEnzyme Immunoassay
TitleDescriptorRangesUnits
Amphetamine/Methamphetamine ScreenNegative< 500ng/mL
Amphetamines by GC/MSng/mL
Methamphetamine by GC/MSng/mL
D-Methamphetamine%
L-Methamphetamine%
EMPLOYEE DRUG SCREEN (EDS20C) PANEL (THC20) URINE SCREEN RFLXEDS20CEDS20CEnzyme Immunoassay
TitleDescriptorRangesUnits
Amphetamines ScreenNegative< 500ng/mL
Amphetamines Confirmation GCMSNot Detected< 250ng/mL
Methamphetamine Confirmation GCMSNot Detected< 250ng/mL
Alternate Amphetamines ScreenNegative< 500ng/mL
MDMA2 Confirmation GCMSNot Detected< 250ng/mL
MDA2 Confirmation GCMSNot Detected< 250ng/mL
MDEA2 Confirmation GCMSNot Detected< 250ng/mL
Benzoylecgonine (Cocaine) ScreenNegative< 150ng/mL
Benzoylecgonine (Cocaine) Confirmation GCMSNot Detected< 100ng/mL
Opiate ScreenNegative< 2000ng/mL
Codeine Confirmation GCMSNot Detected< 2000ng/mL
Morphine Confirmation GCMSNot Detected< 2000ng/mL
6MAM ScreenNegative< 10ng/mL
6MAM Confirmation GCMSNot Detected< 10ng/mL
Cannabinoid ScreenNegative< 20ng/mL
THC Confirmation GCMSNot Detected< 10ng/mL
PCP ScreenNegative< 25ng/mL
PCP Confirmation GCMSNot Detected< 25ng/mL
Barbiturates ScreenNegative< 200ng/mL
Amobarbital Confirmation GCMSNot Detected< 200ng/mL
Butalbital Confirmation GCMSNot Detected< 200ng/mL
Pentobarbital Confirmation GCMSNot Detected< 200ng/mL
Phenobarbital Confirmation GCMSNot Detected< 200ng/mL
Secobarbital Confirmation GCMSNot Detected< 200ng/mL
Benzodiazepines ScreenNegative< 200ng/mL
Clonazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoclonazepam Confirmation LCMSMSNot Detected< 10ng/mL
Flunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoflunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
Diazepam Confirmation LCMSMSNot Detected< 10ng/mL
Temazepam Confirmation LCMSMSNot Detected< 25ng/mL
Nordiazepam Confirmation LCMSMSNot Detected< 25ng/mL
Oxazepam Confirmation LCMSMSNot Detected< 25ng/mL
Lorazepam Confirmation LCMSMSNot Detected< 25ng/mL
Alprazolam Confirmation LCMSMSNot Detected< 10ng/mL
Alpha-Hydroxyalprazolam Confirmation LCMSMSNot Detected< 25ng/mL
Flurazepam Confirmation LCMSMSNot Detected< 10ng/mL
Midazolam Confirmation LCMSMSNot Detected< 25ng/mL
Alpha-Hydroxytriazolam Confirmation LCMSMSNot Detected< 25ng/mL
Methadone Metabolite ScreenNegative< 300ng/mL
Methadone Metabolite Confirmation GCMSNot Detected< 100ng/mL
Methaqualone ScreenNegative< 300ng/mL
Methaqualone Confirmation GCMSNot Detected< 150ng/mL
Propoxyphene ScreenNegative< 300ng/mL
Norpropoxyphene Confirmation GCMSNot Detected< 150ng/mL
Specimen ValidityUrine Creatinine
Urine pH
Urine Specific Gravity
DRUG FREE WORKPLACE (DFW20E) PANEL (THC20) URINE SCREEN RFLXDFW20EDFW20EEnzyme Immunoassay
TitleDescriptorRangesUnits
Amphetamines ScreenNegative< 500ng/mL
Amphetamines Confirmation GCMSNot Detected< 250ng/mL
Methamphetamine Confirmation GCMSNot Detected< 250ng/mL
Alternate Amphetamines ScreenNegative< 500ng/mL
MDMA2 Confirmation GCMSNot Detected< 250ng/mL
MDA2 Confirmation GCMSNot Detected< 250ng/mL
MDEA2 Confirmation GCMSNot Detected< 250ng/mL
Benzoylecgonine (Cocaine) ScreenNegative< 150ng/mL
Benzoylecgonine (Cocaine) Confirmation GCMSNot Detected< 100ng/mL
Opiate ScreenNegative< 2000ng/mL
Codeine Confirmation GCMSNot Detected< 2000ng/mL
Morphine Confirmation GCMSNot Detected< 2000ng/mL
6MAM ScreenNegative< 10ng/mL
6MAM Confirmation GCMSNot Detected< 10ng/mL
Cannabinoid ScreenNegative< 20ng/mL
THC Confirmation GCMSNot Detected< 10ng/mL
PCP ScreenNegative< 25ng/mL
PCP Confirmation GCMSNot Detected< 25ng/mL
ETOH (Ethyl Alcohol) ScreenNegative< 20ng/mL
ETOH (Ethyl Alcohol) Confirmation GCFIDNot Detected< 20ng/mL
Specimen ValidityUrine Creatinine
Urine pH
Urine Specific Gravity
DRUG FREE WORKPLACE (DFW20N) PANEL (THC20) URINE SCREEN RFLXDFW20NDFW20NEnzyme Immunoassay
TitleDescriptorRangesUnits
Amphetamines ScreenNegative< 500ng/mL
Amphetamines Confirmation GCMSNot Detected< 250ng/mL
Methamphetamine Confirmation GCMSNot Detected< 250ng/mL
Alternate Amphetamines ScreenNegative< 500ng/mL
MDMA2 Confirmation GCMSNot Detected< 250ng/mL
MDA2 Confirmation GCMSNot Detected< 250ng/mL
MDEA2 Confirmation GCMSNot Detected< 250ng/mL
Benzoylecgonine (Cocaine) ScreenNegative< 150ng/mL
Benzoylecgonine (Cocaine) Confirmation GCMSNot Detected< 100ng/mL
Opiate ScreenNegative< 2000ng/mL
Codeine Confirmation GCMSNot Detected< 2000ng/mL
Morphine Confirmation GCMSNot Detected< 2000ng/mL
6MAM ScreenNegative< 10ng/mL
6MAM Confirmation GCMSNot Detected< 10ng/mL
Cannabinoid ScreenNegative< 20ng/mL
THC Confirmation GCMSNot Detected< 10ng/mL
PCP ScreenNegative< 25ng/mL
PCP Confirmation GCMSNot Detected< 25ng/mL
Specimen ValidityUrine Creatinine
Urine pH
Urine Specific Gravity
DRUG FREE WORKPLACE (DFW20C) PANEL (THC20) URINE SCREEN RFLXDFW20CDFW20CEnzyme Immunoassay
TitleDescriptorRangesUnits
Amphetamines ScreenNegative< 500ng/mL
Amphetamines Confirmation GCMSNot Detected< 250ng/mL
Methamphetamine Confirmation GCMSNot Detected< 250ng/mL
Alternate Amphetamines ScreenNegative< 500ng/mL
MDMA2 Confirmation GCMSNot Detected< 250ng/mL
MDA2 Confirmation GCMSNot Detected< 250ng/mL
MDEA2 Confirmation GCMSNot Detected< 250ng/mL
Benzoylecgonine (Cocaine) ScreenNegative< 150ng/mL
Benzoylecgonine (Cocaine) Confirmation GCMSNot Detected< 100ng/mL
Opiate ScreenNegative< 2000ng/mL
Codeine Confirmation GCMSNot Detected< 2000ng/mL
Morphine Confirmation GCMSNot Detected< 2000ng/mL
6MAM ScreenNegative< 10ng/mL
6MAM Confirmation GCMSNot Detected< 10ng/mL
Cannabinoid ScreenNegative< 20ng/mL
THC Confirmation GCMSNot Detected< 10ng/mL
PCP ScreenNegative< 25ng/mL
PCP Confirmation GCMSNot Detected< 25ng/mL
Specimen ValidityUrine Creatinine
Urine pH
Urine Specific Gravity
SUBSTANCE ABUSE PANEL (SAP750C) (THC50) URINE SCREEN RFLXSAP750CSAP750CEnzyme Immunoassay
TitleDescriptorRangesUnits
Amphetamines ScreenNegative< 500ng/mL
Amphetamines Confirmation GCMSNot Detected< 250ng/mL
Methamphetamine Confirmation GCMSNot Detected< 250ng/mL
Alternate Amphetamines ScreenNegative< 500ng/mL
MDMA2 Confirmation GCMSNot Detected< 250ng/mL
MDA2 Confirmation GCMSNot Detected< 250ng/mL
MDEA2 Confirmation GCMSNot Detected< 250ng/mL
Benzoylecgonine (Cocaine) ScreenNegative< 150ng/mL
Benzoylecgonine (Cocaine) Confirmation GCMSNot Detected< 100ng/mL
Opiate ScreenNegative< 2000ng/mL
Codeine Confirmation GCMSNot Detected< 2000ng/mL
Morphine Confirmation GCMSNot Detected< 2000ng/mL
6MAM ScreenNegative< 10ng/mL
6MAM Confirmation GCMSNot Detected< 10ng/mL
Cannabinoid ScreenNegative< 50ng/mL
THC Confirmation GCMSNot Detected< 15ng/mL
PCP ScreenNegative< 25ng/mL
PCP Confirmation GCMSNot Detected< 25ng/mL
Barbiturates ScreenNegative< 200ng/mL
Amobarbital Confirmation GCMSNot Detected< 200ng/mL
Butalbital Confirmation GCMSNot Detected< 200ng/mL
Pentobarbital Confirmation GCMSNot Detected< 200ng/mL
Phenobarbital Confirmation GCMSNot Detected< 200ng/mL
Secobarbital Confirmation GCMSNot Detected< 200ng/mL
Benzodiazepines ScreenNegative< 200ng/mL
Clonazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoclonazepam Confirmation LCMSMSNot Detected< 10ng/mL
Flunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoflunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
Diazepam Confirmation LCMSMSNot Detected< 10ng/mL
Temazepam Confirmation LCMSMSNot Detected< 25ng/mL
Nordiazepam Confirmation LCMSMSNot Detected< 25ng/mL
Oxazepam Confirmation LCMSMSNot Detected< 25ng/mL
Lorazepam Confirmation LCMSMSNot Detected< 25ng/mL
Alprazolam Confirmation LCMSMSNot Detected< 10ng/mL
Alpha-Hydroxyalprazolam Confirmation LCMSMSNot Detected< 25ng/mL
Flurazepam Confirmation LCMSMSNot Detected< 10ng/mL
Midazolam Confirmation LCMSMSNot Detected< 25ng/mL
Alpha-Hydroxytriazolam Confirmation LCMSMSNot Detected< 25ng/mL
Specimen ValidityUrine Creatinine
Urine pH
Urine Specific Gravity
SUBSTANCE ABUSE PANEL (SAP950C) (THC50) URINE SCREEN RFLXSAP950CSAP950CEnzyme Immunoassay
TitleDescriptorRangesUnits
Amphetamines ScreenNegative< 500ng/mL
Amphetamines Confirmation GCMSNot Detected< 250ng/mL
Methamphetamine Confirmation GCMSNot Detected< 250ng/mL
Alternate Amphetamines ScreenNegative< 500ng/mL
MDMA2 Confirmation GCMSNot Detected< 250ng/mL
MDA2 Confirmation GCMSNot Detected< 250ng/mL
MDEA2 Confirmation GCMSNot Detected< 250ng/mL
Benzoylecgonine (Cocaine) ScreenNegative< 150ng/mL
Benzoylecgonine (Cocaine) Confirmation GCMSNot Detected< 100ng/mL
Opiate ScreenNegative< 2000ng/mL
Codeine Confirmation GCMSNot Detected< 2000ng/mL
Morphine Confirmation GCMSNot Detected< 2000ng/mL
6MAM ScreenNegative< 10ng/mL
6MAM Confirmation GCMSNot Detected< 10ng/mL
Cannabinoid ScreenNegative< 50ng/mL
THC Confirmation GCMSNot Detected< 15ng/mL
PCP ScreenNegative< 25ng/mL
PCP Confirmation GCMSNot Detected< 25ng/mL
Barbiturates ScreenNegative< 200ng/mL
Amobarbital Confirmation GCMSNot Detected< 200ng/mL
Butalbital Confirmation GCMSNot Detected< 200ng/mL
Pentobarbital Confirmation GCMSNot Detected< 200ng/mL
Phenobarbital Confirmation GCMSNot Detected< 200ng/mL
Secobarbital Confirmation GCMSNot Detected< 200ng/mL
Benzodiazepines ScreenNegative< 200ng/mL
Clonazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoclonazepam Confirmation LCMSMSNot Detected< 10ng/mL
Flunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoflunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
Diazepam Confirmation LCMSMSNot Detected< 10ng/mL
Temazepam Confirmation LCMSMSNot Detected< 25ng/mL
Nordiazepam Confirmation LCMSMSNot Detected< 25ng/mL
Oxazepam Confirmation LCMSMSNot Detected< 25ng/mL
Lorazepam Confirmation LCMSMSNot Detected< 25ng/mL
Alprazolam Confirmation LCMSMSNot Detected< 10ng/mL
Alpha-Hydroxyalprazolam Confirmation LCMSMSNot Detected< 25ng/mL
Flurazepam Confirmation LCMSMSNot Detected< 10ng/mL
Midazolam Confirmation LCMSMSNot Detected< 25ng/mL
Alpha-Hydroxytriazolam Confirmation LCMSMSNot Detected< 25ng/mL
Methadone Metabolite ScreenNegative< 300ng/mL
Methadone Metabolite Confirmation GCMSNot Detected< 100ng/mL
Propoxyphene ScreenNegative< 300ng/mL
Norpropoxyphene Confirmation GCMSNot Detected< 150ng/mL
Specimen ValidityUrine Creatinine
Urine pH
Urine Specific Gravity
EMPLOYEE DRUG SCREEN (EDS50C) PANEL (THC50) URINE SCREEN RFLXEDS50CEDS50CEnzyme Immunoassay
TitleDescriptorRangesUnits
Amphetamines ScreenNegative< 500ng/mL
Amphetamines Confirmation GCMSNot Detected< 250ng/mL
Methamphetamine Confirmation GCMSNot Detected< 250ng/mL
Alternate Amphetamines ScreenNegative< 500ng/mL
MDMA2 Confirmation GCMSNot Detected< 250ng/mL
MDA2 Confirmation GCMSNot Detected< 250ng/mL
MDEA2 Confirmation GCMSNot Detected< 250ng/mL
Benzoylecgonine (Cocaine) ScreenNegative< 150ng/mL
Benzoylecgonine (Cocaine) Confirmation GCMSNot Detected< 100ng/mL
Opiate ScreenNegative< 2000ng/mL
Codeine Confirmation GCMSNot Detected< 2000ng/mL
Morphine Confirmation GCMSNot Detected< 2000ng/mL
6MAM ScreenNegative< 10ng/mL
6MAM Confirmation GCMSNot Detected< 10ng/mL
Cannabinoid ScreenNegative< 50ng/mL
THC Confirmation GCMSNot Detected< 15ng/mL
PCP ScreenNegative< 25ng/mL
PCP Confirmation GCMSNot Detected< 25ng/mL
Barbiturates ScreenNegative< 200ng/mL
Amobarbital Confirmation GCMSNot Detected< 200ng/mL
Butalbital Confirmation GCMSNot Detected< 200ng/mL
Pentobarbital Confirmation GCMSNot Detected< 200ng/mL
Phenobarbital Confirmation GCMSNot Detected< 200ng/mL
Secobarbital Confirmation GCMSNot Detected< 200ng/mL
Benzodiazepines ScreenNegative< 200ng/mL
Clonazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoclonazepam Confirmation LCMSMSNot Detected< 10ng/mL
Flunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoflunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
Diazepam Confirmation LCMSMSNot Detected< 10ng/mL
Temazepam Confirmation LCMSMSNot Detected< 25ng/mL
Nordiazepam Confirmation LCMSMSNot Detected< 25ng/mL
Oxazepam Confirmation LCMSMSNot Detected< 25ng/mL
Lorazepam Confirmation LCMSMSNot Detected< 25ng/mL
Alprazolam Confirmation LCMSMSNot Detected< 10ng/mL
Alpha-Hydroxyalprazolam Confirmation LCMSMSNot Detected< 25ng/mL
Flurazepam Confirmation LCMSMSNot Detected< 10ng/mL
Midazolam Confirmation LCMSMSNot Detected< 25ng/mL
Alpha-Hydroxytriazolam Confirmation LCMSMSNot Detected< 25ng/mL
Methadone Metabolite ScreenNegative< 300ng/mL
Methadone Metabolite Confirmation GCMSNot Detected< 100ng/mL
Methaqualone ScreenNegative< 300ng/mL
Methaqualone Confirmation GCMSNot Detected< 150ng/mL
Propoxyphene ScreenNegative< 300ng/mL
Norpropoxyphene Confirmation GCMSNot Detected< 150ng/mL
Specimen ValidityUrine Creatinine
Urine pH
Urine Specific Gravity
EMPLOYEE DRUG SCREEN (EDS50E) PANEL (THC50) URINE SCREEN RFLXEDS50EEDS50EEnzyme Immunoassay
TitleDescriptorRangesUnits
Amphetamines ScreenNegative< 500ng/mL
Amphetamines Confirmation GCMSNot Detected< 250ng/mL
Methamphetamine Confirmation GCMSNot Detected< 250ng/mL
Alternate Amphetamines ScreenNegative< 500ng/mL
MDMA2 Confirmation GCMSNot Detected< 250ng/mL
MDA2 Confirmation GCMSNot Detected< 250ng/mL
MDEA2 Confirmation GCMSNot Detected< 250ng/mL
Benzoylecgonine (Cocaine) ScreenNegative< 150ng/mL
Benzoylecgonine (Cocaine) Confirmation GCMSNot Detected< 100ng/mL
Opiate ScreenNegative< 2000ng/mL
Codeine Confirmation GCMSNot Detected< 2000ng/mL
Morphine Confirmation GCMSNot Detected< 2000ng/mL
6MAM ScreenNegative< 10ng/mL
6MAM Confirmation GCMSNot Detected< 10ng/mL
Cannabinoid ScreenNegative< 50ng/mL
THC Confirmation GCMSNot Detected< 15ng/mL
PCP ScreenNegative< 25ng/mL
PCP Confirmation GCMSNot Detected< 25ng/mL
Barbiturates ScreenNegative< 200ng/mL
Amobarbital Confirmation GCMSNot Detected< 200ng/mL
Butalbital Confirmation GCMSNot Detected< 200ng/mL
Pentobarbital Confirmation GCMSNot Detected< 200ng/mL
Phenobarbital Confirmation GCMSNot Detected< 200ng/mL
Secobarbital Confirmation GCMSNot Detected< 200ng/mL
Benzodiazepines ScreenNegative< 200ng/mL
Clonazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoclonazepam Confirmation LCMSMSNot Detected< 10ng/mL
Flunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoflunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
Diazepam Confirmation LCMSMSNot Detected< 10ng/mL
Temazepam Confirmation LCMSMSNot Detected< 25ng/mL
Nordiazepam Confirmation LCMSMSNot Detected< 25ng/mL
Oxazepam Confirmation LCMSMSNot Detected< 25ng/mL
Lorazepam Confirmation LCMSMSNot Detected< 25ng/mL
Alprazolam Confirmation LCMSMSNot Detected< 10ng/mL
Alpha-Hydroxyalprazolam Confirmation LCMSMSNot Detected< 25ng/mL
Flurazepam Confirmation LCMSMSNot Detected< 10ng/mL
Midazolam Confirmation LCMSMSNot Detected< 25ng/mL
Alpha-Hydroxytriazolam Confirmation LCMSMSNot Detected< 25ng/mL
Methadone Metabolite ScreenNegative< 300ng/mL
Methadone Metabolite Confirmation GCMSNot Detected< 100ng/mL
Methaqualone ScreenNegative< 300ng/mL
Methaqualone Confirmation GCMSNot Detected< 150ng/mL
Propoxyphene ScreenNegative< 300ng/mL
Norpropoxyphene Confirmation GCMSNot Detected< 150ng/mL
ETOH (Ethyl Alcohol) ScreenNegative< 20ng/mL
ETOH (Ethyl Alcohol) Confirmation GCFIDNot Detected< 20ng/mL
Specimen ValidityUrine Creatinine
Urine pH
Urine Specific Gravity
DRUG FREE WORKPLACE (DFW50E) PANEL (THC50) URINE SCREEN RFLXDFW50EDFW50E
TitleDescriptorRangesUnits
Amphetamines ScreenNegative< 500ng/mL
Amphetamines Confirmation GCMSNot Detected< 250ng/mL
Methamphetamine Confirmation GCMSNot Detected< 250ng/mL
Alternate Amphetamines ScreenNegative< 500ng/mL
MDMA2 Confirmation GCMSNot Detected< 250ng/mL
MDA2 Confirmation GCMSNot Detected< 250ng/mL
MDEA2 Confirmation GCMSNot Detected< 250ng/mL
Benzoylecgonine (Cocaine) ScreenNegative< 150ng/mL
Benzoylecgonine (Cocaine) Confirmation GCMSNot Detected< 100ng/mL
Opiate ScreenNegative< 2000ng/mL
Codeine Confirmation GCMSNot Detected< 2000ng/mL
Morphine Confirmation GCMSNot Detected< 2000ng/mL
6MAM ScreenNegative< 10ng/mL
6MAM Confirmation GCMSNot Detected< 10ng/mL
Cannabinoid ScreenNegative< 50ng/mL
THC Confirmation GCMSNot Detected< 15ng/mL
PCP ScreenNegative< 25ng/mL
PCP Confirmation GCMSNot Detected< 25ng/mL
ETOH (Ethyl Alcohol) ScreenNegative< 20ng/mL
ETOH (Ethyl Alcohol) Confirmation GCFIDNot Detected< 20ng/mL
Specimen ValidityUrine Creatinine
Urine pH
Urine Specific Gravity
DRUG FREE WORKPLACE (DFW50N) PANEL (THC50) URINE SCREEN RFLXDFW50NDFW50NEnzyme Immunoassay
TitleDescriptorRangesUnits
Amphetamines ScreenNegative< 500ng/mL
Amphetamines Confirmation GCMSNot Detected< 250ng/mL
Methamphetamine Confirmation GCMSNot Detected< 250ng/mL
Alternate Amphetamines ScreenNegative< 500ng/mL
MDMA2 Confirmation GCMSNot Detected< 250ng/mL
MDA2 Confirmation GCMSNot Detected< 250ng/mL
MDEA2 Confirmation GCMSNot Detected< 250ng/mL
Benzoylecgonine (Cocaine) ScreenNegative< 150ng/mL
Benzoylecgonine (Cocaine) Confirmation GCMSNot Detected< 100ng/mL
Opiate ScreenNegative< 2000ng/mL
Codeine Confirmation GCMSNot Detected< 2000ng/mL
Morphine Confirmation GCMSNot Detected< 2000ng/mL
6MAM ScreenNegative< 10ng/mL
6MAM Confirmation GCMSNot Detected< 10ng/mL
Cannabinoid ScreenNegative< 50ng/mL
THC Confirmation GCMSNot Detected< 15ng/mL
PCP ScreenNegative< 25ng/mL
PCP Confirmation GCMSNot Detected< 25ng/mL
Specimen ValidityUrine Creatinine
Urine pH
Urine Specific Gravity
DRUG FREE WORKPLACE (DFW50C) PANEL (THC50) URINE SCREEN RFLXDFW50CDFW50CEnzyme Immunoassay
TitleDescriptorRangesUnits
Amphetamines ScreenNegative< 500ng/mL
Amphetamines Confirmation GCMSNot Detected< 250ng/mL
Methamphetamine Confirmation GCMSNot Detected< 250ng/mL
Alternate Amphetamines ScreenNegative< 500ng/mL
MDMA2 Confirmation GCMSNot Detected< 250ng/mL
MDA2 Confirmation GCMSNot Detected< 250ng/mL
MDEA2 Confirmation GCMSNot Detected< 250ng/mL
Benzoylecgonine (Cocaine) ScreenNegative< 150ng/mL
Benzoylecgonine (Cocaine) Confirmation GCMSNot Detected< 100ng/mL
Opiate ScreenNegative< 2000ng/mL
Codeine Confirmation GCMSNot Detected< 2000ng/mL
Morphine Confirmation GCMSNot Detected< 2000ng/mL
6MAM ScreenNegative< 10ng/mL
6MAM Confirmation GCMSNot Detected< 10ng/mL
Cannabinoid ScreenNegative< 50ng/mL
THC Confirmation GCMSNot Detected< 15ng/mL
PCP ScreenNegative< 25ng/mL
PCP Confirmation GCMSNot Detected< 25ng/mL
Specimen ValidityUrine Creatinine
Urine pH
Urine Specific Gravity
DRUG FREE WORKPLACE (DFWNTN) PANEL URINE SCREEN RFLXDFWNTNDFWNTNEnzyme Immunoassay
TitleDescriptorRangesUnits
Amphetamines ScreenNegative< 500ng/mL
Amphetamines Confirmation GCMSNot Detected< 250ng/mL
Methamphetamine Confirmation GCMSNot Detected< 250ng/mL
Alternate Amphetamines ScreenNegative< 500ng/mL
MDMA2 Confirmation GCMSNot Detected< 250ng/mL
MDA2 Confirmation GCMSNot Detected< 250ng/mL
MDEA2 Confirmation GCMSNot Detected< 250ng/mL
Benzoylecgonine (Cocaine) ScreenNegative< 150ng/mL
Benzoylecgonine (Cocaine) Confirmation GCMSNot Detected< 100ng/mL
Opiate ScreenNegative< 2000ng/mL
Codeine Confirmation GCMSNot Detected< 2000ng/mL
Morphine Confirmation GCMSNot Detected< 2000ng/mL
6MAM ScreenNegative< 10ng/mL
6MAM Confirmation GCMSNot Detected< 10ng/mL
PCP ScreenNegative< 25ng/mL
PCP Confirmation GCMSNot Detected< 25ng/mL
Specimen ValidityUrine Creatinine
Urine pH
Urine Specific Gravity
DRUG FREE WORKPLACE (DFWG) PANEL (THC100) URINE SCREEN RFLXDFWGDFWGEnzyme Immunoassay
TitleDescriptorRangesUnits
Amphetamines ScreenNegative< 500ng/mL
Amphetamines Confirmation GCMSNot Detected< 250ng/mL
Methamphetamine Confirmation GCMSNot Detected< 250ng/mL
Alternate Amphetamines ScreenNegative< 500ng/mL
MDMA2 Confirmation GCMSNot Detected< 250ng/mL
MDA2 Confirmation GCMSNot Detected< 250ng/mL
MDEA2 Confirmation GCMSNot Detected< 250ng/mL
Benzoylecgonine (Cocaine) ScreenNegative< 150ng/mL
Benzoylecgonine (Cocaine) Confirmation GCMSNot Detected< 100ng/mL
Opiate ScreenNegative< 2000ng/mL
Codeine Confirmation GCMSNot Detected< 2000ng/mL
Morphine Confirmation GCMSNot Detected< 2000ng/mL
Alternate Opiate ScreenNegative< 300ng/mL
Hydrocodone Confirmation GCMSNot Detected< 300ng/mL
Hydromorphone Confirmation GCMSNot Detected< 300ng/mL
Oxycodone ScreenNegative< 100ng/mL
Oxycodone Confirmation GCMSNot Detected< 100ng/mL
6MAM ScreenNegative< 10ng/mL
6MAM Confirmation GCMSNot Detected< 10ng/mL
Cannabinoid ScreenNegative< 100ng/mL
THC Confirmation GCMSNot Detected< 15ng/mL
PCP ScreenNegative< 25ng/mL
PCP Confirmation GCMSNot Detected< 25ng/mL
Specimen ValidityUrine Creatinine
Urine pH
Urine Specific Gravity
DRUG FREE WORKPLACE (DFW20G) PANEL (THC20) URINE SCREEN RFLXDFW20GDFW20GEnzyme Immunoassay
TitleDescriptorRangesUnits
Amphetamines ScreenNegative< 500ng/mL
Amphetamines Confirmation GCMSNot Detected< 250ng/mL
Methamphetamine Confirmation GCMSNot Detected< 250ng/mL
Alternate Amphetamines ScreenNegative< 500ng/mL
MDMA2 Confirmation GCMSNot Detected< 250ng/mL
MDA2 Confirmation GCMSNot Detected< 250ng/mL
MDEA2 Confirmation GCMSNot Detected< 250ng/mL
Benzoylecgonine (Cocaine) ScreenNegative< 150ng/mL
Benzoylecgonine (Cocaine) Confirmation GCMSNot Detected< 100ng/mL
Opiate ScreenNegative< 2000ng/mL
Codeine Confirmation GCMSNot Detected< 2000ng/mL
Morphine Confirmation GCMSNot Detected< 2000ng/mL
Alternate Opiate ScreenNegative< 300ng/mL
Hydrocodone Confirmation GCMSNot Detected< 300ng/mL
Hydromorphone Confirmation GCMSNot Detected< 300ng/mL
Oxycodone ScreenNegative< 100ng/mL
Oxycodone Confirmation GCMSNot Detected< 100ng/mL
6MAM ScreenNegative< 10ng/mL
6MAM Confirmation GCMSNot Detected< 10ng/mL
Cannabinoid ScreenNegative< 20ng/mL
THC Confirmation GCMSNot Detected< 10ng/mL
PCP ScreenNegative< 25ng/mL
PCP Confirmation GCMSNot Detected< 25ng/mL
Specimen ValidityUrine Creatinine
Urine pH
Urine Specific Gravity
SUBSTANCE ABUSE PANEL (SAP720G) (THC20) URINE SCREEN RFLXSAP720GSAP720GEnzyme Immunoassay
TitleDescriptorRangesUnits
Amphetamines ScreenNegative< 500ng/mL
Amphetamines Confirmation GCMSNot Detected< 250ng/mL
Methamphetamine Confirmation GCMSNot Detected< 250ng/mL
Alternate Amphetamines ScreenNegative< 500ng/mL
MDMA2 Confirmation GCMSNot Detected< 250ng/mL
MDA2 Confirmation GCMSNot Detected< 250ng/mL
MDEA2 Confirmation GCMSNot Detected< 250ng/mL
Benzoylecgonine (Cocaine) ScreenNegative< 150ng/mL
Benzoylecgonine (Cocaine) Confirmation GCMSNot Detected< 100ng/mL
Opiate ScreenNegative< 2000ng/mL
Codeine Confirmation GCMSNot Detected< 2000ng/mL
Morphine Confirmation GCMSNot Detected< 2000ng/mL
Alternate Opiate ScreenNegative< 300ng/mL
Hydrocodone Confirmation GCMSNot Detected< 300ng/mL
Hydromorphone Confirmation GCMSNot Detected< 300ng/mL
Oxycodone ScreenNegative< 100ng/mL
Oxycodone Confirmation GCMSNot Detected< 100ng/mL
6MAM ScreenNegative< 10ng/mL
6MAM Confirmation GCMSNot Detected< 10ng/mL
Cannabinoid ScreenNegative< 20ng/mL
THC Confirmation GCMSNot Detected< 10ng/mL
PCP ScreenNegative< 25ng/mL
PCP Confirmation GCMSNot Detected< 25ng/mL
Barbiturates ScreenNegative< 200ng/mL
Amobarbital Confirmation GCMSNot Detected< 200ng/mL
Butalbital Confirmation GCMSNot Detected< 200ng/mL
Pentobarbital Confirmation GCMSNot Detected< 200ng/mL
Phenobarbital Confirmation GCMSNot Detected< 200ng/mL
Secobarbital Confirmation GCMSNot Detected< 200ng/mL
Benzodiazepines ScreenNegative< 200ng/mL
Clonazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoclonazepam Confirmation LCMSMSNot Detected< 10ng/mL
Flunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoflunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
Diazepam Confirmation LCMSMSNot Detected< 10ng/mL
Temazepam Confirmation LCMSMSNot Detected< 25ng/mL
Nordiazepam Confirmation LCMSMSNot Detected< 25ng/mL
Oxazepam Confirmation LCMSMSNot Detected< 25ng/mL
Lorazepam Confirmation LCMSMSNot Detected< 25ng/mL
Alprazolam Confirmation LCMSMSNot Detected< 10ng/mL
Alpha-Hydroxyalprazolam Confirmation LCMSMSNot Detected< 25ng/mL
Flurazepam Confirmation LCMSMSNot Detected< 10ng/mL
Midazolam Confirmation LCMSMSNot Detected< 25ng/mL
Alpha-Hydroxytriazolam Confirmation LCMSMSNot Detected< 25ng/mL
Specimen ValidityUrine Creatinine
Urine pH
Urine Specific Gravity
DRUG FREE WORKPLACE (DFW20F) PANEL (THC20) URINE SCREEN RFLXDFW20FDFW20FEnzyme Immunoassay
TitleDescriptorRangesUnits
Amphetamines ScreenNegative< 500ng/mL
Amphetamines Confirmation GCMSNot Detected< 250ng/mL
Methamphetamine Confirmation GCMSNot Detected< 250ng/mL
Alternate Amphetamines ScreenNegative< 500ng/mL
MDMA2 Confirmation GCMSNot Detected< 250ng/mL
MDA2 Confirmation GCMSNot Detected< 250ng/mL
MDEA2 Confirmation GCMSNot Detected< 250ng/mL
Benzoylecgonine (Cocaine) ScreenNegative< 150ng/mL
Benzoylecgonine (Cocaine) Confirmation GCMSNot Detected< 100ng/mL
Opiate ScreenNegative< 2000ng/mL
Codeine Confirmation GCMSNot Detected< 2000ng/mL
Morphine Confirmation GCMSNot Detected< 2000ng/mL
Alternate Opiate ScreenNegative< 300ng/mL
Hydrocodone Confirmation GCMSNot Detected< 300ng/mL
Hydromorphone Confirmation GCMSNot Detected< 300ng/mL
Oxycodone ScreenNegative< 100ng/mL
Oxycodone Confirmation GCMSNot Detected< 100ng/mL
6MAM ScreenNegative< 10ng/mL
6MAM Confirmation GCMSNot Detected< 10ng/mL
Cannabinoid ScreenNegative< 20ng/mL
THC Confirmation GCMSNot Detected< 10ng/mL
PCP ScreenNegative< 25ng/mL
PCP Confirmation GCMSNot Detected< 25ng/mL
ETOH (Ethyl Alcohol) ScreenNegative< 20ng/mL
ETOH (Ethyl Alcohol) Confirmation GCFIDNot Detected< 20ng/mL
Specimen ValidityUrine Creatinine
Urine pH
Urine Specific Gravity
SUBSTANCE ABUSE PANEL (SAP720F) (THC20) URINE SCREEN RFLXSAP720FSAP720FEnzyme Immunoassay
TitleDescriptorRangesUnits
Amphetamines ScreenNegative< 500ng/mL
Amphetamines Confirmation GCMSNot Detected< 250ng/mL
Methamphetamine Confirmation GCMSNot Detected< 250ng/mL
Alternate Amphetamines ScreenNegative< 500ng/mL
MDMA2 Confirmation GCMSNot Detected< 250ng/mL
MDA2 Confirmation GCMSNot Detected< 250ng/mL
MDEA2 Confirmation GCMSNot Detected< 250ng/mL
Benzoylecgonine (Cocaine) ScreenNegative< 150ng/mL
Benzoylecgonine (Cocaine) Confirmation GCMSNot Detected< 100ng/mL
Opiate ScreenNegative< 2000ng/mL
Codeine Confirmation GCMSNot Detected< 2000ng/mL
Morphine Confirmation GCMSNot Detected< 2000ng/mL
Alternate Opiate ScreenNegative< 300ng/mL
Hydrocodone Confirmation GCMSNot Detected< 300ng/mL
Hydromorphone Confirmation GCMSNot Detected< 300ng/mL
Oxycodone ScreenNegative< 100ng/mL
Oxycodone Confirmation GCMSNot Detected< 100ng/mL
6MAM ScreenNegative< 10ng/mL
6MAM Confirmation GCMSNot Detected< 10ng/mL
Cannabinoid ScreenNegative< 20ng/mL
THC Confirmation GCMSNot Detected< 10ng/mL
PCP ScreenNegative< 25ng/mL
PCP Confirmation GCMSNot Detected< 25ng/mL
Barbiturates ScreenNegative< 200ng/mL
Amobarbital Confirmation GCMSNot Detected< 200ng/mL
Butalbital Confirmation GCMSNot Detected< 200ng/mL
Pentobarbital Confirmation GCMSNot Detected< 200ng/mL
Phenobarbital Confirmation GCMSNot Detected< 200ng/mL
Secobarbital Confirmation GCMSNot Detected< 200ng/mL
Benzodiazepines ScreenNegative< 200ng/mL
Clonazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoclonazepam Confirmation LCMSMSNot Detected< 10ng/mL
Flunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoflunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
Diazepam Confirmation LCMSMSNot Detected< 10ng/mL
Temazepam Confirmation LCMSMSNot Detected< 25ng/mL
Nordiazepam Confirmation LCMSMSNot Detected< 25ng/mL
Oxazepam Confirmation LCMSMSNot Detected< 25ng/mL
Lorazepam Confirmation LCMSMSNot Detected< 25ng/mL
Alprazolam Confirmation LCMSMSNot Detected< 10ng/mL
Alpha-Hydroxyalprazolam Confirmation LCMSMSNot Detected< 25ng/mL
Flurazepam Confirmation LCMSMSNot Detected< 10ng/mL
Midazolam Confirmation LCMSMSNot Detected< 25ng/mL
Alpha-Hydroxytriazolam Confirmation LCMSMSNot Detected< 25ng/mL
ETOH (Ethyl Alcohol) ScreenNegative< 20ng/mL
ETOH (Ethyl Alcohol) Confirmation GCFIDNot Detected< 20ng/mL
Specimen ValidityUrine Creatinine
Urine pH
Urine Specific Gravity
EMPLOYEE DRUG SCREEN (EDS20F) PANEL (THC20) URINE SCREEN RFLXEDS20FEDS20FEnzyme Immunoassay
TitleDescriptorRangesUnits
Amphetamines ScreenNegative< 500ng/mL
Amphetamines Confirmation GCMSNot Detected< 250ng/mL
Methamphetamine Confirmation GCMSNot Detected< 250ng/mL
Alternate Amphetamines ScreenNegative< 500ng/mL
MDMA2 Confirmation GCMSNot Detected< 250ng/mL
MDA2 Confirmation GCMSNot Detected< 250ng/mL
MDEA2 Confirmation GCMSNot Detected< 250ng/mL
Benzoylecgonine (Cocaine) ScreenNegative< 150ng/mL
Benzoylecgonine (Cocaine) Confirmation GCMSNot Detected< 100ng/mL
Opiate ScreenNegative< 2000ng/mL
Codeine Confirmation GCMSNot Detected< 2000ng/mL
Morphine Confirmation GCMSNot Detected< 2000ng/mL
Alternate Opiate ScreenNegative< 300ng/mL
Hydrocodone Confirmation GCMSNot Detected< 300ng/mL
Hydromorphone Confirmation GCMSNot Detected< 300ng/mL
Oxycodone ScreenNegative< 100ng/mL
Oxycodone Confirmation GCMSNot Detected< 100ng/mL
6MAM ScreenNegative< 10ng/mL
6MAM Confirmation GCMSNot Detected< 10ng/mL
Cannabinoid ScreenNegative< 20ng/mL
THC Confirmation GCMSNot Detected< 10ng/mL
PCP ScreenNegative< 25ng/mL
PCP Confirmation GCMSNot Detected< 25ng/mL
Barbiturates ScreenNegative< 200ng/mL
Amobarbital Confirmation GCMSNot Detected< 200ng/mL
Butalbital Confirmation GCMSNot Detected< 200ng/mL
Pentobarbital Confirmation GCMSNot Detected< 200ng/mL
Phenobarbital Confirmation GCMSNot Detected< 200ng/mL
Secobarbital Confirmation GCMSNot Detected< 200ng/mL
Benzodiazepines ScreenNegative< 200ng/mL
Clonazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoclonazepam Confirmation LCMSMSNot Detected< 10ng/mL
Flunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoflunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
Diazepam Confirmation LCMSMSNot Detected< 10ng/mL
Temazepam Confirmation LCMSMSNot Detected< 25ng/mL
Nordiazepam Confirmation LCMSMSNot Detected< 25ng/mL
Oxazepam Confirmation LCMSMSNot Detected< 25ng/mL
Lorazepam Confirmation LCMSMSNot Detected< 25ng/mL
Alprazolam Confirmation LCMSMSNot Detected< 10ng/mL
Alpha-Hydroxyalprazolam Confirmation LCMSMSNot Detected< 25ng/mL
Flurazepam Confirmation LCMSMSNot Detected< 10ng/mL
Midazolam Confirmation LCMSMSNot Detected< 25ng/mL
Alpha-Hydroxytriazolam Confirmation LCMSMSNot Detected< 25ng/mL
Methadone Metabolite ScreenNegative< 300ng/mL
Methadone Metabolite Confirmation GCMSNot Detected< 100ng/mL
Methaqualone ScreenNegative< 300ng/mL
Methaqualone Confirmation GCMSNot Detected< 150ng/mL
Propoxyphene ScreenNegative< 300ng/mL
Norpropoxyphene Confirmation GCMSNot Detected< 150ng/mL
ETOH (Ethyl Alcohol) ScreenNegative< 20ng/mL
ETOH (Ethyl Alcohol) Confirmation GCFIDNot Detected< 20ng/mL
Specimen ValidityUrine Creatinine
Urine pH
Urine Specific Gravity
EMPLOYEE DRUG SCREEN (EDS20G) PANEL (THC20) URINE SCREEN RFLXEDS20GEDS20GEnzyme Immunoassay
TitleDescriptorRangesUnits
Amphetamines ScreenNegative< 500ng/mL
Amphetamines Confirmation GCMSNot Detected< 250ng/mL
Methamphetamine Confirmation GCMSNot Detected< 250ng/mL
Alternate Amphetamines ScreenNegative< 500ng/mL
MDMA2 Confirmation GCMSNot Detected< 250ng/mL
MDA2 Confirmation GCMSNot Detected< 250ng/mL
MDEA2 Confirmation GCMSNot Detected< 250ng/mL
Benzoylecgonine (Cocaine) ScreenNegative< 150ng/mL
Benzoylecgonine (Cocaine) Confirmation GCMSNot Detected< 100ng/mL
Opiate ScreenNegative< 2000ng/mL
Codeine Confirmation GCMSNot Detected< 2000ng/mL
Morphine Confirmation GCMSNot Detected< 2000ng/mL
Alternate Opiate ScreenNegative< 300ng/mL
Hydrocodone Confirmation GCMSNot Detected< 300ng/mL
Hydromorphone Confirmation GCMSNot Detected< 300ng/mL
Oxycodone ScreenNegative< 100ng/mL
Oxycodone Confirmation GCMSNot Detected< 100ng/mL
6MAM ScreenNegative< 10ng/mL
6MAM Confirmation GCMSNot Detected< 10ng/mL
Cannabinoid ScreenNegative< 20ng/mL
THC Confirmation GCMSNot Detected< 10ng/mL
PCP ScreenNegative< 25ng/mL
PCP Confirmation GCMSNot Detected< 25ng/mL
Barbiturates ScreenNegative< 200ng/mL
Amobarbital Confirmation GCMSNot Detected< 200ng/mL
Butalbital Confirmation GCMSNot Detected< 200ng/mL
Pentobarbital Confirmation GCMSNot Detected< 200ng/mL
Phenobarbital Confirmation GCMSNot Detected< 200ng/mL
Secobarbital Confirmation GCMSNot Detected< 200ng/mL
Benzodiazepines ScreenNegative< 200ng/mL
Clonazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoclonazepam Confirmation LCMSMSNot Detected< 10ng/mL
Flunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoflunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
Diazepam Confirmation LCMSMSNot Detected< 10ng/mL
Temazepam Confirmation LCMSMSNot Detected< 25ng/mL
Nordiazepam Confirmation LCMSMSNot Detected< 25ng/mL
Oxazepam Confirmation LCMSMSNot Detected< 25ng/mL
Lorazepam Confirmation LCMSMSNot Detected< 25ng/mL
Alprazolam Confirmation LCMSMSNot Detected< 10ng/mL
Alpha-Hydroxyalprazolam Confirmation LCMSMSNot Detected< 25ng/mL
Flurazepam Confirmation LCMSMSNot Detected< 10ng/mL
Midazolam Confirmation LCMSMSNot Detected< 25ng/mL
Alpha-Hydroxytriazolam Confirmation LCMSMSNot Detected< 25ng/mL
Methadone Metabolite ScreenNegative< 300ng/mL
Methadone Metabolite Confirmation GCMSNot Detected< 100ng/mL
Methaqualone ScreenNegative< 300ng/mL
Methaqualone Confirmation GCMSNot Detected< 150ng/mL
Propoxyphene ScreenNegative< 300ng/mL
Norpropoxyphene Confirmation GCMSNot Detected< 150ng/mL
Specimen ValidityUrine Creatinine
Urine pH
Urine Specific Gravity
DRUG FREE WORKPLACE (DFW50G) PANEL (THC100) URINE SCREEN RFLXDFW50GDFW50GEnzyme Immunoassay
TitleDescriptorRangesUnits
Amphetamines ScreenNegative< 500ng/mL
Amphetamines Confirmation GCMSNot Detected< 250ng/mL
Methamphetamine Confirmation GCMSNot Detected< 250ng/mL
Alternate Amphetamines ScreenNegative< 500ng/mL
MDMA2 Confirmation GCMSNot Detected< 250ng/mL
MDA2 Confirmation GCMSNot Detected< 250ng/mL
MDEA2 Confirmation GCMSNot Detected< 250ng/mL
Benzoylecgonine (Cocaine) ScreenNegative< 150ng/mL
Benzoylecgonine (Cocaine) Confirmation GCMSNot Detected< 100ng/mL
Opiate ScreenNegative< 2000ng/mL
Codeine Confirmation GCMSNot Detected< 2000ng/mL
Morphine Confirmation GCMSNot Detected< 2000ng/mL
Alternate Opiate ScreenNegative< 300ng/mL
Hydrocodone Confirmation GCMSNot Detected< 300ng/mL
Hydromorphone Confirmation GCMSNot Detected< 300ng/mL
Oxycodone ScreenNegative< 100ng/mL
Oxycodone Confirmation GCMSNot Detected< 100ng/mL
6MAM ScreenNegative< 10ng/mL
6MAM Confirmation GCMSNot Detected< 10ng/mL
Cannabinoid ScreenNegative< 50ng/mL
THC Confirmation GCMSNot Detected< 15ng/mL
PCP ScreenNegative< 25ng/mL
PCP Confirmation GCMSNot Detected< 25ng/mL
Specimen ValidityUrine Creatinine
Urine pH
Urine Specific Gravity
SUBSTANCE ABUSE PANEL (SAP750F) (THC50) URINE SCREEN RFLXSAP750FSAP750FEnzyme Immunoassay
TitleDescriptorRangesUnits
Amphetamines ScreenNegative< 500ng/mL
Amphetamines Confirmation GCMSNot Detected< 250ng/mL
Methamphetamine Confirmation GCMSNot Detected< 250ng/mL
Alternate Amphetamines ScreenNegative< 500ng/mL
MDMA2 Confirmation GCMSNot Detected< 250ng/mL
MDA2 Confirmation GCMSNot Detected< 250ng/mL
MDEA2 Confirmation GCMSNot Detected< 250ng/mL
Benzoylecgonine (Cocaine) ScreenNegative< 150ng/mL
Benzoylecgonine (Cocaine) Confirmation GCMSNot Detected< 100ng/mL
Opiate ScreenNegative< 2000ng/mL
Codeine Confirmation GCMSNot Detected< 2000ng/mL
Morphine Confirmation GCMSNot Detected< 2000ng/mL
Alternate Opiate ScreenNegative< 300ng/mL
Hydrocodone Confirmation GCMSNot Detected< 300ng/mL
Hydromorphone Confirmation GCMSNot Detected< 300ng/mL
Oxycodone ScreenNegative< 100ng/mL
Oxycodone Confirmation GCMSNot Detected< 100ng/mL
6MAM ScreenNegative< 10ng/mL
6MAM Confirmation GCMSNot Detected< 10ng/mL
Cannabinoid ScreenNegative< 50ng/mL
THC Confirmation GCMSNot Detected< 15ng/mL
PCP ScreenNegative< 25ng/mL
PCP Confirmation GCMSNot Detected< 25ng/mL
Barbiturates ScreenNegative< 200ng/mL
Amobarbital Confirmation GCMSNot Detected< 200ng/mL
Butalbital Confirmation GCMSNot Detected< 200ng/mL
Pentobarbital Confirmation GCMSNot Detected< 200ng/mL
Phenobarbital Confirmation GCMSNot Detected< 200ng/mL
Secobarbital Confirmation GCMSNot Detected< 200ng/mL
Benzodiazepines ScreenNegative< 200ng/mL
Clonazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoclonazepam Confirmation LCMSMSNot Detected< 10ng/mL
Flunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoflunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
Diazepam Confirmation LCMSMSNot Detected< 10ng/mL
Temazepam Confirmation LCMSMSNot Detected< 25ng/mL
Nordiazepam Confirmation LCMSMSNot Detected< 25ng/mL
Oxazepam Confirmation LCMSMSNot Detected< 25ng/mL
Lorazepam Confirmation LCMSMSNot Detected< 25ng/mL
Alprazolam Confirmation LCMSMSNot Detected< 10ng/mL
Alpha-Hydroxyalprazolam Confirmation LCMSMSNot Detected< 25ng/mL
Flurazepam Confirmation LCMSMSNot Detected< 10ng/mL
Midazolam Confirmation LCMSMSNot Detected< 25ng/mL
Alpha-Hydroxytriazolam Confirmation LCMSMSNot Detected< 25ng/mL
ETOH (Ethyl Alcohol) ScreenNegative< 20ng/mL
ETOH (Ethyl Alcohol) Confirmation GCFIDNot Detected< 20ng/mL
Specimen ValidityUrine Creatinine
Urine pH
Urine Specific Gravity
SUBSTANCE ABUSE PANEL (SAP950F) (THC50) URINE SCREEN RFLXSAP950FSAP950FEnzyme Immunoassay
TitleDescriptorRangesUnits
Amphetamines ScreenNegative< 500ng/mL
Amphetamines Confirmation GCMSNot Detected< 250ng/mL
Methamphetamine Confirmation GCMSNot Detected< 250ng/mL
Alternate Amphetamines ScreenNegative< 500ng/mL
MDMA2 Confirmation GCMSNot Detected< 250ng/mL
MDA2 Confirmation GCMSNot Detected< 250ng/mL
MDEA2 Confirmation GCMSNot Detected< 250ng/mL
Benzoylecgonine (Cocaine) ScreenNegative< 150ng/mL
Benzoylecgonine (Cocaine) Confirmation GCMSNot Detected< 100ng/mL
Opiate ScreenNegative< 2000ng/mL
Codeine Confirmation GCMSNot Detected< 2000ng/mL
Morphine Confirmation GCMSNot Detected< 2000ng/mL
Alternate Opiate ScreenNegative< 300ng/mL
Hydrocodone Confirmation GCMSNot Detected< 300ng/mL
Hydromorphone Confirmation GCMSNot Detected< 300ng/mL
Oxycodone ScreenNegative< 100ng/mL
Oxycodone Confirmation GCMSNot Detected< 100ng/mL
6MAM ScreenNegative< 10ng/mL
6MAM Confirmation GCMSNot Detected< 10ng/mL
Cannabinoid ScreenNegative< 50ng/mL
THC Confirmation GCMSNot Detected< 15ng/mL
PCP ScreenNegative< 25ng/mL
PCP Confirmation GCMSNot Detected< 25ng/mL
Barbiturates ScreenNegative< 200ng/mL
Amobarbital Confirmation GCMSNot Detected< 200ng/mL
Butalbital Confirmation GCMSNot Detected< 200ng/mL
Pentobarbital Confirmation GCMSNot Detected< 200ng/mL
Phenobarbital Confirmation GCMSNot Detected< 200ng/mL
Secobarbital Confirmation GCMSNot Detected< 200ng/mL
Benzodiazepines ScreenNegative< 200ng/mL
Clonazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoclonazepam Confirmation LCMSMSNot Detected< 10ng/mL
Flunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoflunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
Diazepam Confirmation LCMSMSNot Detected< 10ng/mL
Temazepam Confirmation LCMSMSNot Detected< 25ng/mL
Nordiazepam Confirmation LCMSMSNot Detected< 25ng/mL
Oxazepam Confirmation LCMSMSNot Detected< 25ng/mL
Lorazepam Confirmation LCMSMSNot Detected< 25ng/mL
Alprazolam Confirmation LCMSMSNot Detected< 10ng/mL
Alpha-Hydroxyalprazolam Confirmation LCMSMSNot Detected< 25ng/mL
Flurazepam Confirmation LCMSMSNot Detected< 10ng/mL
Midazolam Confirmation LCMSMSNot Detected< 25ng/mL
Alpha-Hydroxytriazolam Confirmation LCMSMSNot Detected< 25ng/mL
Methadone Metabolite ScreenNegative< 300ng/mL
Methadone Metabolite Confirmation GCMSNot Detected< 100ng/mL
Propoxyphene ScreenNegative< 300ng/mL
Norpropoxyphene Confirmation GCMSNot Detected< 150ng/mL
ETOH (Ethyl Alcohol) ScreenNegative< 20ng/mL
ETOH (Ethyl Alcohol) Confirmation GCFIDNot Detected< 20ng/mL
Specimen ValidityUrine Creatinine
Urine pH
Urine Specific Gravity
DRUG FREE WORKPLACE (DFW50F) PANEL (THC50) URINE SCREEN RFLXDFW50FDFW50FEnzyme Immunoassay
TitleDescriptorRangesUnits
Amphetamines ScreenNegative< 500ng/mL
Amphetamines Confirmation GCMSNot Detected< 250ng/mL
Methamphetamine Confirmation GCMSNot Detected< 250ng/mL
Alternate Amphetamines ScreenNegative< 500ng/mL
MDMA2 Confirmation GCMSNot Detected< 250ng/mL
MDA2 Confirmation GCMSNot Detected< 250ng/mL
MDEA2 Confirmation GCMSNot Detected< 250ng/mL
Benzoylecgonine (Cocaine) ScreenNegative< 150ng/mL
Benzoylecgonine (Cocaine) Confirmation GCMSNot Detected< 100ng/mL
Opiate ScreenNegative< 2000ng/mL
Codeine Confirmation GCMSNot Detected< 2000ng/mL
Morphine Confirmation GCMSNot Detected< 2000ng/mL
Alternate Opiate ScreenNegative< 300ng/mL
Hydrocodone Confirmation GCMSNot Detected< 300ng/mL
Hydromorphone Confirmation GCMSNot Detected< 300ng/mL
Oxycodone ScreenNegative< 100ng/mL
Oxycodone Confirmation GCMSNot Detected< 100ng/mL
6MAM ScreenNegative< 10ng/mL
6MAM Confirmation GCMSNot Detected< 10ng/mL
Cannabinoid ScreenNegative< 50ng/mL
THC Confirmation GCMSNot Detected< 15ng/mL
PCP ScreenNegative< 25ng/mL
PCP Confirmation GCMSNot Detected< 25ng/mL
ETOH (Ethyl Alcohol) ScreenNegative< 20ng/mL
ETOH (Ethyl Alcohol) Confirmation GCFIDNot Detected< 20ng/mL
Specimen ValidityUrine Creatinine
Urine pH
Urine Specific Gravity
SUBSTANCE ABUSE PANEL (SAP750G) (THC50) URINE SCREEN RFLXSAP750GSAP750GEnzyme Immunoassay
TitleDescriptorRangesUnits
Amphetamines ScreenNegative< 500ng/mL
Amphetamines Confirmation GCMSNot Detected< 250ng/mL
Methamphetamine Confirmation GCMSNot Detected< 250ng/mL
Alternate Amphetamines ScreenNegative< 500ng/mL
MDMA2 Confirmation GCMSNot Detected< 250ng/mL
MDA2 Confirmation GCMSNot Detected< 250ng/mL
MDEA2 Confirmation GCMSNot Detected< 250ng/mL
Benzoylecgonine (Cocaine) ScreenNegative< 150ng/mL
Benzoylecgonine (Cocaine) Confirmation GCMSNot Detected< 100ng/mL
Opiate ScreenNegative< 2000ng/mL
Codeine Confirmation GCMSNot Detected< 2000ng/mL
Morphine Confirmation GCMSNot Detected< 2000ng/mL
Alternate Opiate ScreenNegative< 300ng/mL
Hydrocodone Confirmation GCMSNot Detected< 300ng/mL
Hydromorphone Confirmation GCMSNot Detected< 300ng/mL
Oxycodone ScreenNegative< 100ng/mL
Oxycodone Confirmation GCMSNot Detected< 100ng/mL
6MAM ScreenNegative< 10ng/mL
6MAM Confirmation GCMSNot Detected< 10ng/mL
Cannabinoid ScreenNegative< 50ng/mL
THC Confirmation GCMSNot Detected< 15ng/mL
PCP ScreenNegative< 25ng/mL
PCP Confirmation GCMSNot Detected< 25ng/mL
Barbiturates ScreenNegative< 200ng/mL
Amobarbital Confirmation GCMSNot Detected< 200ng/mL
Butalbital Confirmation GCMSNot Detected< 200ng/mL
Pentobarbital Confirmation GCMSNot Detected< 200ng/mL
Phenobarbital Confirmation GCMSNot Detected< 200ng/mL
Secobarbital Confirmation GCMSNot Detected< 200ng/mL
Benzodiazepines ScreenNegative< 200ng/mL
Clonazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoclonazepam Confirmation LCMSMSNot Detected< 10ng/mL
Flunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoflunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
Diazepam Confirmation LCMSMSNot Detected< 10ng/mL
Temazepam Confirmation LCMSMSNot Detected< 25ng/mL
Nordiazepam Confirmation LCMSMSNot Detected< 25ng/mL
Oxazepam Confirmation LCMSMSNot Detected< 25ng/mL
Lorazepam Confirmation LCMSMSNot Detected< 25ng/mL
Alprazolam Confirmation LCMSMSNot Detected< 10ng/mL
Alpha-Hydroxyalprazolam Confirmation LCMSMSNot Detected< 25ng/mL
Flurazepam Confirmation LCMSMSNot Detected< 10ng/mL
Midazolam Confirmation GCLCMSMSMSNot Detected< 25ng/mL
Alpha-Hydroxytriazolam Confirmation LCMSMSNot Detected< 25ng/mL
Specimen ValidityUrine Creatinine
Urine pH
Urine Specific Gravity
SUBSTANCE ABUSE PANEL (SAP950G) (THC50) URINE SCREEN RFLXSAP950GSAP950GEnzyme Immunoassay
TitleDescriptorRangesUnits
Amphetamines ScreenNegative< 500ng/mL
Amphetamines Confirmation GCMSNot Detected< 250ng/mL
Methamphetamine Confirmation GCMSNot Detected< 250ng/mL
Alternate Amphetamines ScreenNegative< 500ng/mL
MDMA2 Confirmation GCMSNot Detected< 250ng/mL
MDA2 Confirmation GCMSNot Detected< 250ng/mL
MDEA2 Confirmation GCMSNot Detected< 250ng/mL
Benzoylecgonine (Cocaine) ScreenNegative< 150ng/mL
Benzoylecgonine (Cocaine) Confirmation GCMSNot Detected< 100ng/mL
Opiate ScreenNegative< 2000ng/mL
Codeine Confirmation GCMSNot Detected< 2000ng/mL
Morphine Confirmation GCMSNot Detected< 2000ng/mL
Alternate Opiate ScreenNegative< 300ng/mL
Hydrocodone Confirmation GCMSNot Detected< 300ng/mL
Hydromorphone Confirmation GCMSNot Detected< 300ng/mL
Oxycodone ScreenNegative< 100ng/mL
Oxycodone Confirmation GCMSNot Detected< 100ng/mL
6MAM ScreenNegative< 10ng/mL
6MAM Confirmation GCMSNot Detected< 10ng/mL
Cannabinoid ScreenNegative< 50ng/mL
THC Confirmation GCMSNot Detected< 15ng/mL
PCP ScreenNegative< 25ng/mL
PCP Confirmation GCMSNot Detected< 25ng/mL
Barbiturates ScreenNegative< 200ng/mL
Amobarbital Confirmation GCMSNot Detected< 200ng/mL
Butalbital Confirmation GCMSNot Detected< 200ng/mL
Pentobarbital Confirmation GCMSNot Detected< 200ng/mL
Phenobarbital Confirmation GCMSNot Detected< 200ng/mL
Secobarbital Confirmation GCMSNot Detected< 200ng/mL
Benzodiazepines ScreenNegative< 200ng/mL
Clonazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoclonazepam Confirmation LCMSMSNot Detected< 10ng/mL
Flunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoflunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
Diazepam Confirmation LCMSMSNot Detected< 10ng/mL
Temazepam Confirmation LCMSMSNot Detected< 25ng/mL
Nordiazepam Confirmation LCMSMSNot Detected< 25ng/mL
Oxazepam Confirmation LCMSMSNot Detected< 25ng/mL
Lorazepam Confirmation LCMSMSNot Detected< 25ng/mL
Alprazolam Confirmation LCMSMSNot Detected< 10ng/mL
Alpha-Hydroxyalprazolam Confirmation LCMSMSNot Detected< 25ng/mL
Flurazepam Confirmation LCMSMSNot Detected< 10ng/mL
Midazolam Confirmation LCMSMSNot Detected< 25ng/mL
Alpha-Hydroxytriazolam Confirmation LCMSMSNot Detected< 25ng/mL
Methadone Metabolite ScreenNegative< 300ng/mL
Methadone Metabolite Confirmation GCMSNot Detected< 100ng/mL
Propoxyphene ScreenNegative< 300ng/mL
Norpropoxyphene Confirmation GCMSNot Detected< 150ng/mL
Specimen ValidityUrine Creatinine
Urine pH
Urine Specific Gravity
EMPLOYEE DRUG SCREEN (EDS50F) PANEL (THC50) URINE SCREEN RFLXEDS50FEDS50FEnzyme Immunoassay
TitleDescriptorRangesUnits
Amphetamines ScreenNegative< 500ng/mL
Amphetamines Confirmation GCMSNot Detected< 250ng/mL
Methamphetamine Confirmation GCMSNot Detected< 250ng/mL
Alternate Amphetamines ScreenNegative< 500ng/mL
MDMA2 Confirmation GCMSNot Detected< 250ng/mL
MDA2 Confirmation GCMSNot Detected< 250ng/mL
MDEA2 Confirmation GCMSNot Detected< 250ng/mL
Benzoylecgonine (Cocaine) ScreenNegative< 150ng/mL
Benzoylecgonine (Cocaine) Confirmation GCMSNot Detected< 100ng/mL
Opiate ScreenNegative< 2000ng/mL
Codeine Confirmation GCMSNot Detected< 2000ng/mL
Morphine Confirmation GCMSNot Detected< 2000ng/mL
Alternate Opiate ScreenNegative< 300ng/mL
Hydrocodone Confirmation GCMSNot Detected< 300ng/mL
Hydromorphone Confirmation GCMSNot Detected< 300ng/mL
Oxycodone ScreenNegative< 100ng/mL
Oxycodone Confirmation GCMSNot Detected< 100ng/mL
6MAM ScreenNegative< 10ng/mL
6MAM Confirmation GCMSNot Detected< 10ng/mL
Cannabinoid ScreenNegative< 50ng/mL
THC Confirmation GCMSNot Detected< 15ng/mL
PCP ScreenNegative< 25ng/mL
PCP Confirmation GCMSNot Detected< 25ng/mL
Barbiturates ScreenNegative< 200ng/mL
Amobarbital Confirmation GCMSNot Detected< 200ng/mL
Butalbital Confirmation GCMSNot Detected< 200ng/mL
Pentobarbital Confirmation GCMSNot Detected< 200ng/mL
Phenobarbital Confirmation GCMSNot Detected< 200ng/mL
Secobarbital Confirmation GCMSNot Detected< 200ng/mL
Benzodiazepines ScreenNegative< 200ng/mL
Clonazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoclonazepam Confirmation LCMSMSNot Detected< 10ng/mL
Flunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoflunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
Diazepam Confirmation LCMSMSNot Detected< 10ng/mL
Temazepam Confirmation LCMSMSNot Detected< 25ng/mL
Nordiazepam Confirmation LCMSMSNot Detected< 25ng/mL
Oxazepam Confirmation LCMSMSNot Detected< 25ng/mL
Lorazepam Confirmation LCMSMSNot Detected< 25ng/mL
Alprazolam Confirmation LCMSMSNot Detected< 10ng/mL
Alpha-Hydroxyalprazolam Confirmation LCMSMSNot Detected< 25ng/mL
Flurazepam Confirmation LCMSMSNot Detected< 10ng/mL
Midazolam Confirmation LCMSMSNot Detected< 25ng/mL
Alpha-Hydroxytriazolam Confirmation LCMSMSNot Detected< 25ng/mL
Methadone Metabolite ScreenNegative< 300ng/mL
Methadone Metabolite Confirmation GCMSNot Detected< 100ng/mL
Methaqualone ScreenNegative< 300ng/mL
Methaqualone Confirmation GCMSNot Detected< 150ng/mL
Propoxyphene ScreenNegative< 300ng/mL
Norpropoxyphene Confirmation GCMSNot Detected< 150ng/mL
ETOH (Ethyl Alcohol) ScreenNegative< 20ng/mL
ETOH (Ethyl Alcohol) Confirmation GCFIDNot Detected< 20ng/mL
Specimen ValidityUrine Creatinine
Urine pH
Urine Specific Gravity
EMPLOYEE DRUG SCREEN (EDS50G) PANEL (THC50) URINE SCREEN RFLXEDS50GEDS50GEnzyme Immunoassay
TitleDescriptorRangesUnits
Amphetamines ScreenNegative< 500ng/mL
Amphetamines Confirmation GCMSNot Detected< 250ng/mL
Methamphetamine Confirmation GCMSNot Detected< 250ng/mL
Alternate Amphetamines ScreenNegative< 500ng/mL
MDMA2 Confirmation GCMSNot Detected< 250ng/mL
MDA2 Confirmation GCMSNot Detected< 250ng/mL
MDEA2 Confirmation GCMSNot Detected< 250ng/mL
Benzoylecgonine (Cocaine) ScreenNegative< 150ng/mL
Benzoylecgonine (Cocaine) Confirmation GCMSNot Detected< 100ng/mL
Opiate ScreenNegative< 2000ng/mL
Codeine Confirmation GCMSNot Detected< 2000ng/mL
Morphine Confirmation GCMSNot Detected< 2000ng/mL
Alternate Opiate ScreenNegative< 300ng/mL
Hydrocodone Confirmation GCMSNot Detected< 300ng/mL
Hydromorphone Confirmation GCMSNot Detected< 300ng/mL
Oxycodone ScreenNegative< 100ng/mL
Oxycodone Confirmation GCMSNot Detected< 100ng/mL
6MAM ScreenNegative< 10ng/mL
6MAM Confirmation GCMSNot Detected< 10ng/mL
Cannabinoid ScreenNegative< 50ng/mL
THC Confirmation GCMSNot Detected< 15ng/mL
PCP ScreenNegative< 25ng/mL
PCP Confirmation GCMSNot Detected< 25ng/mL
Barbiturates ScreenNegative< 200ng/mL
Amobarbital Confirmation GCMSNot Detected< 200ng/mL
Butalbital Confirmation GCMSNot Detected< 200ng/mL
Pentobarbital Confirmation GCMSNot Detected< 200ng/mL
Phenobarbital Confirmation GCMSNot Detected< 200ng/mL
Secobarbital Confirmation GCMSNot Detected< 200ng/mL
Benzodiazepines ScreenNegative< 200ng/mL
Clonazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoclonazepam Confirmation LCMSMSNot Detected< 10ng/mL
Flunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoflunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
Diazepam Confirmation LCMSMSNot Detected< 10ng/mL
Temazepam Confirmation LCMSMSNot Detected< 25ng/mL
Nordiazepam Confirmation LCMSMSNot Detected< 25ng/mL
Oxazepam Confirmation LCMSMSNot Detected< 25ng/mL
Lorazepam Confirmation LCMSMSNot Detected< 25ng/mL
Alprazolam Confirmation LCMSMSNot Detected< 10ng/mL
Alpha-Hydroxyalprazolam Confirmation LCMSMSNot Detected< 25ng/mL
Flurazepam Confirmation LCMSMSNot Detected< 10ng/mL
Midazolam Confirmation LCMSMSNot Detected< 25ng/mL
Alpha-Hydroxytriazolam Confirmation LCMSMSNot Detected< 25ng/mL
Methadone Metabolite ScreenNegative< 300ng/mL
Methadone Metabolite Confirmation GCMSNot Detected< 100ng/mL
Methaqualone ScreenNegative< 300ng/mL
Methaqualone Confirmation GCMSNot Detected< 150ng/mL
Propoxyphene ScreenNegative< 300ng/mL
Norpropoxyphene Confirmation GCMSNot Detected< 150ng/mL
Specimen ValidityUrine Creatinine
Urine pH
Urine Specific Gravity
DRUG FREE WORKPLACE (DFWNTG) PANEL URINE SCREEN RFLXDFWNTGDFWNTGEnzyme Immunoassay
TitleDescriptorRangesUnits
Amphetamines ScreenNegative< 500ng/mL
Amphetamines Confirmation GCMSNot Detected< 250ng/mL
Methamphetamine Confirmation GCMSNot Detected< 250ng/mL
Alternate Amphetamines ScreenNegative< 500ng/mL
MDMA2 Confirmation GCMSNot Detected< 250ng/mL
MDA2 Confirmation GCMSNot Detected< 250ng/mL
MDEA2 Confirmation GCMSNot Detected< 250ng/mL
Benzoylecgonine (Cocaine) ScreenNegative< 150ng/mL
Benzoylecgonine (Cocaine) Confirmation GCMSNot Detected< 100ng/mL
Opiate ScreenNegative< 2000ng/mL
Codeine Confirmation GCMSNot Detected< 2000ng/mL
Morphine Confirmation GCMSNot Detected< 2000ng/mL
Alternate Opiate ScreenNegative< 300ng/mL
Hydrocodone Confirmation GCMSNot Detected< 300ng/mL
Hydromorphone Confirmation GCMSNot Detected< 300ng/mL
Oxycodone ScreenNegative< 100ng/mL
Oxycodone Confirmation GCMSNot Detected< 100ng/mL
6MAM ScreenNegative< 10ng/mL
6MAM Confirmation GCMSNot Detected< 10ng/mL
PCP ScreenNegative< 25ng/mL
PCP Confirmation GCMSNot Detected< 25ng/mL
Specimen ValidityUrine Creatinine
Urine pH
Urine Specific Gravity
EMPLOYEE DRUG SCREEN (EDSNTG) PANEL URINE SCREEN RFLXEDSNTGEDSNTGEnzyme Immunoassay
TitleDescriptorRangesUnits
Amphetamines ScreenNegative< 500ng/mL
Amphetamines Confirmation GCMSNot Detected< 250ng/mL
Methamphetamine Confirmation GCMSNot Detected< 250ng/mL
Alternate Amphetamines ScreenNegative< 500ng/mL
MDMA2 Confirmation GCMSNot Detected< 250ng/mL
MDA2 Confirmation GCMSNot Detected< 250ng/mL
MDEA2 Confirmation GCMSNot Detected< 250ng/mL
Benzoylecgonine (Cocaine) ScreenNegative< 150ng/mL
Benzoylecgonine (Cocaine) Confirmation GCMSNot Detected< 100ng/mL
Opiate ScreenNegative< 2000ng/mL
Codeine Confirmation GCMSNot Detected< 2000ng/mL
Morphine Confirmation GCMSNot Detected< 2000ng/mL
Alternate Opiate ScreenNegative< 300ng/mL
Hydrocodone Confirmation GCMSNot Detected< 300ng/mL
Hydromorphone Confirmation GCMSNot Detected< 300ng/mL
Oxycodone ScreenNegative< 100ng/mL
Oxycodone Confirmation GCMSNot Detected< 100ng/mL
6MAM ScreenNegative< 10ng/mL
6MAM Confirmation GCMSNot Detected< 10ng/mL
PCP ScreenNegative< 25ng/mL
PCP Confirmation GCMSNot Detected< 25ng/mL
Barbiturates ScreenNegative< 200ng/mL
Amobarbital Confirmation GCMSNot Detected< 200ng/mL
Butalbital Confirmation GCMSNot Detected< 200ng/mL
Pentobarbital Confirmation GCMSNot Detected< 200ng/mL
Phenobarbital Confirmation GCMSNot Detected< 200ng/mL
Secobarbital Confirmation GCMSNot Detected< 200ng/mL
Benzodiazepines ScreenNegative< 200ng/mL
Clonazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoclonazepam Confirmation LCMSMSNot Detected< 10ng/mL
Flunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoflunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
Diazepam Confirmation LCMSMSNot Detected< 10ng/mL
Temazepam Confirmation LCMSMSNot Detected< 25ng/mL
Nordiazepam Confirmation LCMSMSNot Detected< 25ng/mL
Oxazepam Confirmation LCMSMSNot Detected< 25ng/mL
Lorazepam Confirmation LCMSMSNot Detected< 25ng/mL
Alprazolam Confirmation LCMSMSNot Detected< 10ng/mL
Alpha-Hydroxyalprazolam Confirmation LCMSMSNot Detected< 25ng/mL
Flurazepam Confirmation LCMSMSNot Detected< 10ng/mL
Midazolam Confirmation LCMSMSNot Detected< 25ng/mL
Alpha-Hydroxytriazolam Confirmation LCMSMSNot Detected< 25ng/mL
Methadone Metabolite ScreenNegative< 300ng/mL
Methadone Metabolite Confirmation GCMSNot Detected< 100ng/mL
Methaqualone ScreenNegative< 300ng/mL
Methaqualone Confirmation GCMSNot Detected< 150ng/mL
Propoxyphene ScreenNegative< 300ng/mL
Norpropoxyphene Confirmation GCMSNot Detected< 150ng/mL
Specimen ValidityUrine Creatinine
Urine pH
Urine Specific Gravity
EMPLOYEE DRUG SCREEN (EDS50F3) PANEL (THC50) URINE SCREEN RFLXEDS50F3EDS50F3Enzyme Immunoassay
TitleDescriptorRangesUnits
Amphetamines ScreenNegative< 500ng/mL
Amphetamines Confirmation GCMSNot Detected< 250ng/mL
Methamphetamine Confirmation GCMSNot Detected< 250ng/mL
Alternate Amphetamines ScreenNegative< 500ng/mL
MDMA2 Confirmation GCMSNot Detected< 250ng/mL
MDA2 Confirmation GCMSNot Detected< 250ng/mL
MDEA2 Confirmation GCMSNot Detected< 250ng/mL
Benzoylecgonine (Cocaine) ScreenNegative< 150ng/mL
Benzoylecgonine (Cocaine) Confirmation GCMSNot Detected< 100ng/mL
Opiate ScreenNegative< 300ng/mL
Codeine Confirmation GCMSNot Detected< 300ng/mL
Morphine Confirmation GCMSNot Detected< 300ng/mL
Alternate Opiate ScreenNegative< 300ng/mL
Hydrocodone Confirmation GCMSNot Detected< 300ng/mL
Hydromorphone Confirmation GCMSNot Detected< 300ng/mL
Oxycodone ScreenNegative< 100ng/mL
Oxycodone Confirmation GCMSNot Detected< 100ng/mL
6MAM ScreenNegative< 10ng/mL
6MAM Confirmation GCMSNot Detected< 10ng/mL
Cannabinoid ScreenNegative< 50ng/mL
THC Confirmation GCMSNot Detected< 15ng/mL
PCP ScreenNegative< 25ng/mL
PCP Confirmation GCMSNot Detected< 25ng/mL
Barbiturates ScreenNegative< 200ng/mL
Amobarbital Confirmation GCMSNot Detected< 200ng/mL
Butalbital Confirmation GCMSNot Detected< 200ng/mL
Pentobarbital Confirmation GCMSNot Detected< 200ng/mL
Phenobarbital Confirmation GCMSNot Detected< 200ng/mL
Secobarbital Confirmation GCMSNot Detected< 200ng/mL
Benzodiazepines ScreenNegative< 200ng/mL
Clonazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoclonazepam Confirmation LCMSMSNot Detected< 10ng/mL
Flunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoflunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
Diazepam Confirmation LCMSMSNot Detected< 10ng/mL
Temazepam Confirmation LCMSMSNot Detected< 25ng/mL
Nordiazepam Confirmation LCMSMSNot Detected< 25ng/mL
Oxazepam Confirmation LCMSMSNot Detected< 25ng/mL
Lorazepam Confirmation LCMSMSNot Detected< 25ng/mL
Alprazolam Confirmation LCMSMSNot Detected< 10ng/mL
Alpha-Hydroxyalprazolam Confirmation LCMSMSNot Detected< 25ng/mL
Flurazepam Confirmation LCMSMSNot Detected< 10ng/mL
Midazolam Confirmation LCMSMSNot Detected< 25ng/mL
Alpha-Hydroxytriazolam Confirmation LCMSMSNot Detected< 25ng/mL
Methadone Metabolite ScreenNegative< 300ng/mL
Methadone Metabolite Confirmation GCMSNot Detected< 100ng/mL
Methaqualone ScreenNegative< 300ng/mL
Methaqualone Confirmation GCMSNot Detected< 150ng/mL
Propoxyphene ScreenNegative< 300ng/mL
Norpropoxyphene Confirmation GCMSNot Detected< 150ng/mL
ETOH (Ethyl Alcohol) ScreenNegative< 20ng/mL
ETOH (Ethyl Alcohol) Confirmation GCFIDNot Detected< 20ng/mL
Specimen ValidityUrine Creatinine
Urine pH
Urine Specific Gravity
EMPLOYEE DRUG SCREEN (EDS50H) PANEL (THC50) URINE SCREEN RFLXEDS50HEnzyme Immunoassay
TitleDescriptorRangesUnits
Amphetamines ScreenNegative< 500ng/mL
Amphetamines Confirmation GCMSNot Detected< 250ng/mL
Methamphetamine Confirmation GCMSNot Detected< 250ng/mL
Alternate Amphetamines ScreenNegative< 500ng/mL
MDMA2 Confirmation GCMSNot Detected< 250ng/mL
MDA2 Confirmation GCMSNot Detected< 250ng/mL
MDEA2 Confirmation GCMSNot Detected< 250ng/mL
Benzoylecgonine (Cocaine) ScreenNegative< 150ng/mL
Benzoylecgonine (Cocaine) Confirmation GCMSNot Detected< 100ng/mL
Opiate ScreenNegative< 300ng/mL
Codeine Confirmation GCMSNot Detected< 300ng/mL
Morphine Confirmation GCMSNot Detected< 300ng/mL
Alternate Opiate ScreenNegative< 300ng/mL
Hydrocodone Confirmation GCMSNot Detected< 300ng/mL
Hydromorphone Confirmation GCMSNot Detected< 300ng/mL
Oxycodone ScreenNegative< 300ng/mL
Oxycodone Confirmation GCMSNot Detected< 300ng/mL
6MAM ScreenNegative< 10ng/mL
6MAM Confirmation GCMSNot Detected< 10ng/mL
Cannabinoid ScreenNegative< 50ng/mL
THC Confirmation GCMSNot Detected< 15ng/mL
PCP ScreenNegative< 25ng/mL
PCP Confirmation GCMSNot Detected< 25ng/mL
Barbiturates ScreenNegative< 200ng/mL
Amobarbital Confirmation GCMSNot Detected< 200ng/mL
Butalbital Confirmation GCMSNot Detected< 200ng/mL
Pentobarbital Confirmation GCMSNot Detected< 200ng/mL
Phenobarbital Confirmation GCMSNot Detected< 200ng/mL
Secobarbital Confirmation GCMSNot Detected< 200ng/mL
Benzodiazepines ScreenNegative< 200ng/mL
Clonazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoclonazepam Confirmation LCMSMSNot Detected< 10ng/mL
Flunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoflunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
Diazepam Confirmation LCMSMSNot Detected< 10ng/mL
Temazepam Confirmation LCMSMSNot Detected< 25ng/mL
Nordiazepam Confirmation LCMSMSNot Detected< 25ng/mL
Oxazepam Confirmation LCMSMSNot Detected< 25ng/mL
Lorazepam Confirmation LCMSMSNot Detected< 25ng/mL
Alprazolam Confirmation LCMSMSNot Detected< 10ng/mL
Alpha-Hydroxyalprazolam Confirmation LCMSMSNot Detected< 25ng/mL
Flurazepam Confirmation LCMSMSNot Detected< 10ng/mL
Midazolam Confirmation LCMSMSNot Detected< 25ng/mL
Alpha-Hydroxytriazolam Confirmation LCMSMSNot Detected< 25ng/mL
Methadone Metabolite ScreenNegative< 300ng/mL
Methadone Metabolite Confirmation GCMSNot Detected< 100ng/mL
Methaqualone ScreenNegative< 300ng/mL
Methaqualone Confirmation GCMSNot Detected< 150ng/mL
Propoxyphene ScreenNegative< 300ng/mL
Norpropoxyphene Confirmation GCMSNot Detected< 150ng/mL
Specimen ValidityUrine Creatinine
Urine pH
Urine Specific Gravity
EMPLOYEE DRUG SCREEN (EDS) PANEL (THC100) URINE SCREEN RFLXEDSEDSEnzyme Immunoassay
TitleDescriptorRangesUnits
Amphetamines ScreenNegative< 500ng/mL
Amphetamines Confirmation GCMSNot Detected< 250ng/mL
Methamphetamine Confirmation GCMSNot Detected< 250ng/mL
Benzoylecgonine (Cocaine) ScreenNegative< 150ng/mL
Benzoylecgonine (Cocaine) Confirmation GCMSNot Detected< 100ng/mL
Opiate ScreenNegative< 2000ng/mL
Codeine Confirmation GCMSNot Detected< 2000ng/mL
Morphine Confirmation GCMSNot Detected< 2000ng/mL
6MAM ScreenNegative< 10ng/mL
6MAM Confirmation GCMSNot Detected< 10ng/mL
Cannabinoid ScreenNegative< 100ng/mL
THC Confirmation GCMSNot Detected< 15ng/mL
PCP ScreenNegative< 25ng/mL
PCP Confirmation GCMSNot Detected< 25ng/mL
Barbiturates ScreenNegative< 200ng/mL
Amobarbital Confirmation GCMSNot Detected< 200ng/mL
Butalbital Confirmation GCMSNot Detected< 200ng/mL
Pentobarbital Confirmation GCMSNot Detected< 200ng/mL
Phenobarbital Confirmation GCMSNot Detected< 200ng/mL
Secobarbital Confirmation GCMSNot Detected< 200ng/mL
Benzodiazepines ScreenNegative< 200ng/mL
Clonazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoclonazepam Confirmation LCMSMSNot Detected< 10ng/mL
Flunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoflunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
Diazepam Confirmation LCMSMSNot Detected< 10ng/mL
Temazepam Confirmation LCMSMSNot Detected< 25ng/mL
Nordiazepam Confirmation LCMSMSNot Detected< 25ng/mL
Oxazepam Confirmation LCMSMSNot Detected< 25ng/mL
Lorazepam Confirmation LCMSMSNot Detected< 25ng/mL
Alprazolam Confirmation LCMSMSNot Detected< 10ng/mL
Alpha-Hydroxyalprazolam Confirmation LCMSMSNot Detected< 25ng/mL
Flurazepam Confirmation LCMSMSNot Detected< 10ng/mL
Midazolam Confirmation LCMSMSNot Detected< 25ng/mL
Alpha-Hydroxytriazolam Confirmation LCMSMSNot Detected< 25ng/mL
Methadone Metabolite ScreenNegative< 300ng/mL
Methadone Metabolite Confirmation GCMSNot Detected< 100ng/mL
Methaqualone ScreenNegative< 300ng/mL
Methaqualone Confirmation GCMSNot Detected< 150ng/mL
Propoxyphene ScreenNegative< 300ng/mL
Norpropoxyphene Confirmation GCMSNot Detected< 150ng/mL
Specimen ValidityUrine Creatinine
Urine pH
Urine Specific Gravity
SUBSTANCE ABUSE PANEL (SAP7) (THC100) URINE SCREEN RFLXSAP7SAP7Enzyme Immunoassay
TitleDescriptorRangesUnits
Amphetamines ScreenNegative< 500ng/mL
Amphetamines Confirmation GCMSNot Detected< 250ng/mL
Methamphetamine Confirmation GCMSNot Detected< 250ng/mL
Benzoylecgonine (Cocaine) ScreenNegative< 150ng/mL
Benzoylecgonine (Cocaine) Confirmation GCMSNot Detected< 100ng/mL
Opiate ScreenNegative< 2000ng/mL
Codeine Confirmation GCMSNot Detected< 2000ng/mL
Morphine Confirmation GCMSNot Detected< 2000ng/mL
6MAM ScreenNegative< 10ng/mL
6MAM Confirmation GCMSNot Detected< 10ng/mL
Cannabinoid ScreenNegative< 100ng/mL
THC Confirmation GCMSNot Detected< 15ng/mL
PCP ScreenNegative< 25ng/mL
PCP Confirmation GCMSNot Detected< 25ng/mL
Barbiturates ScreenNegative< 200ng/mL
Amobarbital Confirmation GCMSNot Detected< 200ng/mL
Butalbital Confirmation GCMSNot Detected< 200ng/mL
Pentobarbital Confirmation GCMSNot Detected< 200ng/mL
Phenobarbital Confirmation GCMSNot Detected< 200ng/mL
Secobarbital Confirmation GCMSNot Detected< 200ng/mL
Benzodiazepines ScreenNegative< 200ng/mL
Clonazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoclonazepam Confirmation LCMSMSNot Detected< 10ng/mL
Flunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoflunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
Diazepam Confirmation LCMSMSNot Detected< 10ng/mL
Temazepam Confirmation LCMSMSNot Detected< 25ng/mL
Nordiazepam Confirmation LCMSMSNot Detected< 25ng/mL
Oxazepam Confirmation LCMSMSNot Detected< 25ng/mL
Lorazepam Confirmation LCMSMSNot Detected< 25ng/mL
Alprazolam Confirmation LCMSMSNot Detected< 10ng/mL
Alpha-Hydroxyalprazolam Confirmation LCMSMSNot Detected< 25ng/mL
Flurazepam Confirmation LCMSMSNot Detected< 10ng/mL
Midazolam Confirmation LCMSMSNot Detected< 25ng/mL
Alpha-Hydroxytriazolam Confirmation LCMSMSNot Detected< 25ng/mL
Specimen ValidityUrine Creatinine
Urine pH
Urine Specific Gravity
DRUG FREE WORKPLACE (DFW) PANEL (THC100) URINE SCREEN RFLXDFWDFWEnzyme Immunoassay
TitleDescriptorRangesUnits
Amphetamines ScreenNegative< 500ng/mL
Amphetamines Confirmation GCMSNot Detected< 250ng/mL
Methamphetamine Confirmation GCMSNot Detected< 250ng/mL
Benzoylecgonine (Cocaine) ScreenNegative< 150ng/mL
Benzoylecgonine (Cocaine) Confirmation GCMSNot Detected< 100ng/mL
Opiate ScreenNegative< 2000ng/mL
Codeine Confirmation GCMSNot Detected< 2000ng/mL
Morphine Confirmation GCMSNot Detected< 2000ng/mL
6MAM ScreenNegative< 10ng/mL
6MAM Confirmation GCMSNot Detected< 10ng/mL
Cannabinoid ScreenNegative< 100ng/mL
THC Confirmation GCMSNot Detected< 15ng/mL
PCP ScreenNegative< 25ng/mL
PCP Confirmation GCMSNot Detected< 25ng/mL
Specimen ValidityUrine Creatinine
Urine pH
Urine Specific Gravity
SUBSTANCE ABUSE PANEL (SAP720) (THC20) URINE SCREEN RFLXSAP720SAP720Enzyme Immunoassay
TitleDescriptorRangesUnits
Amphetamines ScreenNegative< 500ng/mL
Amphetamines Confirmation GCMSNot Detected< 250ng/mL
Methamphetamine Confirmation GCMSNot Detected< 250ng/mL
Benzoylecgonine (Cocaine) ScreenNegative< 150ng/mL
Benzoylecgonine (Cocaine) Confirmation GCMSNot Detected< 100ng/mL
Opiate ScreenNegative< 2000ng/mL
Codeine Confirmation GCMSNot Detected< 2000ng/mL
Morphine Confirmation GCMSNot Detected< 2000ng/mL
6MAM ScreenNegative< 10ng/mL
6MAM Confirmation GCMSNot Detected< 10ng/mL
Cannabinoid ScreenNegative< 20ng/mL
THC Confirmation GCMSNot Detected< 10ng/mL
PCP ScreenNegative< 25ng/mL
PCP Confirmation GCMSNot Detected< 25ng/mL
Barbiturates ScreenNegative< 200ng/mL
Amobarbital Confirmation GCMSNot Detected< 200ng/mL
Butalbital Confirmation GCMSNot Detected< 200ng/mL
Pentobarbital Confirmation GCMSNot Detected< 200ng/mL
Phenobarbital Confirmation GCMSNot Detected< 200ng/mL
Secobarbital Confirmation GCMSNot Detected< 200ng/mL
Benzodiazepines ScreenNegative< 200ng/mL
Clonazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoclonazepam Confirmation LCMSMSNot Detected< 10ng/mL
Flunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoflunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
Diazepam Confirmation LCMSMSNot Detected< 10ng/mL
Temazepam Confirmation LCMSMSNot Detected< 25ng/mL
Nordiazepam Confirmation LCMSMSNot Detected< 25ng/mL
Oxazepam Confirmation LCMSMSNot Detected< 25ng/mL
Lorazepam Confirmation LCMSMSNot Detected< 25ng/mL
Alprazolam Confirmation LCMSMSNot Detected< 10ng/mL
Alpha-Hydroxyalprazolam Confirmation GCMSNot Detected< 25ng/mL
Flurazepam Confirmation LCMSMSNot Detected< 10ng/mL
Midazolam Confirmation LCMSMSNot Detected< 25ng/mL
Alpha-Hydroxytriazolam Confirmation LCMSMSNot Detected< 25ng/mL
Specimen ValidityUrine Creatinine
Urine pH
Urine Specific Gravity
SUBSTANCE ABUSE PANEL (SAP920) (THC20) URINE SCREEN RFLXSAP920SAP920Enzyme Immunoassay
TitleDescriptorRangesUnits
Amphetamines ScreenNegative< 500ng/mL
Amphetamines Confirmation GCMSNot Detected< 250ng/mL
Methamphetamine Confirmation GCMSNot Detected< 250ng/mL
Benzoylecgonine (Cocaine) ScreenNegative< 150ng/mL
Benzoylecgonine (Cocaine) Confirmation GCMSNot Detected< 100ng/mL
Opiate ScreenNegative< 2000ng/mL
Codeine Confirmation GCMSNot Detected< 2000ng/mL
Morphine Confirmation GCMSNot Detected< 2000ng/mL
6MAM ScreenNegative< 10ng/mL
6MAM Confirmation GCMSNot Detected< 10ng/mL
Cannabinoid ScreenNegative< 20ng/mL
THC Confirmation GCMSNot Detected< 10ng/mL
PCP ScreenNegative< 25ng/mL
PCP Confirmation GCMSNot Detected< 25ng/mL
Barbiturates ScreenNegative< 200ng/mL
Amobarbital Confirmation GCMSNot Detected< 200ng/mL
Butalbital Confirmation GCMSNot Detected< 200ng/mL
Pentobarbital Confirmation GCMSNot Detected< 200ng/mL
Phenobarbital Confirmation GCMSNot Detected< 200ng/mL
Secobarbital Confirmation GCMSNot Detected< 200ng/mL
Benzodiazepines ScreenNegative< 200ng/mL
Clonazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoclonazepam Confirmation LCMSMSNot Detected< 10ng/mL
Flunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoflunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
Diazepam Confirmation LCMSMSNot Detected< 10ng/mL
Temazepam Confirmation LCMSMSNot Detected< 25ng/mL
Nordiazepam Confirmation LCMSMSNot Detected< 25ng/mL
Oxazepam Confirmation LCMSMSNot Detected< 25ng/mL
Lorazepam Confirmation LCMSMSNot Detected< 25ng/mL
Alprazolam Confirmation LCMSMSNot Detected< 10ng/mL
Alpha-Hydroxyalprazolam Confirmation LCMSMSNot Detected< 25ng/mL
Flurazepam Confirmation LCMSMSNot Detected< 10ng/mL
Midazolam Confirmation LCMSMSNot Detected< 25ng/mL
Alpha-Hydroxytriazolam Confirmation LCMSMSNot Detected< 25ng/mL
Methadone Metabolite ScreenNegative< 300ng/mL
Methadone Metabolite Confirmation GCMSNot Detected< 100ng/mL
Propoxyphene ScreenNegative< 300ng/mL
Norpropoxyphene Confirmation GCMSNot Detected< 150ng/mL
Specimen ValidityUrine Creatinine
Urine pH
Urine Specific Gravity
EMPLOYEE DRUG SCREEN (EDS20A) PANEL (THC20) URINE SCREEN RFLXEDS20AEDS20AEnzyme Immunoassay
TitleDescriptorRangesUnits
Amphetamines ScreenNegative< 500ng/mL
Amphetamines Confirmation GCMSNot Detected< 250ng/mL
Methamphetamine Confirmation GCMSNot Detected< 250ng/mL
Benzoylecgonine (Cocaine) ScreenNegative< 150ng/mL
Benzoylecgonine (Cocaine) Confirmation GCMSNot Detected< 100ng/mL
Opiate ScreenNegative< 2000ng/mL
Codeine Confirmation GCMSNot Detected< 2000ng/mL
Morphine Confirmation GCMSNot Detected< 2000ng/mL
6MAM ScreenNegative< 10ng/mL
6MAM Confirmation GCMSNot Detected< 10ng/mL
Cannabinoid ScreenNegative< 20ng/mL
THC Confirmation GCMSNot Detected< 10ng/mL
PCP ScreenNegative< 25ng/mL
PCP Confirmation GCMSNot Detected< 25ng/mL
Barbiturates ScreenNegative< 200ng/mL
Amobarbital Confirmation GCMSNot Detected< 200ng/mL
Butalbital Confirmation GCMSNot Detected< 200ng/mL
Pentobarbital Confirmation GCMSNot Detected< 200ng/mL
Phenobarbital Confirmation GCMSNot Detected< 200ng/mL
Secobarbital Confirmation GCMSNot Detected< 200ng/mL
Benzodiazepines ScreenNegative< 200ng/mL
Clonazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoclonazepam Confirmation LCMSMSNot Detected< 10ng/mL
Flunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoflunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
Diazepam Confirmation LCMSMSNot Detected< 10ng/mL
Temazepam Confirmation LCMSMSNot Detected< 25ng/mL
Nordiazepam Confirmation LCMSMSNot Detected< 25ng/mL
Oxazepam Confirmation LCMSMSNot Detected< 25ng/mL
Lorazepam Confirmation LCMSMSNot Detected< 25ng/mL
Alprazolam Confirmation LCMSMSNot Detected< 10ng/mL
Alpha-Hydroxyalprazolam Confirmation LCMSMSNot Detected< 25ng/mL
Flurazepam Confirmation LCMSMSNot Detected< 10ng/mL
Midazolam Confirmation LCMSMSNot Detected< 25ng/mL
Alpha-Hydroxytriazolam Confirmation LCMSMSNot Detected< 25ng/mL
Methadone Metabolite ScreenNegative< 300ng/mL
Methadone Metabolite Confirmation GCMSNot Detected< 100ng/mL
Methaqualone ScreenNegative< 300ng/mL
Methaqualone Confirmation GCMSNot Detected< 150ng/mL
Propoxyphene ScreenNegative< 300ng/mL
Norpropoxyphene Confirmation GCMSNot Detected< 150ng/mL
ETOH (Ethyl Alcohol) ScreenNegative< 20ng/mL
ETOH (Ethyl Alcohol) Confirmation GCFIDNot Detected< 20ng/mL
Specimen ValidityUrine Creatinine
Urine pH
Urine Specific Gravity
DRUG FREE WORKPLACE (DFW20A) PANEL (THC20) URINE SCREEN RFLXDFW20ADFW20AEnzyme Immunoassay
TitleDescriptorRangesUnits
Amphetamines ScreenNegative< 500ng/mL
Amphetamines Confirmation GCMSNot Detected< 250ng/mL
Methamphetamine Confirmation GCMSNot Detected< 250ng/mL
Benzoylecgonine (Cocaine) ScreenNegative< 150ng/mL
Benzoylecgonine (Cocaine) Confirmation GCMSNot Detected< 100ng/mL
Opiate ScreenNegative< 2000ng/mL
Codeine Confirmation GCMSNot Detected< 2000ng/mL
Morphine Confirmation GCMSNot Detected< 2000ng/mL
6MAM ScreenNegative< 10ng/mL
6MAM Confirmation GCMSNot Detected< 10ng/mL
Cannabinoid ScreenNegative< 20ng/mL
THC Confirmation GCMSNot Detected< 10ng/mL
PCP ScreenNegative< 25ng/mL
PCP Confirmation GCMSNot Detected< 25ng/mL
ETOH (Ethyl Alcohol) ScreenNegative< 20ng/mL
ETOH (Ethyl Alcohol) Confirmation GCFIDNot Detected< 20ng/mL
Specimen ValidityUrine Creatinine
Urine pH
Urine Specific Gravity
DRUG FREE WORKPLACE (DFW20) PANEL (THC20) URINE SCREEN RFLXDFW20DFW20Enzyme Immunoassay
TitleDescriptorRangesUnits
Amphetamines ScreenNegative< 500ng/mL
Amphetamines Confirmation GCMSNot Detected< 250ng/mL
Methamphetamine Confirmation GCMSNot Detected< 250ng/mL
Benzoylecgonine (Cocaine) ScreenNegative< 150ng/mL
Benzoylecgonine (Cocaine) Confirmation GCMSNot Detected< 100ng/mL
Opiate ScreenNegative< 2000ng/mL
Codeine Confirmation GCMSNot Detected< 2000ng/mL
Morphine Confirmation GCMSNot Detected< 2000ng/mL
6MAM ScreenNegative< 10ng/mL
6MAM Confirmation GCMSNot Detected< 10ng/mL
Cannabinoid ScreenNegative< 20ng/mL
THC Confirmation GCMSNot Detected< 10ng/mL
PCP ScreenNegative< 25ng/mL
PCP Confirmation GCMSNot Detected< 25ng/mL
Specimen ValidityUrine Creatinine
Urine pH
Urine Specific Gravity
EMPLOYEE DRUG SCREEN (EDS20) PANEL (THC20) URINE SCREEN RFLXEDS20EDS20Enzyme Immunoassay
TitleDescriptorRangesUnits
Amphetamines ScreenNegative< 500ng/mL
Amphetamines Confirmation GCMSNot Detected< 250ng/mL
Methamphetamine Confirmation GCMSNot Detected< 250ng/mL
Benzoylecgonine (Cocaine) ScreenNegative< 150ng/mL
Benzoylecgonine (Cocaine) Confirmation GCMSNot Detected< 100ng/mL
Opiate ScreenNegative< 2000ng/mL
Codeine Confirmation GCMSNot Detected< 2000ng/mL
Morphine Confirmation GCMSNot Detected< 2000ng/mL
6MAM ScreenNegative< 10ng/mL
6MAM Confirmation GCMSNot Detected< 10ng/mL
Cannabinoid ScreenNegative< 20ng/mL
THC Confirmation GCMSNot Detected< 15ng/mL
PCP ScreenNegative< 25ng/mL
PCP Confirmation GCMSNot Detected< 25ng/mL
Barbiturates ScreenNegative< 200ng/mL
Amobarbital Confirmation GCMSNot Detected< 200ng/mL
Butalbital Confirmation GCMSNot Detected< 200ng/mL
Pentobarbital Confirmation GCMSNot Detected< 200ng/mL
Phenobarbital Confirmation GCMSNot Detected< 200ng/mL
Secobarbital Confirmation GCMSNot Detected< 200ng/mL
Benzodiazepines ScreenNegative< 200ng/mL
Clonazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoclonazepam Confirmation LCMSMSNot Detected< 10ng/mL
Flunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoflunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
Diazepam Confirmation LCMSMSNot Detected< 10ng/mL
Temazepam Confirmation LCMSMSNot Detected< 25ng/mL
Nordiazepam Confirmation LCMSMSNot Detected< 25ng/mL
Oxazepam Confirmation LCMSMSNot Detected< 25ng/mL
Lorazepam Confirmation LCMSMSNot Detected< 25ng/mL
Alprazolam Confirmation LCMSMSNot Detected< 10ng/mL
Alpha-Hydroxyalprazolam Confirmation LCMSMSNot Detected< 25ng/mL
Flurazepam Confirmation LCMSMSNot Detected< 10ng/mL
Midazolam Confirmation LCMSMSNot Detected< 25ng/mL
Alpha-Hydroxytriazolam Confirmation LCMSMSNot Detected< 25ng/mL
Methadone Metabolite ScreenNegative< 300ng/mL
Methadone Metabolite Confirmation GCMSNot Detected< 100ng/mL
Methaqualone ScreenNegative< 300ng/mL
Methaqualone Confirmation GCMSNot Detected< 150ng/mL
Propoxyphene ScreenNegative< 300ng/mL
Norpropoxyphene Confirmation GCMSNot Detected< 150ng/mL
Specimen ValidityUrine Creatinine
Urine pH
Urine Specific Gravity
SUBSTANCE ABUSE PANEL (SAP750) (THC50) URINE SCREEN RFLXSAP750SAP750Enzyme Immunoassay
TitleDescriptorRangesUnits
Amphetamines ScreenNegative< 500ng/mL
Amphetamines Confirmation GCMSNot Detected< 250ng/mL
Methamphetamine Confirmation GCMSNot Detected< 250ng/mL
Benzoylecgonine (Cocaine) ScreenNegative< 150ng/mL
Benzoylecgonine (Cocaine) Confirmation GCMSNot Detected< 100ng/mL
Opiate ScreenNegative< 2000ng/mL
Codeine Confirmation GCMSNot Detected< 2000ng/mL
Morphine Confirmation GCMSNot Detected< 2000ng/mL
6MAM ScreenNegative< 10ng/mL
6MAM Confirmation GCMSNot Detected< 10ng/mL
Cannabinoid ScreenNegative< 50ng/mL
THC Confirmation GCMSNot Detected< 15ng/mL
PCP ScreenNegative< 25ng/mL
PCP Confirmation GCMSNot Detected< 25ng/mL
Barbiturates ScreenNegative< 200ng/mL
Amobarbital Confirmation GCMSNot Detected< 200ng/mL
Butalbital Confirmation GCMSNot Detected< 200ng/mL
Pentobarbital Confirmation GCMSNot Detected< 200ng/mL
Phenobarbital Confirmation GCMSNot Detected< 200ng/mL
Secobarbital Confirmation GCMSNot Detected< 200ng/mL
Benzodiazepines ScreenNegative< 200ng/mL
Clonazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoclonazepam Confirmation LCMSMSNot Detected< 10ng/mL
Flunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoflunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
Diazepam Confirmation LCMSMSNot Detected< 10ng/mL
Temazepam Confirmation LCMSMSNot Detected< 25ng/mL
Nordiazepam Confirmation LCMSMSNot Detected< 25ng/mL
Oxazepam Confirmation LCMSMSNot Detected< 25ng/mL
Lorazepam Confirmation LCMSMSNot Detected< 25ng/mL
Alprazolam Confirmation LCMSMSNot Detected< 10ng/mL
Alpha-Hydroxyalprazolam Confirmation LCMSMSNot Detected< 25ng/mL
Flurazepam Confirmation LCMSMSNot Detected< 10ng/mL
Midazolam Confirmation LCMSMSNot Detected< 25ng/mL
Alpha-Hydroxytriazolam Confirmation LCMSMSNot Detected< 25ng/mL
Specimen ValidityUrine Creatinine
Urine pH
Urine Specific Gravity
SUBSTANCE ABUSE PANEL (SAP750A) (THC50) URINE SCREEN RFLXSAP750ASAP750AEnzyme Immunoassay
TitleDescriptorRangesUnits
Amphetamines ScreenNegative< 500ng/mL
Amphetamines Confirmation GCMSNot Detected< 250ng/mL
Methamphetamine Confirmation GCMSNot Detected< 250ng/mL
Benzoylecgonine (Cocaine) ScreenNegative< 150ng/mL
Benzoylecgonine (Cocaine) Confirmation GCMSNot Detected< 100ng/mL
Opiate ScreenNegative< 2000ng/mL
Codeine Confirmation GCMSNot Detected< 2000ng/mL
Morphine Confirmation GCMSNot Detected< 2000ng/mL
6MAM ScreenNegative< 10ng/mL
6MAM Confirmation GCMSNot Detected< 10ng/mL
Cannabinoid ScreenNegative< 50ng/mL
THC Confirmation GCMSNot Detected< 15ng/mL
PCP ScreenNegative< 25ng/mL
PCP Confirmation GCMSNot Detected< 25ng/mL
Barbiturates ScreenNegative< 200ng/mL
Amobarbital Confirmation GCMSNot Detected< 200ng/mL
Butalbital Confirmation GCMSNot Detected< 200ng/mL
Pentobarbital Confirmation GCMSNot Detected< 200ng/mL
Phenobarbital Confirmation GCMSNot Detected< 200ng/mL
Secobarbital Confirmation GCMSNot Detected< 200ng/mL
Benzodiazepines ScreenNegative< 200ng/mL
Clonazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoclonazepam Confirmation LCMSMSNot Detected< 10ng/mL
Flunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoflunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
Diazepam Confirmation LCMSMSNot Detected< 10ng/mL
Temazepam Confirmation LCMSMSNot Detected< 25ng/mL
Nordiazepam Confirmation LCMSMSNot Detected< 25ng/mL
Oxazepam Confirmation LCMSMSNot Detected< 25ng/mL
Lorazepam Confirmation LCMSMSNot Detected< 25ng/mL
Alprazolam Confirmation LCMSMSNot Detected< 10ng/mL
Alpha-Hydroxyalprazolam Confirmation LCMSMSNot Detected< 25ng/mL
Flurazepam Confirmation LCMSMSNot Detected< 10ng/mL
Midazolam Confirmation LCMSMSNot Detected< 25ng/mL
Alpha-Hydroxytriazolam Confirmation LCMSMSNot Detected< 25ng/mL
ETOH (Ethyl Alcohol) ScreenNegative< 20ng/mL
ETOH (Ethyl Alcohol) Confirmation GCFIDNot Detected< 20ng/mL
Specimen ValidityUrine Creatinine
Urine pH
Urine Specific Gravity
SUBSTANCE ABUSE PANEL (SAP950) (THC50) URINE SCREEN RFLXSAP950SAP950Enzyme Immunoassay
TitleDescriptorRangesUnits
Amphetamines ScreenNegative< 500ng/mL
Amphetamines Confirmation GCMSNot Detected< 250ng/mL
Methamphetamine Confirmation GCMSNot Detected< 250ng/mL
Benzoylecgonine (Cocaine) ScreenNegative< 150ng/mL
Benzoylecgonine (Cocaine) Confirmation GCMSNot Detected< 100ng/mL
Opiate ScreenNegative< 2000ng/mL
Codeine Confirmation GCMSNot Detected< 2000ng/mL
Morphine Confirmation GCMSNot Detected< 2000ng/mL
6MAM ScreenNegative< 10ng/mL
6MAM Confirmation GCMSNot Detected< 10ng/mL
Cannabinoid ScreenNegative< 50ng/mL
THC Confirmation GCMSNot Detected< 15ng/mL
PCP ScreenNegative< 25ng/mL
PCP Confirmation GCMSNot Detected< 25ng/mL
Barbiturates ScreenNegative< 200ng/mL
Amobarbital Confirmation GCMSNot Detected< 200ng/mL
Butalbital Confirmation GCMSNot Detected< 200ng/mL
Pentobarbital Confirmation GCMSNot Detected< 200ng/mL
Phenobarbital Confirmation GCMSNot Detected< 200ng/mL
Secobarbital Confirmation GCMSNot Detected< 200ng/mL
Benzodiazepines ScreenNegative< 200ng/mL
Clonazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoclonazepam Confirmation LCMSMSNot Detected< 10ng/mL
Flunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoflunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
Diazepam Confirmation LCMSMSNot Detected< 10ng/mL
Temazepam Confirmation LCMSMSNot Detected< 25ng/mL
Nordiazepam Confirmation LCMSMSNot Detected< 25ng/mL
Oxazepam Confirmation LCMSMSNot Detected< 25ng/mL
Lorazepam Confirmation LCMSMSNot Detected< 25ng/mL
Alprazolam Confirmation LCMSMSNot Detected< 10ng/mL
Alpha-Hydroxyalprazolam Confirmation LCMSMSNot Detected< 25ng/mL
Flurazepam Confirmation LCMSMSNot Detected< 10ng/mL
Midazolam Confirmation LCMSMSNot Detected< 25ng/mL
Alpha-Hydroxytriazolam Confirmation LCMSMSNot Detected< 25ng/mL
Methadone Metabolite ScreenNegative< 300ng/mL
Methadone Metabolite Confirmation GCMSNot Detected< 100ng/mL
Propoxyphene ScreenNegative< 300ng/mL
Norpropoxyphene Confirmation GCMSNot Detected< 150ng/mL
Specimen ValidityUrine Creatinine
Urine pH
Urine Specific Gravity
SUBSTANCE ABUSE PANEL (SAP950A) (THC50) URINE SCREEN RFLXSAP950ASAP950AEnzyme Immunoassay
TitleDescriptorRangesUnits
Amphetamines ScreenNegative< 500ng/mL
Amphetamines Confirmation GCMSNot Detected< 250ng/mL
Methamphetamine Confirmation GCMSNot Detected< 250ng/mL
Benzoylecgonine (Cocaine) ScreenNegative< 150ng/mL
Benzoylecgonine (Cocaine) Confirmation GCMSNot Detected< 100ng/mL
Opiate ScreenNegative< 2000ng/mL
Codeine Confirmation GCMSNot Detected< 2000ng/mL
Morphine Confirmation GCMSNot Detected< 2000ng/mL
6MAM ScreenNegative< 10ng/mL
6MAM Confirmation GCMSNot Detected< 10ng/mL
Cannabinoid ScreenNegative< 50ng/mL
THC Confirmation GCMSNot Detected< 15ng/mL
PCP ScreenNegative< 25ng/mL
PCP Confirmation GCMSNot Detected< 25ng/mL
Barbiturates ScreenNegative< 200ng/mL
Amobarbital Confirmation GCMSNot Detected< 200ng/mL
Butalbital Confirmation GCMSNot Detected< 200ng/mL
Pentobarbital Confirmation GCMSNot Detected< 200ng/mL
Phenobarbital Confirmation GCMSNot Detected< 200ng/mL
Secobarbital Confirmation GCMSNot Detected< 200ng/mL
Benzodiazepines ScreenNegative< 200ng/mL
Clonazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoclonazepam Confirmation LCMSMSNot Detected< 10ng/mL
Flunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoflunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
Diazepam Confirmation LCMSMSNot Detected< 10ng/mL
Temazepam Confirmation LCMSMSNot Detected< 25ng/mL
Nordiazepam Confirmation LCMSMSNot Detected< 25ng/mL
Oxazepam Confirmation LCMSMSNot Detected< 25ng/mL
Lorazepam Confirmation LCMSMSNot Detected< 25ng/mL
Alprazolam Confirmation LCMSMSNot Detected< 10ng/mL
Alpha-Hydroxyalprazolam Confirmation LCMSMSNot Detected< 25ng/mL
Flurazepam Confirmation LCMSMSNot Detected< 10ng/mL
Midazolam Confirmation LCMSMSNot Detected< 25ng/mL
Alpha-Hydroxytriazolam Confirmation LCMSMSNot Detected< 25ng/mL
Methadone Metabolite ScreenNegative< 300ng/mL
Methadone Metabolite Confirmation GCMSNot Detected< 100ng/mL
Propoxyphene ScreenNegative< 300ng/mL
Norpropoxyphene Confirmation GCMSNot Detected< 150ng/mL
ETOH (Ethyl Alcohol) ScreenNegative< 20ng/mL
ETOH (Ethyl Alcohol) Confirmation GCFIDNot Detected< 20ng/mL
Specimen ValidityUrine Creatinine
Urine pH
Urine Specific Gravity
EMPLOYEE DRUG SCREEN (EDS50) PANEL (THC50) URINE SCREEN RFLXEDS50EDS50Enzyme Immunoassay
TitleDescriptorRangesUnits
Amphetamines ScreenNegative< 500ng/mL
Amphetamines Confirmation GCMSNot Detected< 250ng/mL
Methamphetamine Confirmation GCMSNot Detected< 250ng/mL
Benzoylecgonine (Cocaine) ScreenNegative< 150ng/mL
Benzoylecgonine (Cocaine) Confirmation GCMSNot Detected< 100ng/mL
Opiate ScreenNegative< 2000ng/mL
Codeine Confirmation GCMSNot Detected< 2000ng/mL
Morphine Confirmation GCMSNot Detected< 2000ng/mL
6MAM ScreenNegative< 10ng/mL
6MAM Confirmation GCMSNot Detected< 10ng/mL
Cannabinoid ScreenNegative< 50ng/mL
THC Confirmation GCMSNot Detected< 15ng/mL
PCP ScreenNegative< 25ng/mL
PCP Confirmation GCMSNot Detected< 25ng/mL
Barbiturates ScreenNegative< 200ng/mL
Amobarbital Confirmation GCMSNot Detected< 200ng/mL
Butalbital Confirmation GCMSNot Detected< 200ng/mL
Pentobarbital Confirmation GCMSNot Detected< 200ng/mL
Phenobarbital Confirmation GCMSNot Detected< 200ng/mL
Secobarbital Confirmation GCMSNot Detected< 200ng/mL
Benzodiazepines ScreenNegative< 200ng/mL
Clonazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoclonazepam Confirmation LCMSMSNot Detected< 10ng/mL
Flunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoflunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
Diazepam Confirmation LCMSMSNot Detected< 10ng/mL
Temazepam Confirmation LCMSMSNot Detected< 25ng/mL
Nordiazepam Confirmation LCMSMSNot Detected< 25ng/mL
Oxazepam Confirmation LCMSMSNot Detected< 25ng/mL
Lorazepam Confirmation LCMSMSNot Detected< 25ng/mL
Alprazolam Confirmation LCMSMSNot Detected< 10ng/mL
Alpha-Hydroxyalprazolam Confirmation LCMSMSNot Detected< 25ng/mL
Flurazepam Confirmation LCMSMSNot Detected< 10ng/mL
Midazolam Confirmation LCMSMSNot Detected< 25ng/mL
Alpha-Hydroxytriazolam Confirmation LCMSMSNot Detected< 25ng/mL
Methadone Metabolite ScreenNegative< 300ng/mL
Methadone Metabolite Confirmation GCMSNot Detected< 100ng/mL
Methaqualone ScreenNegative< 300ng/mL
Methaqualone Confirmation GCMSNot Detected< 150ng/mL
Propoxyphene ScreenNegative< 300ng/mL
Norpropoxyphene Confirmation GCMSNot Detected< 150ng/mL
Specimen ValidityUrine Creatinine
Urine pH
Urine Specific Gravity
EMPLOYEE DRUG SCREEN (EDS50A) PANEL (THC50) URINE SCREEN RFLXEDS50AEDS50AEnzyme Immunoassay
TitleDescriptorRangesUnits
Amphetamines ScreenNegative< 500ng/mL
Amphetamines Confirmation GCMSNot Detected< 250ng/mL
Methamphetamine Confirmation GCMSNot Detected< 250ng/mL
Benzoylecgonine (Cocaine) ScreenNegative< 150ng/mL
Benzoylecgonine (Cocaine) Confirmation GCMSNot Detected< 100ng/mL
Opiate ScreenNegative< 2000ng/mL
Codeine Confirmation GCMSNot Detected< 2000ng/mL
Morphine Confirmation GCMSNot Detected< 2000ng/mL
6MAM ScreenNegative< 10ng/mL
6MAM Confirmation GCMSNot Detected< 10ng/mL
Cannabinoid ScreenNegative< 50ng/mL
THC Confirmation GCMSNot Detected< 15ng/mL
PCP ScreenNegative< 25ng/mL
PCP Confirmation GCMSNot Detected< 25ng/mL
Barbiturates ScreenNegative< 200ng/mL
Amobarbital Confirmation GCMSNot Detected< 200ng/mL
Butalbital Confirmation GCMSNot Detected< 200ng/mL
Pentobarbital Confirmation GCMSNot Detected< 200ng/mL
Phenobarbital Confirmation GCMSNot Detected< 200ng/mL
Secobarbital Confirmation GCMSNot Detected< 200ng/mL
Benzodiazepines ScreenNegative< 200ng/mL
Clonazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoclonazepam Confirmation LCMSMSNot Detected< 10ng/mL
Flunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoflunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
Diazepam Confirmation LCMSMSNot Detected< 10ng/mL
Temazepam Confirmation LCMSMSNot Detected< 25ng/mL
Nordiazepam Confirmation LCMSMSNot Detected< 25ng/mL
Oxazepam Confirmation LCMSMSNot Detected< 25ng/mL
Lorazepam Confirmation LCMSMSNot Detected< 25ng/mL
Alprazolam Confirmation LCMSMSNot Detected< 10ng/mL
Alpha-Hydroxyalprazolam Confirmation LCMSMSNot Detected< 25ng/mL
Flurazepam Confirmation LCMSMSNot Detected< 10ng/mL
Midazolam Confirmation LCMSMSNot Detected< 25ng/mL
Alpha-Hydroxytriazolam Confirmation LCMSMSNot Detected< 25ng/mL
Methadone Metabolite ScreenNegative< 300ng/mL
Methadone Metabolite Confirmation GCMSNot Detected< 100ng/mL
Methaqualone ScreenNegative< 300ng/mL
Methaqualone Confirmation GCMSNot Detected< 150ng/mL
Propoxyphene ScreenNegative< 300ng/mL
Norpropoxyphene Confirmation GCMSNot Detected< 150ng/mL
ETOH (Ethyl Alcohol) ScreenNegative< 20ng/mL
ETOH (Ethyl Alcohol) Confirmation GCFIDNot Detected< 20ng/mL
Specimen ValidityUrine Creatinine
Urine pH
Urine Specific Gravity
DRUG FREE WORKPLACE (DFW50A) PANEL (THC50) URINE SCREEN RFLXDFW50ADFW50AEnzyme Immunoassay
TitleDescriptorRangesUnits
Amphetamines ScreenNegative< 500ng/mL
Amphetamines Confirmation GCMSNot Detected< 250ng/mL
Methamphetamine Confirmation GCMSNot Detected< 250ng/mL
Benzoylecgonine (Cocaine) ScreenNegative< 150ng/mL
Benzoylecgonine (Cocaine) Confirmation GCMSNot Detected< 100ng/mL
Opiate ScreenNegative< 2000ng/mL
Codeine Confirmation GCMSNot Detected< 2000ng/mL
Morphine Confirmation GCMSNot Detected< 2000ng/mL
6MAM ScreenNegative< 10ng/mL
6MAM Confirmation GCMSNot Detected< 10ng/mL
Cannabinoid ScreenNegative< 50ng/mL
THC Confirmation GCMSNot Detected< 15ng/mL
PCP ScreenNegative< 25ng/mL
PCP Confirmation GCMSNot Detected< 25ng/mL
ETOH (Ethyl Alcohol) ScreenNegative< 20ng/mL
ETOH (Ethyl Alcohol) Confirmation GCFIDNot Detected< 20ng/mL
Specimen ValidityUrine Creatinine
Urine pH
Urine Specific Gravity
DRUG FREE WORKPLACE (DFW50) PANEL (THC50) URINE SCREEN RFLXDFW50DFW50Enzyme Immunoassay
TitleDescriptorRangesUnits
Amphetamines ScreenNegative< 500ng/mL
Amphetamines Confirmation GCMSNot Detected< 250ng/mL
Methamphetamine Confirmation GCMSNot Detected< 250ng/mL
Benzoylecgonine (Cocaine) ScreenNegative< 150ng/mL
Benzoylecgonine (Cocaine) Confirmation GCMSNot Detected< 100ng/mL
Opiate ScreenNegative< 2000ng/mL
Codeine Confirmation GCMSNot Detected< 2000ng/mL
Morphine Confirmation GCMSNot Detected< 2000ng/mL
6MAM ScreenNegative< 10ng/mL
6MAM Confirmation GCMSNot Detected< 10ng/mL
Cannabinoid ScreenNegative< 50ng/mL
THC Confirmation GCMSNot Detected< 15ng/mL
PCP ScreenNegative< 25ng/mL
PCP Confirmation GCMSNot Detected< 25ng/mL
Specimen ValidityUrine Creatinine
Urine pH
Urine Specific Gravity
SUBSTANCE ABUSE PANEL (SAP7NT) URINE SCREEN RFLXSAP7NTEnzyme Immunoassay
TitleDescriptorRangesUnits
Amphetamines ScreenNegative< 500ng/mL
Amphetamines Confirmation GCMSNot Detected< 250ng/mL
Methamphetamine Confirmation GCMSNot Detected< 250ng/mL
Benzoylecgonine (Cocaine) ScreenNegative< 150ng/mL
Benzoylecgonine (Cocaine) Confirmation GCMSNot Detected< 100ng/mL
Opiate ScreenNegative< 2000ng/mL
Codeine Confirmation GCMSNot Detected< 2000ng/mL
Morphine Confirmation GCMSNot Detected< 2000ng/mL
6MAM ScreenNegative< 10ng/mL
6MAM Confirmation GCMSNot Detected< 10ng/mL
PCP ScreenNegative< 25ng/mL
PCP Confirmation GCMSNot Detected< 25ng/mL
Barbiturates ScreenNegative< 200ng/mL
Amobarbital Confirmation GCMSNot Detected< 200ng/mL
Butalbital Confirmation GCMSNot Detected< 200ng/mL
Pentobarbital Confirmation GCMSNot Detected< 200ng/mL
Phenobarbital Confirmation GCMSNot Detected< 200ng/mL
Secobarbital Confirmation GCMSNot Detected< 200ng/mL
Benzodiazepines ScreenNegative< 200ng/mL
Clonazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoclonazepam Confirmation LCMSMSNot Detected< 10ng/mL
Flunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoflunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
Diazepam Confirmation LCMSMSNot Detected< 10ng/mL
Temazepam Confirmation LCMSMSNot Detected< 25ng/mL
Nordiazepam Confirmation LCMSMSNot Detected< 25ng/mL
Oxazepam Confirmation LCMSMSNot Detected< 25ng/mL
Lorazepam Confirmation LCMSMSNot Detected< 25ng/mL
Alprazolam Confirmation LCMSMSNot Detected< 10ng/mL
Alpha-Hydroxyalprazolam Confirmation LCMSMSNot Detected< 25ng/mL
Flurazepam Confirmation LCMSMSNot Detected< 10ng/mL
Midazolam Confirmation LCMSMSNot Detected< 25ng/mL
Alpha-Hydroxytriazolam Confirmation LCMSMSNot Detected< 25ng/mL
Specimen ValidityUrine Creatinine
Urine pH
Urine Specific Gravity
DRUG FREE WORKPLACE (DFWB) PANEL (THC100) URINE SCREEN RFLXDFWBDFWBEnzyme Immunoassay
TitleDescriptorRangesUnits
Amphetamines ScreenNegative< 500ng/mL
Amphetamines Confirmation GCMSNot Detected< 250ng/mL
Methamphetamine Confirmation GCMSNot Detected< 250ng/mL
Benzoylecgonine (Cocaine) ScreenNegative< 150ng/mL
Benzoylecgonine (Cocaine) Confirmation GCMSNot Detected< 100ng/mL
Opiate ScreenNegative< 2000ng/mL
Codeine Confirmation GCMSNot Detected< 2000ng/mL
Morphine Confirmation GCMSNot Detected< 2000ng/mL
Alternate Opiate ScreenNegative< 300ng/mL
Hydrocodone Confirmation GCMSNot Detected< 300ng/mL
Hydromorphone Confirmation GCMSNot Detected< 300ng/mL
Oxycodone ScreenNegative< 100ng/mL
Oxycodone Confirmation GCMSNot Detected< 100ng/mL
6MAM ScreenNegative< 10ng/mL
6MAM Confirmation GCMSNot Detected< 10ng/mL
Cannabinoid ScreenNegative< 100ng/mL
THC Confirmation GCMSNot Detected< 15ng/mL
PCP ScreenNegative< 25ng/mL
PCP Confirmation GCMSNot Detected< 25ng/mL
Specimen ValidityUrine Creatinine
Urine pH
Urine Specific Gravity
EMPLOYEE DRUG SCREEN (EDS20B) PANEL (THC20) URINE SCREEN RFLXEDS20BEDS20BEnzyme Immunoassay
TitleDescriptorRangesUnits
Amphetamines ScreenNegative< 500ng/mL
Amphetamines Confirmation GCMSNot Detected< 250ng/mL
Methamphetamine Confirmation GCMSNot Detected< 250ng/mL
Benzoylecgonine (Cocaine) ScreenNegative< 150ng/mL
Benzoylecgonine (Cocaine) Confirmation GCMSNot Detected< 100ng/mL
Opiate ScreenNegative< 2000ng/mL
Codeine Confirmation GCMSNot Detected< 2000ng/mL
Morphine Confirmation GCMSNot Detected< 2000ng/mL
Alternate Opiate ScreenNegative< 300ng/mL
Hydrocodone Confirmation GCMSNot Detected< 300ng/mL
Hydromorphone Confirmation GCMSNot Detected< 300ng/mL
Oxycodone ScreenNegative< 100ng/mL
Oxycodone Confirmation GCMSNot Detected< 100ng/mL
6MAM ScreenNegative< 10ng/mL
6MAM Confirmation GCMSNot Detected< 10ng/mL
Cannabinoid ScreenNegative< 20ng/mL
THC Confirmation GCMSNot Detected< 10ng/mL
PCP ScreenNegative< 25ng/mL
PCP Confirmation GCMSNot Detected< 25ng/mL
Barbiturates ScreenNegative< 200ng/mL
Amobarbital Confirmation GCMSNot Detected< 200ng/mL
Butalbital Confirmation GCMSNot Detected< 200ng/mL
Pentobarbital Confirmation GCMSNot Detected< 200ng/mL
Phenobarbital Confirmation GCMSNot Detected< 200ng/mL
Secobarbital Confirmation GCMSNot Detected< 200ng/mL
Benzodiazepines ScreenNegative< 200ng/mL
Clonazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoclonazepam Confirmation LCMSMSNot Detected< 10ng/mL
Flunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoflunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
Diazepam Confirmation LCMSMSNot Detected< 10ng/mL
Temazepam Confirmation LCMSMSNot Detected< 25ng/mL
Nordiazepam Confirmation LCMSMSNot Detected< 25ng/mL
Oxazepam Confirmation LCMSMSNot Detected< 25ng/mL
Lorazepam Confirmation LCMSMSNot Detected< 25ng/mL
Alprazolam Confirmation LCMSMSNot Detected< 10ng/mL
Alpha-Hydroxyalprazolam Confirmation LCMSMSNot Detected< 25ng/mL
Flurazepam Confirmation LCMSMSNot Detected< 10ng/mL
Midazolam Confirmation LCMSMSNot Detected< 25ng/mL
Alpha-Hydroxytriazolam Confirmation LCMSMSNot Detected< 25ng/mL
Methadone Metabolite ScreenNegative< 300ng/mL
Methadone Metabolite Confirmation GCMSNot Detected< 100ng/mL
Methaqualone ScreenNegative< 300ng/mL
Methaqualone Confirmation GCMSNot Detected< 150ng/mL
Propoxyphene ScreenNegative< 300ng/mL
Norpropoxyphene Confirmation GCMSNot Detected< 150ng/mL
Specimen ValidityUrine Creatinine
Urine pH
Urine Specific Gravity
DRUG FREE WORKPLACE (DFW20D) PANEL (THC20) URINE SCREEN RFLXDFW20DDFW20DEnzyme Immunoassay
TitleDescriptorRangesUnits
Amphetamines ScreenNegative< 500ng/mL
Amphetamines Confirmation GCMSNot Detected< 250ng/mL
Methamphetamine Confirmation GCMSNot Detected< 250ng/mL
Benzoylecgonine (Cocaine) ScreenNegative< 150ng/mL
Benzoylecgonine (Cocaine) Confirmation GCMSNot Detected< 100ng/mL
Opiate ScreenNegative< 2000ng/mL
Codeine Confirmation GCMSNot Detected< 2000ng/mL
Morphine Confirmation GCMSNot Detected< 2000ng/mL
Alternate Opiate ScreenNegative< 300ng/mL
Hydrocodone Confirmation GCMSNot Detected< 300ng/mL
Hydromorphone Confirmation GCMSNot Detected< 300ng/mL
Oxycodone ScreenNegative< 100ng/mL
Oxycodone Confirmation GCMSNot Detected< 100ng/mL
6MAM ScreenNegative< 10ng/mL
6MAM Confirmation GCMSNot Detected< 10ng/mL
Cannabinoid ScreenNegative< 20ng/mL
THC Confirmation GCMSNot Detected< 10ng/mL
PCP ScreenNegative< 25ng/mL
PCP Confirmation GCMSNot Detected< 25ng/mL
ETOH (Ethyl Alcohol) ScreenNegative< 20ng/mL
ETOH (Ethyl Alcohol) Confirmation GCFIDNot Detected< 20ng/mL
Specimen ValidityUrine Creatinine
Urine pH
Urine Specific Gravity
DRUG FREE WORKPLACE (DFW20B) PANEL (THC20) URINE SCREEN RFLXDFW20BDFW20BEnzyme Immunoassay
TitleDescriptorRangesUnits
Amphetamines ScreenNegative< 500ng/mL
Amphetamines Confirmation GCMSNot Detected< 250ng/mL
Methamphetamine Confirmation GCMSNot Detected< 250ng/mL
Benzoylecgonine (Cocaine) ScreenNegative< 150ng/mL
Benzoylecgonine (Cocaine) Confirmation GCMSNot Detected< 100ng/mL
Opiate ScreenNegative< 2000ng/mL
Codeine Confirmation GCMSNot Detected< 2000ng/mL
Morphine Confirmation GCMSNot Detected< 2000ng/mL
Alternate Opiate ScreenNegative< 300ng/mL
Hydrocodone Confirmation GCMSNot Detected< 300ng/mL
Hydromorphone Confirmation GCMSNot Detected< 300ng/mL
Oxycodone ScreenNegative< 100ng/mL
Oxycodone Confirmation GCMSNot Detected< 100ng/mL
6MAM ScreenNegative< 10ng/mL
6MAM Confirmation GCMSNot Detected< 10ng/mL
Cannabinoid ScreenNegative< 20ng/mL
THC Confirmation GCMSNot Detected< 10ng/mL
PCP ScreenNegative< 25ng/mL
PCP Confirmation GCMSNot Detected< 25ng/mL
Specimen ValidityUrine Creatinine
Urine pH
Urine Specific Gravity
SUBSTANCE ABUSE PANEL (SAP750B) (THC50) URINE SCREEN RFLXSAP750BSAP750BEnzyme Immunoassay
TitleDescriptorRangesUnits
Amphetamines ScreenNegative< 500ng/mL
Amphetamines Confirmation GCMSNot Detected< 250ng/mL
Methamphetamine Confirmation GCMSNot Detected< 250ng/mL
Benzoylecgonine (Cocaine) ScreenNegative< 150ng/mL
Benzoylecgonine (Cocaine) Confirmation GCMSNot Detected< 100ng/mL
Opiate ScreenNegative< 2000ng/mL
Codeine Confirmation GCMSNot Detected< 2000ng/mL
Morphine Confirmation GCMSNot Detected< 2000ng/mL
Alternate Opiate ScreenNegative< 300ng/mL
Hydrocodone Confirmation GCMSNot Detected< 300ng/mL
Hydromorphone Confirmation GCMSNot Detected< 300ng/mL
Oxycodone ScreenNegative< 100ng/mL
Oxycodone Confirmation GCMSNot Detected< 100ng/mL
6MAM ScreenNegative< 10ng/mL
6MAM Confirmation GCMSNot Detected< 10ng/mL
Cannabinoid ScreenNegative< 50ng/mL
THC Confirmation GCMSNot Detected< 15ng/mL
PCP ScreenNegative< 25ng/mL
PCP Confirmation GCMSNot Detected< 25ng/mL
Barbiturates ScreenNegative< 200ng/mL
Amobarbital Confirmation GCMSNot Detected< 200ng/mL
Butalbital Confirmation GCMSNot Detected< 200ng/mL
Pentobarbital Confirmation GCMSNot Detected< 200ng/mL
Phenobarbital Confirmation GCMSNot Detected< 200ng/mL
Secobarbital Confirmation GCMSNot Detected< 200ng/mL
Benzodiazepines ScreenNegative< 200ng/mL
Clonazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoclonazepam Confirmation LCMSMSNot Detected< 10ng/mL
Flunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoflunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
Diazepam Confirmation LCMSMSNot Detected< 10ng/mL
Temazepam Confirmation LCMSMSNot Detected< 25ng/mL
Nordiazepam Confirmation LCMSMSNot Detected< 25ng/mL
Oxazepam Confirmation LCMSMSNot Detected< 25ng/mL
Lorazepam Confirmation LCMSMSNot Detected< 25ng/mL
Alprazolam Confirmation LCMSMSNot Detected< 10ng/mL
Alpha-Hydroxyalprazolam Confirmation LCMSMSNot Detected< 25ng/mL
Flurazepam Confirmation LCMSMSNot Detected< 10ng/mL
Midazolam Confirmation LCMSMSNot Detected< 25ng/mL
Alpha-Hydroxytriazolam Confirmation LCMSMSNot Detected< 25ng/mL
Specimen ValidityUrine Creatinine
Urine pH
Urine Specific Gravity
SUBSTANCE ABUSE PANEL (SAP750D) (THC50) URINE SCREEN RFLXSAP750DSAP750DEnzyme Immunoassay
TitleDescriptorRangesUnits
Amphetamines ScreenNegative< 500ng/mL
Amphetamines Confirmation GCMSNot Detected< 250ng/mL
Methamphetamine Confirmation GCMSNot Detected< 250ng/mL
Benzoylecgonine (Cocaine) ScreenNegative< 150ng/mL
Benzoylecgonine (Cocaine) Confirmation GCMSNot Detected< 100ng/mL
Opiate ScreenNegative< 2000ng/mL
Codeine Confirmation GCMSNot Detected< 2000ng/mL
Morphine Confirmation GCMSNot Detected< 2000ng/mL
Alternate Opiate ScreenNegative< 300ng/mL
Hydrocodone Confirmation GCMSNot Detected< 300ng/mL
Hydromorphone Confirmation GCMSNot Detected< 300ng/mL
Oxycodone ScreenNegative< 100ng/mL
Oxycodone Confirmation GCMSNot Detected< 100ng/mL
6MAM ScreenNegative< 10ng/mL
6MAM Confirmation GCMSNot Detected< 10ng/mL
Cannabinoid ScreenNegative< 50ng/mL
THC Confirmation GCMSNot Detected< 15ng/mL
PCP ScreenNegative< 25ng/mL
PCP Confirmation GCMSNot Detected< 25ng/mL
Barbiturates ScreenNegative< 200ng/mL
Amobarbital Confirmation GCMSNot Detected< 200ng/mL
Butalbital Confirmation GCMSNot Detected< 200ng/mL
Pentobarbital Confirmation GCMSNot Detected< 200ng/mL
Phenobarbital Confirmation GCMSNot Detected< 200ng/mL
Secobarbital Confirmation GCMSNot Detected< 200ng/mL
Benzodiazepines ScreenNegative< 200ng/mL
Clonazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoclonazepam Confirmation LCMSMSNot Detected< 10ng/mL
Flunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoflunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
Diazepam Confirmation LCMSMSNot Detected< 10ng/mL
Temazepam Confirmation LCMSMSNot Detected< 25ng/mL
Nordiazepam Confirmation LCMSMSNot Detected< 25ng/mL
Oxazepam Confirmation LCMSMSNot Detected< 25ng/mL
Lorazepam Confirmation LCMSMSNot Detected< 25ng/mL
Alprazolam Confirmation LCMSMSNot Detected< 10ng/mL
Alpha-Hydroxyalprazolam Confirmation LCMSMSNot Detected< 25ng/mL
Flurazepam Confirmation LCMSMSNot Detected< 10ng/mL
Midazolam Confirmation LCMSMSNot Detected< 25ng/mL
Alpha-Hydroxytriazolam Confirmation LCMSMSNot Detected< 25ng/mL
ETOH (Ethyl Alcohol) ScreenNegative< 20ng/mL
ETOH (Ethyl Alcohol) Confirmation GCFIDNot Detected< 20ng/mL
Specimen ValidityUrine Creatinine
Urine pH
Urine Specific Gravity
SUBSTANCE ABUSE PANEL (SAP950B) (THC50) URINE SCREEN RFLXSAP950BSAP950BEnzyme Immunoassay
TitleDescriptorRangesUnits
Amphetamines ScreenNegative< 500ng/mL
Amphetamines Confirmation GCMSNot Detected< 250ng/mL
Methamphetamine Confirmation GCMSNot Detected< 250ng/mL
Benzoylecgonine (Cocaine) ScreenNegative< 150ng/mL
Benzoylecgonine (Cocaine) Confirmation GCMSNot Detected< 100ng/mL
Opiate ScreenNegative< 2000ng/mL
Codeine Confirmation GCMSNot Detected< 2000ng/mL
Morphine Confirmation GCMSNot Detected< 2000ng/mL
Alternate Opiate ScreenNegative< 300ng/mL
Hydrocodone Confirmation GCMSNot Detected< 300ng/mL
Hydromorphone Confirmation GCMSNot Detected< 300ng/mL
Oxycodone ScreenNegative< 100ng/mL
Oxycodone Confirmation GCMSNot Detected< 100ng/mL
6MAM ScreenNegative< 10ng/mL
6MAM Confirmation GCMSNot Detected< 10ng/mL
Cannabinoid ScreenNegative< 50ng/mL
THC Confirmation GCMSNot Detected< 15ng/mL
PCP ScreenNegative< 25ng/mL
PCP Confirmation GCMSNot Detected< 25ng/mL
Barbiturates ScreenNegative< 200ng/mL
Amobarbital Confirmation GCMSNot Detected< 200ng/mL
Butalbital Confirmation GCMSNot Detected< 200ng/mL
Pentobarbital Confirmation GCMSNot Detected< 200ng/mL
Phenobarbital Confirmation GCMSNot Detected< 200ng/mL
Secobarbital Confirmation GCMSNot Detected< 200ng/mL
Benzodiazepines ScreenNegative< 200ng/mL
Clonazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoclonazepam Confirmation LCMSMSNot Detected< 10ng/mL
Flunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoflunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
Diazepam Confirmation LCMSMSNot Detected< 10ng/mL
Temazepam Confirmation LCMSMSNot Detected< 25ng/mL
Nordiazepam Confirmation LCMSMSNot Detected< 25ng/mL
Oxazepam Confirmation LCMSMSNot Detected< 25ng/mL
Lorazepam Confirmation LCMSMSNot Detected< 25ng/mL
Alprazolam Confirmation LCMSMSNot Detected< 10ng/mL
Alpha-Hydroxyalprazolam Confirmation LCMSMSNot Detected< 25ng/mL
Flurazepam Confirmation LCMSMSNot Detected< 10ng/mL
Midazolam Confirmation LCMSMSNot Detected< 25ng/mL
Alpha-Hydroxytriazolam Confirmation LCMSMSNot Detected< 25ng/mL
Methadone Metabolite ScreenNegative< 300ng/mL
Methadone Metabolite Confirmation GCMSNot Detected< 100ng/mL
Propoxyphene ScreenNegative< 300ng/mL
Norpropoxyphene Confirmation GCMSNot Detected< 150ng/mL
Specimen ValidityUrine Creatinine
Urine pH
Urine Specific Gravity
EMPLOYEE DRUG SCREEN (EDS50B) PANEL (THC50) URINE SCREEN RFLXEDS50BEDS50BEnzyme Immunoassay
TitleDescriptorRangesUnits
Amphetamines ScreenNegative< 500ng/mL
Amphetamines Confirmation GCMSNot Detected< 250ng/mL
Methamphetamine Confirmation GCMSNot Detected< 250ng/mL
Benzoylecgonine (Cocaine) ScreenNegative< 150ng/mL
Benzoylecgonine (Cocaine) Confirmation GCMSNot Detected< 100ng/mL
Opiate ScreenNegative< 2000ng/mL
Codeine Confirmation GCMSNot Detected< 2000ng/mL
Morphine Confirmation GCMSNot Detected< 2000ng/mL
Alternate Opiate ScreenNegative< 300ng/mL
Hydrocodone Confirmation GCMSNot Detected< 300ng/mL
Hydromorphone Confirmation GCMSNot Detected< 300ng/mL
Oxycodone ScreenNegative< 100ng/mL
Oxycodone Confirmation GCMSNot Detected< 100ng/mL
6MAM ScreenNegative< 10ng/mL
6MAM Confirmation GCMSNot Detected< 10ng/mL
Cannabinoid ScreenNegative< 50ng/mL
THC Confirmation GCMSNot Detected< 15ng/mL
PCP ScreenNegative< 25ng/mL
PCP Confirmation GCMSNot Detected< 25ng/mL
Barbiturates ScreenNegative< 200ng/mL
Amobarbital Confirmation GCMSNot Detected< 200ng/mL
Butalbital Confirmation GCMSNot Detected< 200ng/mL
Pentobarbital Confirmation GCMSNot Detected< 200ng/mL
Phenobarbital Confirmation GCMSNot Detected< 200ng/mL
Secobarbital Confirmation GCMSNot Detected< 200ng/mL
Benzodiazepines ScreenNegative< 200ng/mL
Clonazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoclonazepam Confirmation LCMSMSNot Detected< 10ng/mL
Flunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoflunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
Diazepam Confirmation LCMSMSNot Detected< 10ng/mL
Temazepam Confirmation LCMSMSNot Detected< 25ng/mL
Nordiazepam Confirmation LCMSMSNot Detected< 25ng/mL
Oxazepam Confirmation LCMSMSNot Detected< 25ng/mL
Lorazepam Confirmation LCMSMSNot Detected< 25ng/mL
Alprazolam Confirmation LCMSMSNot Detected< 10ng/mL
Alpha-Hydroxyalprazolam Confirmation LCMSMSNot Detected< 25ng/mL
Flurazepam Confirmation LCMSMSNot Detected< 10ng/mL
Midazolam Confirmation LCMSMSNot Detected< 25ng/mL
Alpha-Hydroxytriazolam Confirmation LCMSMSNot Detected< 25ng/mL
Methadone Metabolite ScreenNegative< 300ng/mL
Methadone Metabolite Confirmation GCMSNot Detected< 100ng/mL
Methaqualone ScreenNegative< 300ng/mL
Methaqualone Confirmation GCMSNot Detected< 150ng/mL
Propoxyphene ScreenNegative< 300ng/mL
Norpropoxyphene Confirmation GCMSNot Detected< 150ng/mL
Specimen ValidityUrine Creatinine
Urine pH
Urine Specific Gravity
EMPLOYEE DRUG SCREEN (EDS50D) PANEL (THC50) URINE SCREEN RFLXEDS50DEDS50DEnzyme Immunoassay
TitleDescriptorRangesUnits
Amphetamines ScreenNegative< 500ng/mL
Amphetamines Confirmation GCMSNot Detected< 250ng/mL
Methamphetamine Confirmation GCMSNot Detected< 250ng/mL
Benzoylecgonine (Cocaine) ScreenNegative< 150ng/mL
Benzoylecgonine (Cocaine) Confirmation GCMSNot Detected< 100ng/mL
Opiate ScreenNegative< 2000ng/mL
Codeine Confirmation GCMSNot Detected< 2000ng/mL
Morphine Confirmation GCMSNot Detected< 2000ng/mL
Alternate Opiate ScreenNegative< 300ng/mL
Hydrocodone Confirmation GCMSNot Detected< 300ng/mL
Hydromorphone Confirmation GCMSNot Detected< 300ng/mL
Oxycodone ScreenNegative< 100ng/mL
Oxycodone Confirmation GCMSNot Detected< 100ng/mL
6MAM ScreenNegative< 10ng/mL
6MAM Confirmation GCMSNot Detected< 10ng/mL
Cannabinoid ScreenNegative< 50ng/mL
THC Confirmation GCMSNot Detected< 15ng/mL
PCP ScreenNegative< 25ng/mL
PCP Confirmation GCMSNot Detected< 25ng/mL
Barbiturates ScreenNegative< 200ng/mL
Amobarbital Confirmation GCMSNot Detected< 200ng/mL
Butalbital Confirmation GCMSNot Detected< 200ng/mL
Pentobarbital Confirmation GCMSNot Detected< 200ng/mL
Phenobarbital Confirmation GCMSNot Detected< 200ng/mL
Secobarbital Confirmation GCMSNot Detected< 200ng/mL
Benzodiazepines ScreenNegative< 200ng/mL
Clonazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoclonazepam Confirmation LCMSMSNot Detected< 10ng/mL
Flunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoflunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
Diazepam Confirmation LCMSMSNot Detected< 10ng/mL
Temazepam Confirmation LCMSMSNot Detected< 25ng/mL
Nordiazepam Confirmation LCMSMSNot Detected< 25ng/mL
Oxazepam Confirmation LCMSMSNot Detected< 25ng/mL
Lorazepam Confirmation LCMSMSNot Detected< 25ng/mL
Alprazolam Confirmation LCMSMSNot Detected< 10ng/mL
Alpha-Hydroxyalprazolam Confirmation LCMSMSNot Detected< 25ng/mL
Flurazepam Confirmation LCMSMSNot Detected< 10ng/mL
Midazolam Confirmation LCMSMSNot Detected< 25ng/mL
Alpha-Hydroxytriazolam Confirmation LCMSMSNot Detected< 25ng/mL
Methadone Metabolite ScreenNegative< 300ng/mL
Methadone Metabolite Confirmation GCMSNot Detected< 100ng/mL
Methaqualone ScreenNegative< 300ng/mL
Methaqualone Confirmation GCMSNot Detected< 150ng/mL
Propoxyphene ScreenNegative< 300ng/mL
Norpropoxyphene Confirmation GCMSNot Detected< 150ng/mL
ETOH (Ethyl Alcohol) ScreenNegative< 20ng/mL
ETOH (Ethyl Alcohol) Confirmation GCFIDNot Detected< 20ng/mL
Specimen ValidityUrine Creatinine
Urine pH
Urine Specific Gravity
DRUG FREE WORKPLACE (DFW50D) PANEL (THC50) URINE SCREEN RFLXDFW50DDFW50DEnzyme Immunoassay
TitleDescriptorRangesUnits
Amphetamines ScreenNegative< 500ng/mL
Amphetamines Confirmation GCMSNot Detected< 250ng/mL
Methamphetamine Confirmation GCMSNot Detected< 250ng/mL
Benzoylecgonine (Cocaine) ScreenNegative< 150ng/mL
Benzoylecgonine (Cocaine) Confirmation GCMSNot Detected< 100ng/mL
Opiate ScreenNegative< 2000ng/mL
Codeine Confirmation GCMSNot Detected< 2000ng/mL
Morphine Confirmation GCMSNot Detected< 2000ng/mL
Alternate Opiate ScreenNegative< 300ng/mL
Hydrocodone Confirmation GCMSNot Detected< 300ng/mL
Hydromorphone Confirmation GCMSNot Detected< 300ng/mL
Oxycodone ScreenNegative< 100ng/mL
Oxycodone Confirmation GCMSNot Detected< 100ng/mL
6MAM ScreenNegative< 10ng/mL
6MAM Confirmation GCMSNot Detected< 10ng/mL
Cannabinoid ScreenNegative< 50ng/mL
THC Confirmation GCMSNot Detected< 15ng/mL
PCP ScreenNegative< 25ng/mL
PCP Confirmation GCMSNot Detected< 25ng/mL
ETOH (Ethyl Alcohol) ScreenNegative< 20ng/mL
ETOH (Ethyl Alcohol) Confirmation GCFIDNot Detected< 20ng/mL
Specimen ValidityUrine Creatinine
Urine pH
Urine Specific Gravity
DRUG FREE WORKPLACE (DFW50B) PANEL (THC50) URINE SCREEN RFLXDFW50BDFW50BEnzyme Immunoassay
TitleDescriptorRangesUnits
Amphetamines ScreenNegative< 500ng/mL
Amphetamines Confirmation GCMSNot Detected< 250ng/mL
Methamphetamine Confirmation GCMSNot Detected< 250ng/mL
Benzoylecgonine (Cocaine) ScreenNegative< 150ng/mL
Benzoylecgonine (Cocaine) Confirmation GCMSNot Detected< 100ng/mL
Opiate ScreenNegative< 2000ng/mL
Codeine Confirmation GCMSNot Detected< 2000ng/mL
Morphine Confirmation GCMSNot Detected< 2000ng/mL
Alternate Opiate ScreenNegative< 300ng/mL
Hydrocodone Confirmation GCMSNot Detected< 300ng/mL
Hydromorphone Confirmation GCMSNot Detected< 300ng/mL
Oxycodone ScreenNegative< 100ng/mL
Oxycodone Confirmation GCMSNot Detected< 100ng/mL
6MAM ScreenNegative< 10ng/mL
6MAM Confirmation GCMSNot Detected< 10ng/mL
Cannabinoid ScreenNegative< 50ng/mL
THC Confirmation GCMSNot Detected< 15ng/mL
PCP ScreenNegative< 25ng/mL
PCP Confirmation GCMSNot Detected< 25ng/mL
Specimen ValidityUrine Creatinine
Urine pH
Urine Specific Gravity
EMPLOYEE DRUG SCREEN (EDS+) PANEL (THC100) URINE SCREEN RFLXEDS+EDS+Enzyme Immunoassay
TitleDescriptorRangesUnits
Amphetamines ScreenNegative< 500ng/mL
Amphetamines Confirmation GCMSNot Detected< 250ng/mL
Methamphetamine Confirmation GCMSNot Detected< 250ng/mL
Benzoylecgonine (Cocaine) ScreenNegative< 150ng/mL
Benzoylecgonine (Cocaine) Confirmation GCMSNot Detected< 100ng/mL
Opiate ScreenNegative< 2000ng/mL
Codeine Confirmation GCMSNot Detected< 2000ng/mL
Morphine Confirmation GCMSNot Detected< 2000ng/mL
Cannabinoid ScreenNegative< 100ng/mL
THC Confirmation GCMSNot Detected< 15ng/mL
PCP ScreenNegative< 25ng/mL
PCP Confirmation GCMSNot Detected< 25ng/mL
Barbiturates ScreenNegative< 200ng/mL
Amobarbital Confirmation GCMSNot Detected< 200ng/mL
Butalbital Confirmation GCMSNot Detected< 200ng/mL
Pentobarbital Confirmation GCMSNot Detected< 200ng/mL
Phenobarbital Confirmation GCMSNot Detected< 200ng/mL
Secobarbital Confirmation GCMSNot Detected< 200ng/mL
Benzodiazepines ScreenNegative< 200ng/mL
Clonazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoclonazepam Confirmation LCMSMSNot Detected< 10ng/mL
Flunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoflunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
Diazepam Confirmation LCMSMSNot Detected< 10ng/mL
Temazepam Confirmation LCMSMSNot Detected< 25ng/mL
Nordiazepam Confirmation LCMSMSNot Detected< 25ng/mL
Oxazepam Confirmation LCMSMSNot Detected< 25ng/mL
Lorazepam Confirmation LCMSMSNot Detected< 25ng/mL
Alprazolam Confirmation LCMSMSNot Detected< 10ng/mL
Alpha-Hydroxyalprazolam Confirmation LCMSMSNot Detected< 25ng/mL
Flurazepam Confirmation LCMSMSNot Detected< 10ng/mL
Midazolam Confirmation LCMSMSNot Detected< 25ng/mL
Alpha-Hydroxytriazolam Confirmation LCMSMSNot Detected< 25ng/mL
Methadone Metabolite ScreenNegative< 300ng/mL
Methadone Metabolite Confirmation GCMSNot Detected< 100ng/mL
Methaqualone ScreenNegative< 300ng/mL
Methaqualone Confirmation GCMSNot Detected< 150ng/mL
Propoxyphene ScreenNegative< 300ng/mL
Norpropoxyphene Confirmation GCMSNot Detected< 150ng/mL
ETOH (Ethyl Alcohol) ScreenNegative< 20ng/mL
ETOH (Ethyl Alcohol) Confirmation GCFIDNot Detected< 20ng/mL
Specimen ValidityUrine Creatinine
Urine pH
Urine Specific Gravity
AMPHETAMINE SCREEN RFLXAMPAMPHEnzyme Immunoassay
TitleDescriptorRangesUnits
Amphetamines ScreenNegative< 500ng/mL
AMYLASEAMYAMYEnzymatic
TitleDescriptorRangesUnits
Amylase3-90 days0-30U/L
3-6 months7-40
7-8 months7-57
9-11 months11-70
12-17 months11-79
18-35 months19-92
3-4 years26-106
5-12 years30-119
13-17 years30-110
18+ years28-100
ANA SCREEN (EIA) RFLXANAESRANAESREnzyme-Linked Immunosorbent Assay, Multiplex Luminex
TitleDescriptorRangesUnits
ANA by EIA, AB< 1.0U
ANA by EIA, InterpNegative
ANA CONFIRMATORY ANTIBODIES
DSDNA AutoantibodyNegative< 5IU/mL
Smith AutoantibodyNegative< 1.0AI
JO-1 AutoantibodyNegative< 1.0AI
Ribosomal P AutoantibodyNegative< 1.0AI
Chromatin AutoantibodyNegative< 1.0AI
RNP AutoantibodyNegative< 1.0AI
SMRMP AutoantibodyNegative< 1.0AI
SCL-70 AutoantibodyNegative< 1.0AI
Centromere B AutoantibodyNegative< 1.0AI
SSA (RO) AutoantibodyNegative< 1.0AI
SSB (LA) AutoantibodyNegative< 1.0AI
ANA TITER (IFA) RFLXIFANARIFANARIFA
TitleDescriptorRangesUnits
ANA by IFA Titer LT 1:40Titer
ANA by IFA Pattern
ANA SPECIFIC ANTIBODIES
DSDNA AutoantibodyNegativeLT 5IU/mL
Smith AutoantibodyNegativeLT 1.0AI
JO-1 AutoantibodyNegativeLT 1.0AI
Ribosomal P AutoantibodyNegativeLT 1.0AI
Chromatin AutoantibodyNegativeLT 1.0AI
RNP AutoantibodyNegativeLT 1.0AI
SMRNP AutoantibodyNegativeLT 1.0AI
SCL-70 AutoantibodyNegativeLT 1.0AI
Centromere B AutoantibodyNegativeLT 1.0AI
SSA (RO) AutoantibodyNegativeLT 1.0AI
SSB (LA) AutoantibodyNegativeLT 1.0AI
ANA SPECIFIC ABANASABANASABMultiplex Luminex
TitleDescriptorRangesUnits
ANA SPECIFIC ANTIBODIES
DSDNA AutoantibodyNegative< 5IU/mL
Smith AutoantibodyNegative< 1.0AI
JO-1 AutoantibodyNegative< 1.0AI
Ribosomal P AutoantibodyNegative< 1.0AI
Chromatin AutoantibodyNegative< 1.0AI
RNP AutoantibodyNegative< 1.0AI
SMRNP AutoantibodyNegative< 1.0 AI
SCL-70 AutoantibodyNegative< 1.0AI
Centromere B AutoantibodyNegative< 1.0AI
SSA (RO) AutoantibodyNegative< 1.0AI
SSB (LA) AutoantibodyNegative< 1.0AI
CONNECTIVE TISSUE DISEASE RFLXCTDCTDMultiplex Bead Immunoassay (ANA), Nephelometry (C3, C4), Chemiluminescence Assays (CCP IgG)
TitleDescriptorRangesUnits
ANANegative
A multiplex screen for 11 autoantibodies (dsDNA, Smith, Ribosomal P, Chromatin, RNP, SmRNP, Scl-70, Centromere B, SSA, SSB and J0-1) was performed and no autoantibodies were detected. A negative multiplex ANA does not rule out all possibility of a connective tissue or autoimmune disease, and further studies should be considered if clinical suspicion is high.
DSDNA AutoantibodyNegative< 5IU/mL
Indeterminate5-9
Positive> or = 10
Smith AutoantibodyNegative< 1.0AI
Positive> or = 1.0
Ribosomal P AutoantibodyNegative< 1.0AI
Positive> or = 1.0
Chromatin AutoantibodyNegative< 1.0AI
Positive> or = 1.0
RNP AutoantibodyNegative< 1.0AI
Positive> or = 1.0
SMRNP AutoantibodyNegative< 1.0AI
Positive> or = 1.0
SCL-70 AutoantibodyNegative< 1.0AI
Positive> or = 1.0
Centromere B AutoantibodyNegative< 1.0AI
Positive> or = 1.0
SSA (RO) AutoantibodyNegative< 1.0AI
Positive> or = 1.0
SSB (LA) AutoantibodyNegative< 1.0AI
Positive> or = 1.0
JO-1 AutoantibodyNegative< 1.0AI
Positive> or = 1.0
Complement, C30-1 days50-168mg/dL
2-60 days55-170
2-5 months59-176
6-24 months66-180
25-60 months74-184
5-9 years74-190
10-14 years77-198
15+ years90-200
Complement, C40-7 days0.0-45.7mg/dL
8-60 days1.5-47.9
2-5 months1.5-47.9
6-24 months3.0-47.9
25-60 months4.5-48.4
5-9 years5.3-50.6
10-14 years6.0-52.8
15+ years15.0-55.0
Cyclic Citrullinated Peptide Ab, IgGNegative< 20CU
Positive> or = 20
Approximately 70% of patients with RA are positive for CCP IgG, while only 2% of random blood donors and disease controls are positive. The diagnostic value of antibodies to arthritis patients has not been determined.
RA< 20IU/mL
AUTOIMMUNE PROFILE RFLXAIPAIPMultiplex luminex, Nephelometry, Immunoturbidimetric
TitleDescriptorRangesUnits
ANANegative
A multiplex screen for 11 autoantibodies (dsDNA, Smith, Ribosomal P, Chromatin, RNP, SmRNP, Scl-70, Centromere B, SSA, SSB and J0-1) was performed and no autoantibodies were detected. A negative multiplex ANA does not rule out all possibility of a connective tissue or autoimmune disease, and further studies should be considered if clinical suspicion is high.
DSDNA AutoantibodyNegative< 5IU/mL
Indeterminate5-9
Positive10 or more
Smith AutoantibodyNegative< 1.0AI
Positive1.0 or more
Ribosomal P AutoantibodyNegative< 1.0AI
Positive1.0 or more
Chromatin AutoantibodyNegative< 1.0AI
Positive1.0 or more
RNP AutoantibodyNegative< 1.0AI
Positive1.0 or more
SMRNP AutoantibodyNegative< 1.0AI
Positive1.0 or more
SCL-70 AutoantibodyNegative< 1.0AI
Positive1.0 or more
Centromere B AutoantibodyNegative< 1.0AI
Positive1.0 or more
SSA (RO) AutoantibodyNegative< 1.0AI
Positive1.0 or more
SSB (LA) AutoantibodyNegative< 1.0AI
Positive1.0 or more
JO-1 AutoantibodyNegative< 1.0AI
Positive1.0 or more
Complement, C30-1 day50-168mg/dL
2-60 days55-170
2-5 months59-176
6-24 months66-180
25-60 months74-184
5-9 years74-190
10-14 years77-198
15+ years90-200
CRP< 0.5mg/dL
RA< 20IU/mL
ANALYZER RFLXANALZ4.LCAANALZ4Electrochemiluminescence Immunoassay
TitleDescriptorRangesUnits
ANA< 7.5IU/mL
ANA Pattern
dsDNA AutoAbs< 5.0
RNP/SmNegative< 11
Borderline11-20
Positive> 20
Sm(Smith) IgG AutoAbsNegative< 11
Borderline11-20
Positive> 20
SS-A IgG AutoAbsNegative< 11
Borderline11-20
Positive> 20
SS-B IgG AutoAbsNegative< 11
Borderline11-20
Positive> 20
Scl-70 IgG AutoAbsNegative< 11
Borderline11-20
Positve> 20
Thyroid Peroxidase AutoAbs< 60U/mL
C3 Complement90-180mg/dL
C4 Complement16-47mg/dL
Rheumatoid Factor< 14IU/mL
Ribosmal P AutoAbsNegative< 11Units
Borderline11-20
Positive> 20
ANA SCREEN RFLXANAMPANAMPMultiplex Luminex
TitleDescriptorRangesUnits
ANANegative
A multiplex screen for 11 autoantibodies (dsDNA, Smith, Ribosomal P, Chromatin, RNP, SmRNP, Scl-70, Centromere B, SSA, SSB and J0-1) was performed and no autoantibodies were detected. A negative multiplex ANA does not rule out all possibility of a connective tissue or autoimmune disease, and further studies should be considered if clinical suspicion is high.
DSDNA AutoantibodyNegativeLT 5IU/mL
Indeterminate5-9
Positive10 or more
Smith AutoantibodyNegativeLT 1.0AI
Positive 1.0 or more
Ribosomal P Autoantibody Negative LT 1.0 AI
Positive 1.0 or more
Chromatin Autoantibody Negative LT 1.0 AI
Positive 1.0 or more
RNP Autoantibody Negative LT 1.0 AI
Positive 1.0 or more
SMRNP Autoantibody Negative LT 1.0 AI
Positive 1.0 or more
SCL-70 Autoantibody Negative LT 1.0 AI
Positive 1.0 or more
Centromere B Autoantibody Negative LT 1.0 AI
Positive 1.0 or more
SSA (RO) Autoantibody Negative LT 1.0 AI
Positive 1.0 or more
SSB (LA) Autoantibody Negative LT 1.0 AI
Positive 1.0 or more
JO-1 Autoantibody Negative LT 1.0 AI
Positive 1.0 or more
ANTIPHOSPHATIDLYSERINE-PROTHROMBIN IGG AND IGMPSPTGMPSPTGMEnzyme-Linked Immunosorbent Assay
TitleDescriptorRangesUnits
Anti PS/PT IgGNegative0-30Units
Positive> 30
Anti PS/PT IgMNegative0-30Units
Positive> 30
Interpretive Comment
LOW MOLECULAR WEIGHT HEPARINLMW.HEPARINHEPLMWAntiXa Chromogenic
TitleDescriptorRangesUnits
Anti XaIU/mL
EnoxaparinTarget peak concentration for prophylaxis0.2-0.4
Target peak concentration for treatment, 2 doses daily0.6-1.0
Target peak concentration for treatment, 1 dose daily1.3-2.0
DalteparinTarget peak concentration for prophylaxis0.2-0.4IU/mL
Target peak concentration for treatment, 2 doses daily0.6-1.0
Target peak concentration for treatment, 1 dose daily0.85-1.25
ANTI-C1Q ANTIBODY, IGGACQG.LCAACQGEnzyme Immunoassay
TitleDescriptorRangesUnits
Anti-C1q Antibody, IgGWeak Positive20-39Units
Moderate Positive40-80
Strong Positive> 80
The presence of the anti-C1q antibody may be associated with increased risk of lupus nephritis or with systemic lupus erythematosus (SLE) global activity. Anti-C1q antibodies are not specific for SLE; strong clinical correlation with disease is recommended.
ISLET CELL AB, IGGISLET.LCAISLETIndirect Fluorescent Antibody
TitleDescriptorRangesUnits
Anti-Islet Cell AbNegative< 1:1Titer
Interpretive Data: Islet cell antibodies (ICAs) are associated with type 1 diabetes (T1D), an autoimmune endocrine disorder. ICAs may be present years before the onset of clinical symptoms. To calculate Juvenile Diabetes Foundation (JDF) units: multiply the titer x 5 (1:8 8 x 5 = 40 JDF Units).
PHOSPHOLIPASE A2 RECEPTOR AUTOANTIBODIES, IGGPLA2RAPLA2RAEnzyme-Linked Immunosorbent Assay
TitleDescriptorRangesUnits
Anti-PLA2RNegative< 14.0RU/mL
Borderline14.0-19.9
Positive> 19.9
ANTI-PM/SCL ABPOLYMY.LCAPOLYMYEnzyme Immunoassay
TitleDescriptorRangesUnits
Anti-PM/Scl Ab EIA InterpretationNegative< 20Units
Weak Positive20-39
Moderate Positive40-80
Strong Positive> 80
Anti-PM/Scl antibodies are found in 10% of idiopathic inflammatory myopathy, 25% of Scleroderma/myositis overlap and 2% of Scleroderma. The antibodies are associated with myositis, arthritis, Raynaud's, Scleroderma cutaneous changes and ILD.
ANTIBODY IDENTIFICATIONAB IDMABIDHemagglutination/Solid Phase
Antibody Screen 
Antibody ID
Antibody Titer
ANTIPHOSPHATIDYLSERINE AB, IGAAPSAAPSAELISA
TitleDescriptorRangesUnits
Antiphosphatidylserine, IgANegative< 20APS U/mL
Positive> = 20
The presence of phosphatidylserine Abs maybe associated with anti-phospholipid syndrome characterized by recurrent fetal loss, thrombosis and thrombocytopenia.
PHOSPHATIDYLSERINE ABSAPSAGMAPSAGMEIA
TitleDescriptorRangesUnits
Antiphosphatidylserine, IgANegativeLT 20APS U/mL
Positive20 or more
Antiphosphatidylserine, IgGNegativeLT 11GPS U/mL
Positive11 or more
Antiphosphatidylserine IgMNegativeLT 25MPS U/mL
Positive25 or more
The presence of phosphatidylserine antibodies may be associated with antiphospholipid syndrome characterized by recurrent fetal loss, thrombosis and thrombocytopenia.
ANTIPHOSPHATIDYLSERINE AB, IGGAPSGAPSGEIA
TitleDescriptorRangesUnits
Antiphosphatidylserine, IgGNegativeLT 11GPS U/mL
Positive11 or more
The presence of phosphatidylserine Abs maybe associated with anti-phospholipid syndrome characterized by recurrent fetal loss, thrombosis and thrombocytopenia.
ANTIPHOSPHATIDYLSERINE AB, IGMAPSMAPSMEIA
TitleDescriptorRangesUnits
Antiphosphatidylserine, IgMNegative< 25MPS U/mL
Positive> = 25
The presence of phosphatidylserine Abs maybe associated with anti-phospholipid syndrome characterized by recurrent fetal loss, thrombosis and thrombocytopenia.
ANTITHROMBIN ACTIVITYTHROMBIN III.ACTAT3Chromogenic
TitleDescriptorRangesUnits
Antithrombin Activity1 day75-91%
3 days77-90
1 month-1 year93-136
1-5 years82-139
6-10 years90-131
11-16 years77-132
16+ years74-126
ACTIVATED PROTEIN C RESISTANCEAPCRESAPCRClot-based Assay
TitleDescriptorRangesUnits
APC ResistanceNormalGT 2.0ratio
AQUAPORIN-4 RECEPTOR ABAQP4ABAQP4ABEnzyme Linked Immunosorbent Assay
TitleDescriptorRangesUnits
Aquaporin-Receptor Antibody 4Negative< = 4.4U/mL
Indeterminate4.5-5.4
Positive> = 5.5
ARSENIC, URINE RANDOMURASURASInductively Coupled Plasma-Mass Spectrometry (ICP-MS)
TitleDescriptorRangesUnits
Arsenic, Urine0.0-35.0 (based on biological exposure index)ug/L
Creatinine, UrineMale39-259mg/dL
Female28-217
Arsenic: Creatinine Ratio< = 30.0ug/gCR
GM1 COMBINATIONGM1COMGM1COMELISA
TitleDescriptorRangesUnits
Asialo-GM1 Abs, IgG/IgMIV
GM1 Abs IgG/IgMIV
GM2 Abs IgG/IgMIV
GD1a Abs IgG/IgMIV
GD1b Abs IgG/IgMIV
GQ1b Abs IgG/IgMIV
Negative29 or less
Weak Positive30-50
Positive51-150
Strong Positive151 or more
B12 AND FOLATEB12/FOLB12FOLElectrochemiluminescence Immunoassay
TitleDescriptorRangesUnits
B12Normal211-946pg/mL
FolateNormal4.8-24.2ng/mL
VITAMIN B12 RFLXB12REFB12REFElectrochemiluminescence Immunoassay
TitleDescriptorRangesUnits
B12Normal211-946pg/mL
Methylmalonic Acid0.00-0.40umol/L
VITAMIN B12B12B12Electrochemiluminescence Immunoassay
TitleDescriptorRangesUnits
B12Normal211-946pg/mL
BETA 2 GLYCOPROTEIN 1-DOMAIN 1B2GPD1B2GPD1Chemiluminescence Assay
TitleDescriptorRangesUnits
B2 Glycoprotein1 Domain1Negative< 20CU
Positive> = 20
PAIN MANAGEMENT BARBITURATES RFLXPMBARBPMBARBEnzyme Immunoassay
TitleDescriptorRangesUnits
Barbiturates ScreenNegative< 200ng/mL
BARBITURATE SCREEN RFLXBARBBARBSEnzyme Immunoassay
TitleDescriptorRangesUnits
Barbiturates ScreenNegative< 200ng/mL
BARTONELLA DNA (RT-PCR)BARPCRBARPCRReal-Time Polymerase Chain Reaction
TitleDescriptorRangesUnits
Bartonella henselae DNA by PCRNot detected
Bartonella quintana DNA by PCRNot detected
The detection of Bartonella henselae and Bartonella quintana DNA is based upon the amplification of specific Bartonella genomic DNA sequences by PCR form total DNA extracted from the specimen. Probes specific for B. henselae and B. quintana are used to identify and differentiate the products of the PCR amplification. The diagnosis of B. henselae or B. quintana infection should not rely solely upon the result of a PCR assay. A positive PCR result should be considered in conjunction with the clinical presentation and additional established diagnostic tests prior to establishing diagnosis.
A negative PCR result indicates only the absence of B. henselae or B. quintana DNA in the sample tested and does not exclude the diagnosis of disease.
PAIN MGMT BENZODIAZEPINES RFLXPMBENZPMBENZEnzyme Immunoassay
TitleDescriptorRangesUnits
Benzodiazepine ScreenNegative< 200ng/mL
BENZODIAZEPINE SCREEN RFLXBENZBENZEnzyme Immunoassay
TitleDescriptorRangesUnits
Benzodiazepines ScreenNegative< 200ng/mL
PAIN MANAGEMENT COCAINE CONFPCOCPCOCGas Chromatography Mass Spectrometry
TitleDescriptorRangesUnits
Benzoylecgonine (Cocaine Metabolite)Not Detected< 30ng/mL
COCAINE METAB (GCMS)MSCOCMSCOCGas Chromatography Mass Spectrometry
TitleDescriptorRangesUnits
Benzoylecgonine (Cocaine Metabolite)Not Detected< 30ng/mL
BETA 2 GLYCOPROTEIN 1, IGAB2GP1AB2GP1AChemiluminescence Assay
TitleDescriptorRangesUnits
Beta-2 Glycoprotein 1, IgANegative0-20CU
Positive> 20
BETA 2 GLYCOPROTEIN 1, IGG, IGMB2GPGMB2GPGMChemiluminescence Assay
TitleDescriptorRangesUnits
Beta-2 Glycoprotein 1, IgGNegative0-20CU
Positive> 20
Beta-2 Glycoprotein 1, IgMNegative0-20CU
Positive> 20
BETA 2 GLYCOPROTEIN 1, IGGB2GP1GB2GP1GChemiluminescence Assay
TitleDescriptorRangesUnits
Beta-2 Glycoprotein 1, IgGNegative0-20CU
Positive> 20
BETA 2 GLYCOPROTEIN 1, IGMB2GP1MB2GP1MChemiluminescence Assay
TitleDescriptorRangesUnits
Beta-2 Glycoprotein 1, IgMNegative0-20CU
Positive> 20
BILE ACIDS, TOTALBILE ACIDSBILEAEnzymatic
TitleDescriptorRangesUnits
Bile AcidsFasting0-10umol/L
BILIRUBIN, TOTALBILTBILColorimetric
TitleDescriptorRangesUnits
Bilirubin, Total0-30 daysLT 11.7mg/dL
1 month-18 yearsLT 2.0
18-60 years0.1-1.5
60-90 years0.2-1.1
90+ years0.2-0.9
BIOAVAILABLE VITAMIN D 25BIO25DBIO25DImmunoassay/Spectrophotometry
TitleDescriptorRangesUnits
Bioavailable Vitamin D1.92-8.82ng/mL
Vitamin D Binding protein104-477ug/mL
Total Vitamin D (25 Hydroxy)ng/mL
Severe DeficiencyLT 10.0
Mild to Moderate Deficiency10.0-23.9
Optimum Levels24.0-80.0
Toxicity Possible
Pediatrics (0-18 years)80.0 or greater
Adults (19+ years)150.0 or greater
BORON, SERUM OR PLASMABORONS.LCABORONSInductively Coupled Plasma/Optical Emission Spectrometry (ICP/OES)
TitleDescriptorRangesUnits
BoronNone Detectedmcg/L
Normally< 100
BROMIDEBROMIDE.LCABROMIDIon Chromatography
TitleDescriptorRangesUnits
BromideTherapeutic Range:mg/dL
Sedation10-50
Values greater than 50 mg/dL may be associated with mild toxicity.
Epilesy seizure control75-150
Many patients will exhibit toxic symptoms within this range.
May be associated with debilitating toxicity> 150
May be fatal> 300
COMP CONFIRM BUPRENORPHINEMSBUPMSBUPGas Chromatography Mass Spectrometry
TitleDescriptorRangesUnits
Buprenorphine Confirmation by GC/MSNot Detected< 5ng/mL
Norbuprenorphine Confirmation by GC/MSNot Detected< 5ng/mL
PAIN MANAGEMENT BUPRENORPHINE RFLXPMBUPPMBUPEnzyme Immunoassay
TitleDescriptorRangesUnits
Buprenorphine ScreenNegative< 25ng/mL
Buprenorphine by GC/MSng/mL
Nor-Buprenorphine by GC/MSng/mL
BUPRENORPHINE CMPLNC SCRN RFLXCBUPSCBUPSEnzyme Immunoassay
TitleDescriptorRangesUnits
Buprenorphine ScreenNegative< 25ng/mL
PAIN MANAGEMENT BUPRE CONFIRMPBUPPBUPGas Chromatography Mass Spectrometry
TitleDescriptorRangesUnits
BuprenorphineNot Detected< 5ng/mL
Nor-BuprenorphineNot Detected< 5ng/mL
BUPROPIONBUPROPIONBUPROQuantitative Liquid Chromatography-Tandem Mass Spectrometry
TitleDescriptorRangesUnits
BupropionTherapeutic Range50-100ng/mL
Toxic Level> 400
BUTALBITALBUT.LCABUTALBQuantitative GC-MS
TitleDescriptorRangesUnits
Butalbitalug/mL
Therapeutic1-10
ToxicGT 30
C PEPTIDECPEPSCPEPSElectrochemiluminescence Immunoassay
TitleDescriptorRangesUnits
C-PeptideFasting1.1-4.4ng/mL
C-1 ESTERASE INHIB FUNCTIONALC1FUNCC1FUNCELISA
TitleDescriptorRangesUnits
C1 Esterase Inhibitor, FunctionalNormal> 67%
Indeterminate41-67
Abnormal< = 40
C1Q BINDING ASSAYC1Q.LCAC1QEnzyme Immunoassay (EIA)
TitleDescriptorRangesUnits
C1Q BindingNegative< 4.4ug Eq/mL
Equivocal4.4-10.7
Positive> 10.7
FATTY ACID PROF, PEROXISOMALFATTYAFATTYAGC/MS Stable Isotope
TitleDescriptorRangesUnits
C22:096.3 or lessnmol/mL
C24:091.4 or lessnmol/mL
C26:01.30 or lessnmol/mL
C24:0/C22:01.39 or lessRatio
C26:0/C22:00.023 or lessRatio
Pristanic Acid0-4 mo0.60 or lessnmol/mL
5-8 mo0.84 or less
9-12 mo0.77 or less
13-24 mo1.47 or less
GT 24 mo2.98 or less
Phytanic Acid0-4 mo5.28 or lessnmol/mL
5-8 mo5.70 or less
9-12 mo4.40 or less
13-24 mo8.62 or less
GT 24 mo9.88 or less
Pristanic Acid/Phytanic Acid Ratio0-4 mo0.35 or lessRatio
5-8 mo0.28 or less
9-12 mo0.23 or less
13-24 mo0.24 or less
GT 24 mo0.39 or less
C3, C4 C3/C4C3C4Nephelometry
TitleDescriptorRangesUnits
C3C0-1 days50-168mg/dL
2-60 days55-170
2-5 months59-176
6-24 months66-180
25-60 months74-184
5-9 years74-190
10-14 years77-198
15+ years90-200
C40-7 days0.0-45.7mg/dL
8-60 days1.5-47.9
2-5 months1.5-47.9
6-24 months3.0-47.9
25-60 months4.5-48.4
5-9 years5.3-50.6
10-14 years6.0-52.8
15+ years15.0-55.0
COMPLEMENT C3C3C3Nephelometry
TitleDescriptorRangesUnits
C3C0-1 days50-168mg/dL
2-60 days55-170
2-5 months59-176
6-24 months66-180
25-60 months74-184
5-9 years74-190
10-14 years77-198
15+ years90-200
COMPLEMENT C4C4C4Nephelometry
TitleDescriptorRangesUnits
C40-7 days0.0-45.7mg/dL
8-60 days1.5-47.9
2-5 months1.5-47.9
6-24 months3.0-47.9
25-60 months4.5-48.4
5-9 years5.3-50.6
10-14 years6.0-52.8
15+ years15.0-55.0
CADMIUM, URINE RANDOMURCDURCDInductively Coupled Plasma-Mass Spectrometry (ICP-MS)
TitleDescriptorRangesUnits
Cadmium, Urine0.0-2.6ug/L
Creatinine, UrineMale39-259mg/dL
Female28-217
Cadmium, Urine0.0-3.0ug/gCr
CAFFEINECAFNCAFNEIA
TitleDescriptorRangesUnits
CaffeineTherapeutic6-20ug/mL
Toxic> 40
CALCIUM, IONIZED (INPATIENT)CAL-IONICALISE
TitleDescriptorRangesUnits
Calcium, Ionized0-18 years4.90-5.50mg/dL
19+ years4.75-5.30
Calcium, Normalized0-18 years4.90-5.50mg/dL
19+ years4.75-5.30
CALPROTECTIN, FECALCALPFCCALPFCELISA
TitleDescriptorRangesUnits
Calprotectin, FecalNormal< = 50ug/g
Borderline elevated, test should be re-evaluated in 4-6 weeks51-120
Abnormal, suggestive of inflammatory bowel disease (IBD)> = 121
CANNABINOID SCREEN (20) RFLXCANN20CAN20Enzyme Immunoassay
TitleDescriptorRangesUnits
Cannabinoid ScreenNegative< 20ng/mL
CANNABINOIDS SCREEN (50) RFLXCANN50CAN50Enzyme Immunoassay
TitleDescriptorRangesUnits
Cannabinoid ScreenNegative< 50ng/mL
PAIN MANAGEMENT THC CONFIRMPTHCCPTHCCGas Chromatography Mass Spectrometry
TitleDescriptorRangesUnits
Cannabinoids (THC)Not Detected< 4ng/mL
PAIN MANAGEMENT THC RFLXPMTHCPMTHCEnzyme Immunoassay
TitleDescriptorRangesUnits
Cannabinoids ScreenNegative< 20ng/mL
CARBAMAZEPINE EPOXIDE/TOTALCAREPXCAREPXQuantitative Liquid Chromatography-Tandem Mass Spectrometry/Quantitative Enzyme Multiplied Immunoassay Technique
TitleDescriptorRangesUnits
Carbamazepine 10-11 EpoxideTherapeutic RangeNot well establishedug/mL
Toxic> 15.0
Carbamazepine, TotalTherapeutic Range4.0-12.0ug/mL
Toxic> 20.0
A proposed therapeutic range is 0.4-4.0 ug/mL. The metabolite, Carbamazepine-10, 11-Epoxide, has anticonvulsant activity to the parent drug.
CARBAMAZEPINELCCARLCCARLiquid Chromatography Tandem Mass Spectrometry
TitleDescriptorRangesUnits
CarbamazepineNot Detected< 350ng/mL
CARBAMAZEPINECARBACARBAElectrochemiluminescence Immunoassay
TitleDescriptorRangesUnits
CarbamazepineTherapeutic4.0-12.0ug/mL
Toxic> 15.0
CARBOXY-THC (GCMS)MSTHCMSTHCGas Chromatography Mass Spectrometry
TitleDescriptorRangesUnits
Carboxy THC Confirmation by GC/MSNot Detected< 4ng/mL
CARDIOLIPIN AB, IGG, IGM, IGACARDSCARDSChemiluminescence Assay
TitleDescriptorRangesUnits
Cardiolipin Antibody, IgANegative0-20CU
Positive> 20
Cardiolipin Antibody, IgGNegative0-20CU
Positive> 20
Cardiolipin Antibody, IgMNegative0-20CU
Positive> 20
CARDIOLIPIN AB, IGACARDACARDAChemiluminescence Assay
TitleDescriptorRangesUnits
Cardiolipin Antibody, IgANegative0-20CU
Positive> 20
CARDIOLIPIN AB PANEL, IGG, IGMCARD.ABCARDChemiluminescence Assay
TitleDescriptorRangesUnits
Cardiolipin Antibody, IgGNegative0-20CU
Positive> 20
Cardiolipin Antibody, IgMNegative0-20CU
Positive> 20
CARDIOLIPIN AB, IGGCARDGCARDGChemiluminescence Assay
TitleDescriptorRangesUnits
Cardiolipin Antibody, IgGNegative0-20CU
Positive> 20
CARDIOLIPIN AB, IGMCARDMCARDMChemiluminescence Assay
TitleDescriptorRangesUnits
Cardiolipin Antibody, IgMNegative0-20CU
Positive> 20
CARISOPRODOL, MEPROBAM (GCMS)MSCARIMSCARIGas Chromatography Mass Spectrometry
TitleDescriptorRangesUnits
Carisoprodol Confirmation by GC/MSNot Detected< 2.5ug/mL
Meprobamate Confirmation by GC/MSNot Detected< 2.5ug/mL
PAIN MANAGE CARI/MEPROPMCARIPMCARIEnzyme Immunoassay
TitleDescriptorRangesUnits
Carisoprodol ScreenNegative< .1ug/mL
Carisoprodol by GC/MSug/mL
Meprobamate by GC/MSug/mL
CARISOPRODOL AND MEPROBAMATE CARMEP.LCACARMEPQuantitative Liquid Chromatography/Tandem Mass Spectrometry
TitleDescriptorRangesUnits
Carisoprodol, Serum or PlasmaTherapeutic< 8.0ug/mL
Toxic> or = 8.0
Meprobamate, Serum or PlasmaTherapeutic5-20ug/mL
Toxic> 40
OBSTETRIC PANEL W CBC RFLX OBPAN1OBPAN1Hemagglutination, Electrochemiluminescent Immunoassay, Automated Hematology, Chemiluminescent Immunoassay (CLIA), Solid Phase
TitleDescriptorRangesUnits
CBCSee CBC
ABO
RH
Antibody ScreenNegative
Hepatitis B Surface AntigenNonreactive
Hepatitis B Surface Antigen Confirmation
Treponema pallidum Ab by CLIANegative
RPRNonreactive
RPR Titer< 1:1
Treponema pallidum Ab by TP-PANonreactive
Rubella Ab, IgGPresumed Immune> 9IU/mL
Presumed Non-Immune< 10
Result flagging is based on presumed immune status
OBSTETRIC PANEL W HIV, CBC RFLXOBPAN4OBPAN4Hemagglutination, Electrochemiluminescent Immunoassay, Automated Hematology, Chemiluminescent Immunoassay (CLIA), Solid Phase, Multiplex Bead Immunoassay
TitleDescriptorRangesUnits
CBCSee CBC
ABO
RH
Antibody ScreenNegative
Hepatitis B Surface AntigenNonreactive
Hepatitis B Surface Antigen ConfirmationNegative
HIV 1/2 Ag/Ab ComboNonreactive
HIV 1/2 AB Differentiation, Supplemental
HIV-1 Antibody by Supplemental AssayNegative
HIV-2 Antibody by Supplemental AssayNegative
HIV InterpretationNegative
Treponema pallidum Ab by CLIANegative
RPRNonreactive
RPR Titer< 1:1
Treponema pallidum Ab by TP-PANonreactive
Rubella Ab, IgGPresumed Immune> 9IU/mL
Presumed Non-Immune< 10
Result flagging is based on presumed immune status
CEACEACEAElectrochemiluminescence Immunoassay
TitleDescriptorRangesUnits
CEA (ECLIA)Non-Smokers0.0-3.7ng/mL
Smokers0.0-5.4
CENTROMERE B AUTOANTIBODY, IGGCENTMPCENTMPMultiplex Luminex
TitleDescriptorRangesUnits
Centromere B Autoantibody, IgGNegativeLT 1.0AI
Positive1.0 or more
HEART LIPID PANEL RFLXHRTLIPHRTLIPEnzymatic, Homogeneous Enzymatic Colorimetric
TitleDescriptorRangesUnits
CholesterolDesirable< 200mg/dL
Borderline high200-239
High240 or more
TriglyceridesNormal< 150mg/dL
Borderline high150-199
High200-499
Very high500 or more
HDLLow< 40mg/dL
Within normal limits40-59
High60 or more
HDL Cholesterol greater than or equal to 60 mg/dL is considered to be a 'negative' risk factor, serving to remove one risk factor from the total count.
LDL (calculated)Optimal< 100mg/dL
Near or above normal100-129
Borderline high130-159
High160-189
Very high190 or more
To calculate 10-year cardiac risk for the patient, go to http://www.paml.com, click on testing information, and then on lipid calculator.
Cholesterol/HDL RatioMale< 5.0
Female< 4.5
LDL Cholesterol, DirectOptimal< 100mg/dL
Near or above normal100-129
Borderline high130-159
High160-189
LIPID PANEL WITH REFLEX TO DIRECT LDLLIPREFLIPREFEnzymatic, Homogeneous Enzymatic Colorimetric
TitleDescriptorRangesUnits
CholesterolDesirable< 200mg/dL
Borderline high200-239
High> = 240
TriglyceridesNormal< 150mg/dL
Borderline high150-199
High200-499
Very high> = 500
HDLLow< 40mg/dL
Within normal limits40-59
High> = 60
HDL Cholesterol greater than or equal to 60 mg/dL is considered to be a 'negative' risk factor, serving to remove one risk factor from the total count.
LDL (calculated)Optimal< 100mg/dL
Near or above normal100-129
Borderline high130-159
High160-189
Very high> = 190
To calculate 10-year cardiac risk for the patient, go to http://www.paml.com, click on testing information, and then on lipid calculator.
Cholesterol/HDL RatioFemale< 4.5
Male< 5.0
LDL Cholesterol, DirectOptimal< 100mg/dL
Near or above normal100-129
Borderline high130-159
High160-189
Very high> = 190
CHOLESTEROLCHOCHOLEnzymatic
TitleDescriptorRangesUnits
CholesterolDesirable< 200mg/dL
Borderline High200-239
High240 or more
LIPID PROFILELIPIDLIPIDEnzymatic, Homogeneous Enzymatic Colorimetric
TitleDescriptorRangesUnits
CholesterolDesirableLT 200mg/dL
Borderline high200-239
High240 or more
TriglyceridesNormalLT 150mg/dL
Borderline high150-199
High200-499
Very high500 or more
HDLLowLT 40mg/dL
Within normal limits40-59
High60 or more
HDL Cholesterol greater than or equal to 60 mg/dL is considered to be a 'negative' risk factor, serving to remove one risk factor from thetotal count.
LDL (calculated)OptimalLT 100mg/dL
Near or above normal100-129
Borderline high130-159
High160-189
Very high190 or more
To calculate 10-year cardiac risk for the patient, go to http://www.paml.com, click on testing information, and then on lipid calculator.
LIPID PROFILE, LP PLA2 (PLAC)LIPID2LIPID2Enzymatic, ELISA
TitleDescriptorRangesUnits
CholesterolDesirableLT 200mg/dL
Borderline high200-239
High240 or more
TriglyceridesNormalLT 150mg/dL
Borderline high150-199
High200-499
Very high500 or more
HDLLowLT 40mg/dL
Within normal limits40-59
High60 or more
HDL Cholesterol greater than or equal to 60 mg/dL is considered to be a 'negative' risk factor, serving to remove one risk factor from the total count.
LDL (calculated)OptimalLT 100mg/dL
Near or above normal100-129
Borderline high130-159
High160-189
Very high190 or more
To calculate 10-year cardiac risk for the patient, go to http://www.paml.com, click on testing, then on ranges/algorithms, and then on lipid results.
LP-PLA2 (PLAC)0-200ng/mL
A new consensus panel recommends a cutoff value of 200 ng/mL for Lp-PLA2 (PLAC). Patients at moderate or high risk for CVD based on ATPIII criteria who also have an Lp-PLA2 value GT 200 ng/mL should be shifted from high to very high risk. This will lower the LDL goal for these patients.
LIPOPROTEIN ELECTROPHORESISLIPELPLIPELPElectrophoresis, Spectrometry
TitleDescriptorRangesUnits
Cholesterol125-200mg/dL
Triglycerides5-19 years< 130mg/dL
19+ years< 150 Normal
150-199 Borderline high
200-499 High
> 499 Very high
ChylomicronsNormal
Beta Lipoproteins42.3-69.5%
Pre Beta Lipoprotiens2.0-31.2%
Alpha Lipoproteins15.1-39.9%
Appearance Clear
Interpretation
CHROMATIN AUTOANTIBODY, IGGCHROMPCHROMPMultiplex Luminex
TitleDescriptorRangesUnits
Chromatin Autoantibody, IgGNegative< 1.0AI
Positive> = 1.0
CITALOPRAMLCCITLCCITLiquid Chromatography Tandem Mass Spectrometry
TitleDescriptorRangesUnits
CitalopramNot Detected< 350ng/mL
CITALOPRAMCITALMCITALMHigh-Pressure Liquid Chromatography with Fluorescence Detection
TitleDescriptorRangesUnits
CitalopramSteady-state plasma concentrations of citalopram in patients receiving recommended daily dosagesUp to 120ng/mL
Desmethylcitalopram concentraitons are around one-third of the citalopram concentration.
CITRATE GEL ELECTROPHORESISCITGELCITGELGel Electrophoresis
Citrate Gel Electrophoresis, Interpretation
Citrate Gel Electrophoresis, Reviewed by
CK, MBCKMBCKMBEnzymatic, Chemiluminescence Assays
TitleDescriptorRangesUnits
CK (CPK) TotalMale55-400U/L
Female30-240
CK-MB7.4 or lessng/mL
Relative IndexTo be used only if CK-MB and total CK (CPK) are elevated.3.0 or less%
CREATINE KINASE (CK)CPKCKSpectrophotometric
TitleDescriptorRangesUnits
CK (CPK)Male39-308U/L
Female26-192
CLOMIPRAMINE AND METABOLITECLOMIPCLOMIPTandem Mass Spectrometry
TitleDescriptorRangesUnits
ClomipramineNo reference range established for parent drug. See total reference range.ng/mL
DesmethylclomipramineNo reference range established for parent drug. See total reference range.ng/mL
Total (Clomipramine + Desmethylclomipramine)Therapeutic220-500ng/mL
Toxic> 900
Plasma concentrations vary widely among patients. The therapeutic range listed relates to the antidepressant characteristics of the drug. A therapeutic range for treating obsessive compulsive disorder is not well defined.
BENZODIAZEPINE CONF (LCMSMS)BENZLCBENZLCLiquid Chromatography Tandem Mass Spectrometry
TitleDescriptorRangesUnits
Clonazepam Confirmation by LC-MS/MSNot Detected< 10ng/mL
7-Aminoclonazepam Confirmation by LC-MS/MSNot Detected< 10ng/mL
Flunitrazepam Confirmation by LC-MS/MSNot Detected< 10ng/mL
7-Aminoflunitrazepam Confirmation by LC-MS/MSNot Detected< 10ng/mL
Diazepam Confirmation by LC-MS/MSNot Detected< 10ng/mL
Temazepam Confirmation by LC-MS/MSNot Detected< 25ng/mL
Nordiazepam Confirmation by LC-MS/MSNot Detected< 25ng/mL
Oxazepam Confirmation by LC-MS/MSNot Detected< 25ng/mL
Lorazepam Confirmation by LC-MS/MSNot Detected< 25ng/mL
Alprazolam Confirmation by LC-MS/MSNot Detected< 10ng/mL
alpha-hydroxyalprazolam Confirmation by LC-MS/MSNot Detected< 25ng/mL
Flurazepam Confirmation by LC-MS/MSNot Detected< 10ng/mL
Midazolam Confirmation by LC-MS/MSNot Detected< 25ng/mL
alpha-hydroxytriazolam Confirmation by LC-MS/MSNot Detected< 25ng/mL
PAIN MANAGEMENT BENZ CONFIRMPBENPBENLiquid Chromatography Tandem Mass Spectrometry
TitleDescriptorRangesUnits
ClonazepamNot Detected< 10ng/mL
7-AminoclonazepamNot Detected< 10ng/mL
FlunitrazepamNot Detected< 10ng/mL
7-AminoflunitrazepamNot Detected< 10ng/mL
DiazepamNot Detected< 10ng/mL
TemazepamNot Detected< 25ng/mL
NordiazepamNot Detected< 25ng/mL
OxazepamNot Detected< 25ng/mL
LorazepamNot Detected< 25ng/mL
AlprazolamNot Detected< 10ng/mL
Alpha-hydroxyalprazolamNot Detected< 25ng/mL
FlurazepamNot Detected< 10ng/mL
MidazolamNot Detected< 25ng/mL
Alpha-hydroxytriazolamNot Detected< 25ng/mL
CLONIDINECLONID.LCACLONIDLiquid Chromatography/Tandem Mass Spectrometry LCMSMS
TitleDescriptorRangesUnits
Clonidine (Catapres)Therapeutic0.5-4.5ng/mL
COBALT, URINE RANDOMURCOURCOQuantitative Inductively Coupled Plasma-Mass Spectrometry (ICP-MS)
TitleDescriptorRangesUnits
Cobalt, Urine0.1-2.0ug/L
Creatinine, UrineMale39-259mg/dL
Female28-217
Cobalt, Creatinine RatioNo reference intervalug/gCRT
PAIN MANAGEMENT COCAINE RFLXPMCOCPMCOCEnzyme Immunoassay
TitleDescriptorRangesUnits
Cocaine (BEG) ScreenNegative< 150ng/mL
COCAINE SCREEN RFLXCOC+COCEnzyme Immunoassay
TitleDescriptorRangesUnits
Cocaine (BEG) ScreenNegative< 150ng/mL
COCCIDIOIDES AB BY CFCOCCAB.LCACOCCABComplement Fixation
TitleDescriptorRangesUnits
Coccidioides Ab by CFNo antibody detectedLT 1:2Titer
COCCIDIOIDES ABS PANEL, CSFCOCPSF.LCACOCPSFCF, ELISA, ID
TitleDescriptorRangesUnits
Coccidioides Ab, CSF by CFNo Antibody DetectedLT 1:2
Coccidioides Ab, CSF, IgGNegative - No significant level of Coccidioides IgG Ab detected0.9 or lessIV
Equivocal - Questionable presence of Coccidioides IgG AB detected. Repeat testing in 10-14 days may be helpful1.0-1.4
Positive - Presence of IgG Ab to Coccidioides detected, suggestive of current or past infection1.5 or more
Coccidioides Ab, IgM, CSFNegative - No significant level of Coccidioides IgM Ab detected0.9 or lessIV
Equivocal - Questionable presence of Coccidioides IgM Ab detected. Repeat testing in 10-14 days may be helpful1.0-1.4
Positive - Presence of IgM Ab to Coccidioides detected, suggestive of current or past infection1.5 or more
Coccidioides Ab, CSF by IDNone detected
COLLAGEN TYPE II ABCT2ABI.LCACT2ABIELISA
TitleDescriptorRangesUnits
Collagen Type II AntibodiesNegativeLT 20EU/mL
Borderline20-25
Equivocal
PositiveGT 25
Anti-collagen II Abs occur in 22% of patients with idiopathic SNHL, 30% of patients with sudden deafness and 20% of patients with Meniere's disease. Anti-collagen II antibodies also occur in patients with relapsing poly-chondritis and in rheumatoid arthritis.
This test was developed and its performance characteristics determined by IMMCO. It has not been cleared or approved by the U.S. Food and Drug Administration.
AMYLASE, URINE 24HRAMYUQAMYUQEnzymatic
TitleDescriptorRangesUnits
Collection Periodh
VolumemL
Amylase, UrineMale1-20U/h
Female1-19
CATECHOLAMINES, FRACT, UR 24HRCAT.UFCATUQTandem Mass Spectrometry
TitleDescriptorRangesUnits
Collection Periodh
VolumemL
EpinephrineNo reference range establishedug/L
Epinephrine ug/24 hr< 1 year< 2.6ug/24hr
1 year< 3.6
2-3 years< 6.1
4-9 years0.2-10
10 years and older0.5-20
NorepinephrineNo reference range establishedug/L
Norepinephrine ug/24 hr< 1 year< 11ug/24 hr
1 year1-17
2-3 years4-29
4-6 years8-45
7-9 years13-65
10 years and older15-80
DopamineNo reference range establishedug/L
Dopamine ug/24 hr< 1 year< 86ug/24 hr
1 year10-140
2-3 years40-260
4 years and older65-400
These reference ranges for 24 hr urine collections are based on literature review.
PROTEIN, URINE 24HRPRO-UPROUQPColorimetric (IDMS Traceable), Turbidimetric, Calculation
TitleDescriptorRangesUnits
Collection Periodh
VolumemL
Protein, UrineAt rest50-80mg/24h
Following intense exerciseLT 250
Protein/Creatinine RatioLT 0.2Ratio
FAT, FECAL, QUANTITATIVEFATQNT.LCAFATQNTExtraction, Spectrophotometry
TitleDescriptorRangesUnits
Collection Periodhr
Fecal Total Weightg
Fecal Fats0-18 years0.0-3.1g/24h
> 18 years0.0-7.1
IODINE, URINE 24HRIODUQM.LCAIODUQMInductively Coupled Plasma-Mass Spectrometry (ICP-MS)
TitleDescriptorRangesUnits
Collection Periodhrs
Urine VolumemL
Iodine, 24 hour16-150 years93-1125mcg/species
Iodine Concentration16-150 years26-705mcg/L
CORTISOL STIMULATION TESTCOR-STIMCSTElectrochemiluminescence Immunoassay
TitleDescriptorRangesUnits
Cortisol BaselineAM Sample6.0-18.4ug/dL
PM Sample2.7-10.5
Time Drawn
Cortisol Post-StimNormal peak serum cortisol is GT 20 ug/dL, 30 to 60 minutes after 25 units cosyntropin IV.ug/dL
Time Drawn
CORTISOL STIMULATION (3 SPEC)COR-STIM2CST3Electrochemiluminescence Immunoassay
TitleDescriptorRangesUnits
Cortisol BaselineAM Sample6.0-18.4ug/dL
PM Sample2.7-10.5
Time Drawn
Cortisol, Post #1ug/dL
Time Drawn
Cortisol, Post #2Normal peak serum cortisol is GT 20 ug/dL, 30 to 60 minutes after 25 units cosyntropin IV.ug/dL
Time Drawn
DEXAMETHASONE SUPPRESSION (X4)DST4DST4Electrochemiluminescence Immunoassay
TitleDescriptorRangesUnits
Cortisol Pre-SuppressionTime Drawn6.0-18.4ug/dL
Cortisol Post-Suppression #1Time DrawnLow Dose: < 1.8ug/dL
High Dose: Decrease of more than 50%
Cortisol Post-Suppression #2Time Drawnug/dL
Cortisol Post-Suppression #3Time Drawnug/dL
DEXAMETHASONE SUPPRESSION (X3)DST3DST3Electrochemiluminescence Immunoassay
TitleDescriptorRangesUnits
Cortisol Pre-SuppressionTime Drawn6.0-18.4ug/dL
Cortisol Post-Suppression #1Time DrawnLow Dose: < 1.8ug/dL
High Dose: Decrease of more than 50%
Cortisol Post-Suppression #2Time Drawnug/dL
DEXAMETHASONE SUPPRESSION TESTDST2DSTElectrochemiluminescence Immunoassay
TitleDescriptorRangesUnits
Cortisol Pre-SuppressionTime Drawn6.0-18.4ug/dL
Cortisol Post-SuppressionTime DrawnLow Dose: < 1.8ug/dL
High Dose: Decrease of more than 50%
CORTISOL, RANDOMCORRANCORRANElectrochemiluminescence Immunoassay
TitleDescriptorRangesUnits
Cortisol, Random2.7-18.4ug/dL
The reference ranges for Cortisol are dependent on the time of draw.
CortisolAM6.0-18.4ug/dL
CortisolPM2.7-10.5ug/dL
CORTISOL, URINARY FREECORFULCORFULLiquid Chromatography/Tandem Mass Spectrometry
TitleDescriptorRangesUnits
Cortisol, Urine0-1 yearNot establishedug/24 hours
2-11 years1-21
12-16 years2-38
16+ years0-50
CORTISOL PAIRED SAMPLESCOR-2CORPElectrochemiluminescence Immunoassay
TitleDescriptorRangesUnits
CortisolAM6.0-18.4ug/dL
PM2.7-10.5
COTININE, SERUMCOTQCOTQEnzyme Multiplied Immunoassay
TitleDescriptorRangesUnits
CotinineDaily Smokers> 100ng/mL
Light Smokers15-100
Passive or Non Smokers< 15
COTININENICNICEnzyme Immunoassay
TitleDescriptorRangesUnits
CotinineNegative< 250ng/mL
CREATININE EFFLUENTCREFLTCREFLTEnzymatic, IDMS Traceable
TitleDescriptorRangesUnits
Creatinine EffluentNo reference range established.Method not validated for this fluid. Clinical correlation necessary.mg/dL
CREATININE, DIALYSATECRDLSTCRDLSTEnzymatic, IDMS Traceable
TitleDescriptorRangesUnits
Creatinine, DialysateNo reference range establishedMethod not validated for this fluid. Clinical correlation necessary.mg/dL
CATECHOLAMINES, URINE RANDOMCATEURCATEURTandem Mass Spectrometry/Enzymatic (IDMS traceable)
TitleDescriptorRangesUnits
Creatinine, UrineMale39-259mg/dL
Female28-217
Epinephrine, Urine RandomNo reference range establishedug/L
Epinephrine ug/gCr< 1 year< 381ug/gCr
1-3 years< 81
4-9 years< 91
10-17 years< 61
18 years and older< 41
Norepinephrine, Urine RandomNo reference range establishedug/L
Norepinephrine ug/gCr< 1 year< 311ug/gCr
1-3 years< 291
4 years and older< 111
Dopamine, Urine RandomNo reference range establishedug/L
Dopamine ug/gCr< 1 year< 1291ug/gCr
1-3 years< 1221
4-9 years< 721
10-17 years< 451
18 years and older< 351
Please note: A 24-hr urine collection is the preferred specimen. These reference ranges for random urine collections are based on literature review.
NICKEL, URINE RANDOMURNIURNIInductively Coupled Plasma-Mass Spectrometry (ICP-MS)
TitleDescriptorRangesUnits
Creatinine, UrineMale39-259mg/dL
Female28-217
Nickel, Urine< 6.0ug/L
Nickel, Urine< 6.0ug/gCR
CHROMIUM, URINE RANDOMURCRURCRInductively Coupled Plasma-Mass Spectrometry (ICP-MS)
TitleDescriptorRangesUnits
Creatinine, UrineMale39-259mg/dL
Female28-217
Chromium, Urine0.0-5.0ug/L
Chromium, UrineNo reference rangeug/gCr
COPPER, URINE RANDOMURCOPURCOPInductively Coupled Plasma-Mass Spectrometry (ICP-MS)
TitleDescriptorRangesUnits
Creatinine, UrineMale39-259mg/dL
Female28-217
Copper, Urine0.2-8.0ug/dL
Copper, Creatinine RatioNo Reference Intervalug/gCR
MANGANESE, URINE RANDOMURMNURMNInductively Coupled Plasma-Mass Spectrometry (ICP-MS)
TitleDescriptorRangesUnits
Creatinine, UrineMale39-259mg/dL
Female28-217
Manganese, Urine0.0-2.0ug/L
Manganese, UrineNo reference rangeug/gCRT
CRP (C-REACTIVE PROTEIN)CRPCRPImmunoturbidimetric
TitleDescriptorRangesUnits
CRP18+ years0.0-0.4mg/dL
CULT E COLI 0157/SHIGA RFLXCECSTCECSTCulture and Enzyme Immunoassay
Culture, E.coli 0157 with Shiga Toxin Report
Culture, E.coli 0157 with Shiga Toxin Status
CULTURE ESBL CONFIRMATIONCESBLSCESBLSDisk diffusion
Culture, ESBL Confirmation Report
Culture, ESBL Confirmation Report Status
CULTURE STOOL/YER/SHIGA RFLXCSTLYSCSTLYSCulture and Enzyme Immunoassay
Culture, Stool with Yersinia & Shiga Toxin, Result
Culture, Stool with Yersinia & Shiga Toxin, Status
CYCLIC CITRULLINE PEP AB, IGGCCPABGCCPABGChemiluminescence Assay
TitleDescriptorRangesUnits
Cyclic Citrullinated Peptide Ab, IgGNegative< 20CU
Positive> = 20
Approximately 70% of patients with RA are positive for CCP IgG, while only 2% of random blood donors and disease controls are positive. The diagnostic value of antibodies to CCP in juvenile rheumatoid arthritis patients has not been determined.
CYCLOBENZAPRINELCCYCLCCYCLiquid Chromatography Tandem Mass Spectrometry
TitleDescriptorRangesUnits
CyclobenzaprineNot Detected< 350ng/mL
CYCLOSPORINE A BY LC/MS/MSCYCCYCLiquid Chromatography-Tandem Mass Spectrometry LCMSMS
TitleDescriptorRangesUnits
Cyclosporine A by LCMSMSHeart and Kidney Transplant up to 3 months post-transplant350.0-525ng/mL
Cyclosporine A by LCMSMSHeart and Kidney Transplant 4 months and older post-transplant145.0-350ng/mL
Cyclosporine A by LCMSMSLiver Transplant290.0-525ng/mL
Cyclosporine A by LCMSMSToxic alert value700ng/mL
CYCLOSPORINE, HEART TRANSPLANTCYCLO.WB.TDXCYCTDXCMIA
TitleDescriptorRangesUnits
Cyclosporine TDXTherapeutic trough150-250ng/mL
ToxicGT 600
CYTOCHROME P450 CYP2D6CYP2D6CYP2D6Polymerase Chain Reaction (PCR), Single Nucleotide Primer Extension Reaction (SNP-IT)
CYP2D6 Result
CYSTATIN CCYSTCGCYSTCGNephelometry
TitleDescriptorRangesUnits
Cystatin C0.53-0.95mg/L
Estimated Glomerular Filtration RateChronic kidney disease, if over a 3 month periodLT 60mL/min/1.73m2
Kidney FailureLT 15
CYSTICERCOSIS AB, IGG, CSFCYSGCF.LCACYSGCFSemi-Quantitative Enzyme-Linked Immunosorbent Assay
TitleDescriptorRangesUnits
Cysticercosis Antibody IgG, CSFNegative-no significant level of cysticercosis IgG antibody detected0.34 or lessOD
Equivocal-questionable presence of cysticercosis IgG. Repeat testing in 10-14 days may be helpful0.35-0.50
Positive-IgG antibody detected, which may suggest current or past infection0.51 or more
Diagnosis of central nervous system infections can be accomplished by demonstrating the presence of intrathecally produced specific antibody.
Interpretation of results may be complicated by low antibody levels found in CSF, passive transfer of antibody from blood, and contamination via bloody taps.
HSV IGG 1 AND 2 (IMMBLOT)HSVB12HSVB12Immunoblot
Descriptor
Negative for antibody to HSV 1 and HSV 2 by Immunoblot. No evidence of past infection with HSV 1 or 2. Individuals infected with HSV may not exhibit detectable IgG Ab to glycoprotein G in the early stages of infection and 5-10% of infections may occur with glycoprotein G-deficient virus.
Detection of antibody presence in these cases may only be possible using a non-type, specific screening test. All results from this and other serologies must be correlated with clinical history, epidemiological data, and other date available to the attending physician in making the differentiation between HSV type 1 and HSV type 2 infection.
ANA TITER (IFA)IFANAIFANAIFA
DescriptorRange
ANA by IFA TiterLT 1:40 Titer
ANA by IFA Pattern
B-TYPE NATRIURETIC PEPTIDEBTNPBNPEPRICMA
DescriptorRangeUnits
B-Type Natriuretic Peptide< 100pg/mL
ANTI-THYROID PEROXIDASE ANTIBODY (TPOAB)TPOABUTPOABURIA
DescriptorRangeUnits
TPO-AB< 1.0IU/mL
T. GONDII AB, IGM CONFIRMATIONTXMCFTXMCFEnzyme-Linked Immunosorbent Assay
DescriptorRanges
Negative0.0-1.6
Equivocal1.7-1.9
Positive>= 2.0
CALCITONINCALCTNCALCTNImmunochemiluminometric Assay (ICMA)
DescriptorRangesUnits
Adult Males< = 10pg/mL
Adult Females< = 5
Children (Males and Females)
Less than 6 months< = 41
6 months-3 years< = 14
3-17 years< = 6
BUNBUNBUNEnzymatic
DescriptorRangesUnits
BUN (UREA)8-25mg/dL
BILIRUBIN, FLUIDBILFLBILFLColorimetric
DescriptorUnits
Bilirubin, Fluidmg/dL
No reference range established.
Method not validated for this fluid.
Clinical correlation necessary.
DESIPRAMINELCDESLCDESLiquid Chromatography Tandem Mass Spectrometry
TitleDescriptorRangesUnits
DesipramineNot Detected< 350ng/mL
DESIPRAMINEDESDESIPTandem Mass Spectrometry
TitleDescriptorRangesUnits
DesipramineTherapeutic100-300ng/mL
Toxic> 500
DEXTROMETHORPHAN LCDEXLCDEXLiquid Chromatography Tandem Mass Spectrometry
TitleDescriptorRangesUnits
DextromethorphanNot Detected< 350ng/mL
EARLY CDT LUNGECDTLECDTLELISA
Diagnosis ProcedureLow Cut OffModerate Cut OffHigh Cut OffUnits
CAGE Autoantibody< 4.25> = 4.25 - < 5.27> = 5.27RU
GBU4-5 Autoantibody< 4.36> = 4.36 - < 5.92> = 5.92RU
HuD Autoantibody< 7.31> = 7.31 - < 8.15> = 8.15RU
MAGE A4 Autoantibody< 6.19> = 6.19 - < 7.94> = 7.94RU
NY ESO 1 Autoantibody< 3.02> = 3.02 - < 4.27> = 4.27RU
p53 Autoantibody< 5.79> = 5.79 - < 6.47> = 6.47RU
SOX 2 Autoantibody< 5.48> = 5.48 - < 5.58> = 5.58RU
Interpretive Comments:This test is not intended for patients who have previously had cancer.
Low LevelA Low Level result is reported when all of the autoantibodies in the EarlyCDT-Lung panel are below the low cutoff value. This result suggests a lower likelihood of lung cancer than the Moderate Level and High Level results. However, a Low Level result does not mean the patient does not have, or will not develop, lung cancer. Continued monitoring is recommended consistent with the patient's history and other clinical findings.
Moderate LevelA Moderate Level result is reported when any one or more autoantibodies in the EarlyCDT-Lung panel are above the low cutoff value but all are below the high cutoff value. This result suggests a greater likelihood of lung cancer than predicted by gender, age, smoking history and other clinical factors. Additional monitoring for lung cancer is recommended, including imaging with low-dose CT, consistent with the patient's history and other clinical findings.
High LevelA High Level result is reported when any one or more autoantibodies in the EarlyCDT-Lung panel are above the high cutoff value. This result suggests a greater likelihood of lung cancer than predicted by gender, age, smoking history and other clinical factors. Additional monitoring for lung cancer is recommended, including imaging with low-dose CT, consistent with the patient's history and other clinical findings.
InvalidThe sample submitted for EarlyCDT-Lung testing has been assessed to be Invalid. A very small proportion of the population has non-specific immunoreactive components in their blood that interfere with the results of this test. The patient's sample demonstrates these characteristics. An Invalid result cannot be used to assess if the patient has a lung cancer or not.
DIAZEPAM AND NORDIAZEPAMDIANODIANOQuantitative Liquid Chromatography/Tandem Mass Spectrometry
TitleDescriptorRangesUnits
DiazepamBased on normal dosage amounts200-1000ng/mL
NordiazepamBased on normal dosage amounts100-1500ng/mL
Toxic> 2500
Interpretive Data: Adverse effects may include drowsiness, fatigue, ataxia, and muscle weakness.
DIFFERENTIAL, MANUALDIF.ADAMDIF2Microscopic
TitleDescriptorRangesUnits
Differential
Segs%
0-1 day33-70
1-7 days15-50
7-30 days15-45
1-12 months15-70
1-4 years25-70
4-10 years30-70
10-14 years25-70
14-18 years30-70
18+ years38-70
Segs, AbsK/uL
0-1 day3.00-12.00
1-7 days2.00-6.00
1 wk-1 yr1.50-5.00
1-4 years1.50-7.50
4-10 years1.80-7.00
10-18 years1.50-7.00
18+ years1.80-7.70
Bands%
0-18 years0-9
18+ years0-8
Bands, AbsK/uL
0-1 day0.00-1.50
1-7 days0.00-1.20
7-30 days0.00-0.50
1-12 months0.00-0.40
1-4 years0.00-0.30
4-10 years0.00-0.20
10-18 years0.00-0.20
Lymphocytes%
0-1 day10-35
1-7 days15-70
1 week-4 years30-70
4-6 years20-70
6-10 years20-50
10-18 years20-40
19+ years15-48
Lymphocytes, AbsK/uL
0-1 day2.00-11.00
1-7 days2.00-7.00
7-30 days3.00-7.00
1-12 months1.50-8.50
1-4 years1.50-5.00
4-10 years1.20-5.00
10-18 years1.10-4.50
19+ years1.00-3.90
Variant Lymph0-6%
Variant Lymphs, AbsK/uL
Monocytes%
0-18 years0-10
18+ years3-11
Monocytes, AbsK/uL
0-1 day0.00-1.10
1-7 days0.00-0.90
7-30 days0.00-0.60
1-12 months0.00-0.50
1-4 years0.00-0.50
4-10 years0.00-0.40
10-18 years0.00-0.90
18+ years0.00-0.80
Eosinophils%
0-18 years0-4
18+ years0-7
Eosinophils, AbsK/uL
0-1 day0.00-0.40
1-7 days0.00-0.50
7 days-1 year0.00-0.30
1-10 years0.00-0.30
10-18 years0.00-0.20
18+ years0.00-0.50
Basophils%
1-18 years0-1
18+ years0-2
Basophils, AbsK/uL
0-7 days0.00-0.10
1 week-4 years0.00-0.01
4-18 years0.00-0.01
18+ years0.00-0.20
Metamyelocytes%
Myelocytes%
Promyelocytes%
Blast Cells%
Other%
NRBC/100WBC
Meg Frag/100WBC
RBC Morph
WBC Morph
Platelet Morph
Cells Counted
DIGITOXINDGTXN.LCADGTXNQuantitative CEDIA Immunoassay
TitleDescriptorRangesUnits
DigitoxinTherapeutic10.0-25.0ng/mL
DIGOXINDIGOXDIGOXElectrochemiluminescence Immunoassay
TitleDescriptorRangesUnits
DigoxinTherapeutic0.6-2.0ng/mL
Toxic> 2.0
Increased risk of Digoxin toxicity at levels GT 2.0 ng/mL, with a wide zone of concentrations that may be toxic in one individual and not in another. The risk is greater with CHD and with decreases in Potassium, Calcium and Magnesium. Digoxin distribution phase complete after 8-15 hours.
DIPENHYDRAMINELCDIPLCDIPLiquid Chromatography Tandem Mass Spectrometry
TitleDescriptorRangesUnits
DiphenhydramineNot Detected< 350ng/mL
DIPHTHERIA AND TETANUS ABDIPTEN.LCADIPTENEnzyme Immunoassay
TitleDescriptorRangesUnits
Diphtheria AbNonprotective< 0.10IU/mL
Protective> = 0.10
Tetanus AbNonprotective< 0.10IU/mL
Protective> = 0.10
DIPHTHERIA AB, IGGDIPAB.LCADIPABEnzyme Immunoassay
TitleDescriptorRangesUnits
Diphtheria Antibody, IgGNonprotective< 0.10IU/mL
Protective> = 0.10
DISOPYRAMIDEDISOP.LCADISOPQuantitative Enzyme Multiplied Immunoassay Technique
TitleDescriptorRangesUnits
DisopyramideTherapeutic2.0-6.0ug/mL
Toxic> 6.0
Interpretive Data: The therapeutic range is based on serum pre-dose (trough) draw at steady-state concentration. Toxic concentrations may cause dry mouth, hypotension, and cardiac abnormalities.
DSDNA (CRITHIDIA IFA)IFDNAIFDNAIFA-Crithidia
TitleDescriptorRangesUnits
DNA Double Strand (Crithidia)NegativeLT 1:10
DOXEPIN LCDXPLCDXPLiquid Chromatography Tandem Mass Spectrometry
TitleDescriptorRangesUnits
DoxepinNot Detected< 350ng/mL
DOXEPIN AND METABOLITEDOXMPDOXMPTandem Mass Spectrometry
TitleDescriptorRangesUnits
DoxepinNo reference range established for parent drug. See total reference range.ng/mL
NordoxepinNo reference range established for parent drug. See total reference range.ng/mL
Total (Doxepin + Nordoxepin)Therapeutic100-300ng/mL
Toxic> 500ng/mL
DOXYLAMINE LCDXLLCDXLLiquid Chromatography Tandem Mass Spectrometry
TitleDescriptorRangesUnits
DoxylamineNot Detected< 350ng/mL
DILUTE RUSSELL VIPER RFLXADRVVTADRVVTElectromechanical
TitleDescriptorRangesUnits
dRVVT31.8-45.7sec
dRVVT Mix RatioNegative for Lupus Inhibitor Screen0.0-1.2
dRVVT Confirm RatioNegative for Lupus Inhibitor Screen< 1.2
dRVVT Confirm Mix RatioNegative for Lupus Inhibitor Screen< 1.2
DSDNA AUTOANTIBODY, IGGDNAMPDNAMPMultiplex Luminex
TitleDescriptorRangesUnits
DSDNA Autoantibody, IgGNegativeLT 5IU/mL
Indeterminate5-9
Positive10 or more
DULOXETINEDUL.LCADULLiquid Chromatography/Tandem Mass Spectrometry LCMSMS
TitleDescriptorRangesUnits
Duloxetineng/mL
Steady state trough plasma concentrations after 5 days of oral therapy
20 mg twice daily4-20
30 mg twice daily8-48
40 mg twice daily12-60
UPEP, URINE RANDOMELP-RPELPURAgarose Gel ELP (high resolution)
Electrophoresis, Urine, Random
IMMUNOFIXATION, URINE RANDOMIEP-RUIEPURImmunofixation ELP/High Resolution
ELP Urine Interp
Immunofixation Urine Interp
IMMUNOFIXATION, SER/UR RANDOMIEP.SU-RIEPSURImmunofixation ELP/High Resolution
ELP, Serum
ELP, Serum Interpretation
Monoclonal Peak
Immunofixation Serum Interp
ELP Urine Interp
Immunofixation Urine Interp
ENDOMYSIAL AB TITER IGA + IGG RFLXEDTGLEDTGLIndirect Immunofluorescent Assay
TitleDescriptorRangesUnits
Endomysial (EMA) IgG AntibodyNegative< 1:2.5Titer
Endomysial (EMA) IgA AntibodyNegative< 1:2.5Titer
ESTRONE SULFATEESTRSESTRSHydrolysis, Extraction, Chromatography, Radioimmunoassay
TitleDescriptorRangesUnits
Estrone Sulfatepg/mL
Adult Males230-2200
Premenopausal Females, Follicular Phase300-2600
Premenopausal Females, Luteal Phase100-3200
Postmenopausal Females100-1300
ETHYL GLUCURONIDE/SULFATEETGAETGALC-MS/MS
TitleDescriptorRangesUnits
ETGPositive cutoff250ng/mL
ETSPositive cutoff150ng/mL
ETHOSUXIMIDEETHO.LCAETHOQuantitative Enzyme Immunoassay
TitleDescriptorRangesUnits
EthosuximideTherapeutic40-100ug/mL
Toxic> 150
PAIN MANAGEMENT ETG/ETS RFLXPMETGSPMETGSEnzyme Immunoassay
TitleDescriptorRangesUnits
Ethyl Glucuronide/Ethyl Sulfate ScreenNegative< 250ng/mL
Ethyl Glucuronide by LC-MS/MSng/mL
Ethyl Sulfate by LC-MS/MSng/mL
ETHYL GLUCURONIDE, UR RFLXETGUETGUEnzyme Immunoassay
TitleDescriptorRangesUnits
Ethyl GlucuronideNegative< 250ng/mL
ETHYLENE GLYCOLETHYETHYGas Chromatography/NPD
TitleDescriptorRangesUnits
Ethylene GlycolNot Detected< 2.5mg/dL
EVEROLIMUS BY LC/MS/MSEVERMSEVERMSLiquid Chromatography-Tandem Mass Spectrometry LCMSMS
TitleDescriptorRangesUnits
Everolimus by LCMSMS3.0-8.0ng/mL
Tox Alert> = 15
Heart and Kidney Transplant
HEALTHCARE WORKER PANEL (HWP1) URINE SCREEN RFLXHWP1HWP1Enzyme Immunoassay
TitleDescriptorRangesUnits
Extended Amphetamines ScreenNegative< 500ng/mL
Amphetamines Confirmation GCMSNot Detected< 250ng/mL
Methamphetamine Confirmation GCMSNot Detected< 250ng/mL
MDMA2 Confirmation GCMSNot Detected< 250ng/mL
MDA2 Confirmation GCMSNot Detected< 250ng/mL
MDEA2 Confirmation GCMSNot Detected< 250ng/mL
Benzoylecgonine (Cocaine) ScreenNegative< 150ng/mL
Benzoylecgonine (Cocaine) Confirmation GCMSNot Detected< 100ng/mL
Extended Opiate ScreenNegative< 300ng/mL
Morphine Confirmation LCMSMSNot Detected< 50ng/mL
Oxymorphone Confirmation LCMSMSNot Detected< 50ng/mL
Hydromorphone Confirmation LCMSMSNot Detected< 50ng/mL
Noroxycodone Confirmation LCMSMSNot Detected< 50ng/mL
Norhydrocodone Confirmation LCMSMSNot Detected< 50ng/mL
Oxycodone Confirmation LCMSMSNot Detected< 50ng/mL
Codeine Confirmation LCMSMSNot Detected< 50ng/mL
6MAM Confirmation LCMSMSNot Detected< 10ng/mL
Hydrocodone Confirmation LCMSMSNot Detected< 50ng/mL
Cannabinoid ScreenNegative< 50ng/mL
THC Confirmation GCMSNot Detected< 15ng/mL
PCP ScreenNegative< 25ng/mL
PCP Confirmation GCMSNot Detected< 25ng/mL
Barbiturates ScreenNegative< 200ng/mL
Amobarbital Confirmation GCMSNot Detected< 200ng/mL
Butalbital Confirmation GCMSNot Detected< 200ng/mL
Pentobarbital Confirmation GCMSNot Detected< 200ng/mL
Phenobarbital Confirmation GCMSNot Detected< 200ng/mL
Secobarbital Confirmation GCMSNot Detected< 200ng/mL
Benzodiazepines ScreenNegative< 200ng/mL
Clonazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoclonazepam Confirmation LCMSMSNot Detected< 10ng/mL
Flunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoflunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
Diazepam Confirmation LCMSMSNot Detected< 10ng/mL
Temazepam Confirmation LCMSMSNot Detected< 25ng/mL
Nordiazepam Confirmation LCMSMSNot Detected< 25ng/mL
Oxazepam Confirmation LCMSMSNot Detected< 25ng/mL
Lorazepam Confirmation LCMSMSNot Detected< 25ng/mL
Alprazolam Confirmation LCMSMSNot Detected< 10ng/mL
Alpha-Hydroxyalprazolam Confirmation LCMSMSNot Detected< 25ng/mL
Flurazepam Confirmation LCMSMSNot Detected< 10ng/mL
Midazolam Confirmation LCMSMSNot Detected< 25ng/mL
Alpha-Hydroxytriazolam Confirmation LCMSMSNot Detected< 25ng/mL
Fentanyl ScreenNegative< 5ng/mL
Fentanyl Confirmation LCMSMSNot Detected< 2ng/mL
Norfentanyl Confirmation LCMSMSNot Detected< 4ng/mL
Meperidine ScreenNegative< 200ng/mL
Meperidine Confirmation GCMSNot Detected< 100ng/mL
Normeperidine Confirmation GCMSNot Detected< 100ng/mL
Tramadol ScreenNegative< 200ng/mL
Tramadol Confirmation GCMSNot Detected< 100ng/mL
Methadone ScreenNegative< 300ng/mL
Methadone Confirmation GCMSNot Detected< 100ng/mL
Methadone Metabolite Confirmation GCMSNot Detected< 100ng/mL
Propoxyphene ScreenNegative< 300ng/mL
Norpropoxyphene Confirmation GCMSNot Detected< 150ng/mL
Specimen ValidityUrine Creatinine
Urine pH
Urine Specific Gravity
HEALTHCARE WORKER PANEL (HWP1A) URINE SCREEN RFLXHWP1AHWP1AEnzyme Immunoassay
TitleDescriptorRangesUnits
Extended Amphetamines ScreenNegative< 500ng/mL
Amphetamines Confirmation GCMSNot Detected< 250ng/mL
Methamphetamine Confirmation GCMSNot Detected< 250ng/mL
MDMA2 Confirmation GCMSNot Detected< 250ng/mL
MDA2 Confirmation GCMSNot Detected< 250ng/mL
MDEA2 Confirmation GCMSNot Detected< 250ng/mL
Benzoylecgonine (Cocaine) ScreenNegative< 150ng/mL
Benzoylecgonine (Cocaine) Confirmation GCMSNot Detected< 100ng/mL
Extended Opiate ScreenNegative< 300ng/mL
Morphine Confirmation LCMSMSNot Detected< 50ng/mL
Oxymorphone Confirmation LCMSMSNot Detected< 50ng/mL
Hydromorphone Confirmation LCMSMSNot Detected< 50ng/mL
Noroxycodone Confirmation LCMSMSNot Detected< 50ng/mL
Norhydrocodone Confirmation LCMSMSNot Detected< 50ng/mL
Oxycodone Confirmation LCMSMSNot Detected< 50ng/mL
Codeine Confirmation LCMSMSNot Detected< 50ng/mL
6MAM Confirmation LCMSMSNot Detected< 10ng/mL
Hydrocodone Confirmation LCMSMSNot Detected< 50ng/mL
Cannabinoid ScreenNegative< 50ng/mL
THC Confirmation GCMSNot Detected< 15ng/mL
PCP ScreenNegative< 25ng/mL
PCP Confirmation GCMSNot Detected< 25ng/mL
Barbiturates ScreenNegative< 200ng/mL
Amobarbital Confirmation GCMSNot Detected< 200ng/mL
Butalbital Confirmation GCMSNot Detected< 200ng/mL
Pentobarbital Confirmation GCMSNot Detected< 200ng/mL
Phenobarbital Confirmation GCMSNot Detected< 200ng/mL
Secobarbital Confirmation GCMSNot Detected< 200ng/mL
Benzodiazepines ScreenNegative< 200ng/mL
Clonazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoclonazepam Confirmation LCMSMSNot Detected< 10ng/mL
Flunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoflunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
Diazepam Confirmation LCMSMSNot Detected< 10ng/mL
Temazepam Confirmation LCMSMSNot Detected< 25ng/mL
Nordiazepam Confirmation LCMSMSNot Detected< 25ng/mL
Oxazepam Confirmation LCMSMSNot Detected< 25ng/mL
Lorazepam Confirmation LCMSMSNot Detected< 25ng/mL
Alprazolam Confirmation LCMSMSNot Detected< 10ng/mL
Alpha-Hydroxyalprazolam Confirmation LCMSMSNot Detected< 25ng/mL
Flurazepam Confirmation LCMSMSNot Detected< 10ng/mL
Midazolam Confirmation LCMSMSNot Detected< 25ng/mL
Alpha-Hydroxytriazolam Confirmation LCMSMSNot Detected< 25ng/mL
Fentanyl ScreenNegative< 5ng/mL
Fentanyl Confirmation LCMSMSNot Detected< 2ng/mL
Norfentanyl Confirmation LCMSMSNot Detected< 4ng/mL
Meperidine ScreenNegative< 200ng/mL
Meperidine Confirmation GCMSNot Detected< 100ng/mL
Normeperidine Confirmation GCMSNot Detected< 100ng/mL
Tramadol ScreenNegative< 200ng/mL
Tramadol Confirmation GCMSNot Detected< 100ng/mL
Methadone ScreenNegative< 300ng/mL
Methadone Confirmation GCMSNot Detected< 100ng/mL
Methadone Metabolite Confirmation GCMSNot Detected< 100ng/mL
Propoxyphene ScreenNegative< 300ng/mL
Norpropoxyphene Confirmation GCMSNot Detected< 150ng/mL
ETOH (Ethyl Alcohol) ScreenNegative< 20ng/mL
ETOH (Ethyl Alcohol) Confirmation GCFIDNot Detected< 20ng/mL
Specimen ValidityUrine Creatinine
Urine pH
Urine Specific Gravity
HEALTHCARE WORKER PANEL (HWP1C) URINE SCREEN RFLXHWP1CHWP1CEnzyme Immunoassay
TitleDescriptorRangesUnits
Extended Amphetamines ScreenNegative< 500ng/mL
Amphetamines Confirmation GCMSNot Detected< 250ng/mL
Methamphetamine Confirmation GCMSNot Detected< 250ng/mL
MDMA2 Confirmation GCMSNot Detected< 250ng/mL
MDA2 Confirmation GCMSNot Detected< 250ng/mL
MDEA2 Confirmation GCMSNot Detected< 250ng/mL
Benzoylecgonine (Cocaine) ScreenNegative< 150ng/mL
Benzoylecgonine (Cocaine) Confirmation GCMSNot Detected< 100ng/mL
Extended Opiate ScreenNegative< 300ng/mL
Morphine Confirmation LCMSMSNot Detected< 50ng/mL
Oxymorphone Confirmation LCMSMSNot Detected< 50ng/mL
Hydromorphone Confirmation LCMSMSNot Detected< 50ng/mL
Noroxycodone Confirmation LCMSMSNot Detected< 50ng/mL
Norhydrocodone Confirmation LCMSMSNot Detected< 50ng/mL
Oxycodone Confirmation LCMSMSNot Detected< 50ng/mL
Codeine Confirmation LCMSMSNot Detected< 50ng/mL
6MAM Confirmation LCMSMSNot Detected< 10ng/mL
Hydrocodone Confirmation LCMSMSNot Detected< 50ng/mL
Cannabinoid ScreenNegative< 50ng/mL
THC Confirmation GCMSNot Detected< 15ng/mL
PCP ScreenNegative< 25ng/mL
PCP Confirmation GCMSNot Detected< 25ng/mL
Barbiturates ScreenNegative< 200ng/mL
Amobarbital Confirmation GCMSNot Detected< 200ng/mL
Butalbital Confirmation GCMSNot Detected< 200ng/mL
Pentobarbital Confirmation GCMSNot Detected< 200ng/mL
Phenobarbital Confirmation GCMSNot Detected< 200ng/mL
Secobarbital Confirmation GCMSNot Detected< 200ng/mL
Benzodiazepines ScreenNegative< 200ng/mL
Clonazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoclonazepam Confirmation LCMSMSNot Detected< 10ng/mL
Flunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoflunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
Diazepam Confirmation LCMSMSNot Detected< 10ng/mL
Temazepam Confirmation LCMSMSNot Detected< 25ng/mL
Nordiazepam Confirmation LCMSMSNot Detected< 25ng/mL
Oxazepam Confirmation LCMSMSNot Detected< 25ng/mL
Lorazepam Confirmation LCMSMSNot Detected< 25ng/mL
Alprazolam Confirmation LCMSMSNot Detected< 10ng/mL
Alpha-Hydroxyalprazolam Confirmation LCMSMSNot Detected< 25ng/mL
Flurazepam Confirmation LCMSMSNot Detected< 10ng/mL
Midazolam Confirmation LCMSMSNot Detected< 25ng/mL
Alpha-Hydroxytriazolam Confirmation LCMSMSNot Detected< 25ng/mL
Fentanyl ScreenNegative< 5ng/mL
Fentanyl Confirmation LCMSMSNot Detected< 2ng/mL
Norfentanyl Confirmation LCMSMSNot Detected< 4ng/mL
Meperidine ScreenNegative< 200ng/mL
Meperidine Confirmation GCMSNot Detected< 100ng/mL
Normeperidine Confirmation GCMSNot Detected< 100ng/mL
Tramadol ScreenNegative< 200ng/mL
Tramadol Confirmation GCMSNot Detected< 100ng/mL
Methadone ScreenNegative< 300ng/mL
Methadone Confirmation GCMSNot Detected< 100ng/mL
Methadone Metabolite Confirmation GCMSNot Detected< 100ng/mL
Propoxyphene ScreenNegative< 300ng/mL
Norpropoxyphene Confirmation GCMSNot Detected< 150ng/mL
Cotinine ScreenNegative< 300ng/mL
Cotinine Confirmation GCMSNot Detected< 50ng/mL
Specimen ValidityUrine Creatinine
Urine pH
Urine Specific Gravity
HEALTHCARE WORKER PANEL (HWP2A) URINE SCREEN RFLXHWP2AHWP2AEnzyme Immunoassay
TitleDescriptorRangesUnits
Extended Amphetamines ScreenNegative< 500ng/mL
Amphetamines Confirmation GCMSNot Detected< 250ng/mL
Methamphetamine Confirmation GCMSNot Detected< 250ng/mL
MDMA2 Confirmation GCMSNot Detected< 250ng/mL
MDA2 Confirmation GCMSNot Detected< 250ng/mL
MDEA2 Confirmation GCMSNot Detected< 250ng/mL
Benzoylecgonine (Cocaine) ScreenNegative< 150ng/mL
Benzoylecgonine (Cocaine) Confirmation GCMSNot Detected< 100ng/mL
Extended Opiate ScreenNegative< 300ng/mL
Morphine Confirmation LCMSMSNot Detected< 50ng/mL
Oxymorphone Confirmation LCMSMSNot Detected< 50ng/mL
Hydromorphone Confirmation LCMSMSNot Detected< 50ng/mL
Noroxycodone Confirmation LCMSMSNot Detected< 50ng/mL
Norhydrocodone Confirmation LCMSMSNot Detected< 50ng/mL
Oxycodone Confirmation LCMSMSNot Detected< 50ng/mL
Codeine Confirmation LCMSMSNot Detected< 50ng/mL
6MAM Confirmation LCMSMSNot Detected< 10ng/mL
Hydrocodone Confirmation LCMSMSNot Detected< 50ng/mL
Cannabinoid ScreenNegative< 50ng/mL
THC Confirmation GCMSNot Detected< 15ng/mL
PCP ScreenNegative< 25ng/mL
PCP Confirmation GCMSNot Detected< 25ng/mL
Barbiturates ScreenNegative< 200ng/mL
Amobarbital Confirmation GCMSNot Detected< 200ng/mL
Butalbital Confirmation GCMSNot Detected< 200ng/mL
Pentobarbital Confirmation GCMSNot Detected< 200ng/mL
Phenobarbital Confirmation GCMSNot Detected< 200ng/mL
Secobarbital Confirmation GCMSNot Detected< 200ng/mL
Benzodiazepines ScreenNegative< 200ng/mL
Clonazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoclonazepam Confirmation LCMSMSNot Detected< 10ng/mL
Flunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoflunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
Diazepam Confirmation LCMSMSNot Detected< 10ng/mL
Temazepam Confirmation LCMSMSNot Detected< 25ng/mL
Nordiazepam Confirmation LCMSMSNot Detected< 25ng/mL
Oxazepam Confirmation LCMSMSNot Detected< 25ng/mL
Lorazepam Confirmation LCMSMSNot Detected< 25ng/mL
Alprazolam Confirmation LCMSMSNot Detected< 10ng/mL
Alpha-Hydroxyalprazolam Confirmation LCMSMSNot Detected< 25ng/mL
Flurazepam Confirmation LCMSMSNot Detected< 10ng/mL
Midazolam Confirmation LCMSMSNot Detected< 25ng/mL
Alpha-Hydroxytriazolam Confirmation LCMSMSNot Detected< 25ng/mL
Fentanyl ScreenNegative< 5ng/mL
Fentanyl Confirmation LCMSMSNot Detected< 2ng/mL
Norfentanyl Confirmation LCMSMSNot Detected< 4ng/mL
Meperidine ScreenNegative< 200ng/mL
Meperidine Confirmation GCMSNot Detected< 100ng/mL
Normeperidine Confirmation GCMSNot Detected< 100ng/mL
Tramadol ScreenNegative< 200ng/mL
Tramadol Confirmation GCMSNot Detected< 100ng/mL
Methadone ScreenNegative< 300ng/mL
Methadone Confirmation GCMSNot Detected< 100ng/mL
Methadone Metabolite Confirmation GCMSNot Detected< 100ng/mL
Propoxyphene ScreenNegative< 300ng/mL
Norpropoxyphene Confirmation GCMSNot Detected< 150ng/mL
Carisoprodol ScreenNegative< 100ng/mL
Carisoprodol Confirmation GCMSNot Detected< 2.5ug/mL
Meprobamate Confirmation GCMSNot Detected< 2.5ug/mL
Ethyl Glucuronide ScreenNegative< 250ng/mL
Ethyl Glucuronide Confirmation GCMSNot Detected< 250ng/mL
Ethyl Sulfate Confirmation GCMSNot Detected< 150ng/mL
ETOH (Ethyl Alcohol) ScreenNegative< 20ng/mL
ETOH (Ethyl Alcohol) Confirmation GCFIDNot Detected< 20ng/mL
Specimen ValidityUrine Creatinine
Urine pH
Urine Specific Gravity
HEALTHCARE WORKER PANEL (HWP2C) URINE SCREEN RFLXHWP2CHWP2CEnzyme Immunoassay
TitleDescriptorRangesUnits
Extended Amphetamines ScreenNegative< 500ng/mL
Amphetamines Confirmation GCMSNot Detected< 250ng/mL
Methamphetamine Confirmation GCMSNot Detected< 250ng/mL
MDMA2 Confirmation GCMSNot Detected< 250ng/mL
MDA2 Confirmation GCMSNot Detected< 250ng/mL
MDEA2 Confirmation GCMSNot Detected< 250ng/mL
Benzoylecgonine (Cocaine) ScreenNegative< 150ng/mL
Benzoylecgonine (Cocaine) Confirmation GCMSNot Detected< 100ng/mL
Extended Opiate ScreenNegative< 300ng/mL
Morphine Confirmation LCMSMSNot Detected< 50ng/mL
Oxymorphone Confirmation LCMSMSNot Detected< 50ng/mL
Hydromorphone Confirmation LCMSMSNot Detected< 50ng/mL
Noroxycodone Confirmation LCMSMSNot Detected< 50ng/mL
Norhydrocodone Confirmation LCMSMSNot Detected< 50ng/mL
Oxycodone Confirmation LCMSMSNot Detected< 50ng/mL
Codeine Confirmation LCMSMSNot Detected< 50ng/mL
6MAM Confirmation LCMSMSNot Detected< 10ng/mL
Hydrocodone Confirmation LCMSMSNot Detected< 50ng/mL
Cannabinoid ScreenNegative< 50ng/mL
THC Confirmation GCMSNot Detected< 15ng/mL
PCP ScreenNegative< 25ng/mL
PCP Confirmation GCMSNot Detected< 25ng/mL
Barbiturates ScreenNegative< 200ng/mL
Amobarbital Confirmation GCMSNot Detected< 200ng/mL
Butalbital Confirmation GCMSNot Detected< 200ng/mL
Pentobarbital Confirmation GCMSNot Detected< 200ng/mL
Phenobarbital Confirmation GCMSNot Detected< 200ng/mL
Secobarbital Confirmation GCMSNot Detected< 200ng/mL
Benzodiazepines ScreenNegative< 200ng/mL
Clonazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoclonazepam Confirmation LCMSMSNot Detected< 10ng/mL
Flunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoflunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
Diazepam Confirmation LCMSMSNot Detected< 10ng/mL
Temazepam Confirmation LCMSMSNot Detected< 25ng/mL
Nordiazepam Confirmation LCMSMSNot Detected< 25ng/mL
Oxazepam Confirmation LCMSMSNot Detected< 25ng/mL
Lorazepam Confirmation LCMSMSNot Detected< 25ng/mL
Alprazolam Confirmation LCMSMSNot Detected< 10ng/mL
Alpha-Hydroxyalprazolam Confirmation LCMSMSNot Detected< 25ng/mL
Flurazepam Confirmation LCMSMSNot Detected< 10ng/mL
Midazolam Confirmation LCMSMSNot Detected< 25ng/mL
Alpha-Hydroxytriazolam Confirmation LCMSMSNot Detected< 25ng/mL
Fentanyl ScreenNegative< 5ng/mL
Fentanyl Confirmation LCMSMSNot Detected< 2ng/mL
Norfentanyl Confirmation LCMSMSNot Detected< 4ng/mL
Meperidine ScreenNegative< 200ng/mL
Meperidine Confirmation GCMSNot Detected< 100ng/mL
Normeperidine Confirmation GCMSNot Detected< 100ng/mL
Tramadol ScreenNegative< 200ng/mL
Tramadol Confirmation GCMSNot Detected< 100ng/mL
Methadone ScreenNegative< 300ng/mL
Methadone Confirmation GCMSNot Detected< 100ng/mL
Methadone Metabolite Confirmation GCMSNot Detected< 100ng/mL
Propoxyphene ScreenNegative< 300ng/mL
Norpropoxyphene Confirmation GCMSNot Detected< 150ng/mL
Carisoprodol ScreenNegative< 100ng/mL
Carisoprodol Confirmation GCMSNot Detected< 2.5ug/mL
Meprobamate Confirmation GCMSNot Detected< 2.5ug/mL
Cotinine ScreenNegative< 300ng/mL
Cotinine Confirmation GCMSNot Detected< 50ng/mL
Specimen ValidityUrine Creatinine
Urine pH
Urine Specific Gravity
HEALTHCARE WORKER PANEL (HWP3) URINE SCREEN RFLXHWP3HWP3Enzyme Immunoassay
TitleDescriptorRangesUnits
Extended Amphetamines ScreenNegative< 500ng/mL
Amphetamines Confirmation GCMSNot Detected< 250ng/mL
Methamphetamine Confirmation GCMSNot Detected< 250ng/mL
MDMA2 Confirmation GCMSNot Detected< 250ng/mL
MDA2 Confirmation GCMSNot Detected< 250ng/mL
MDEA2 Confirmation GCMSNot Detected< 250ng/mL
Benzoylecgonine (Cocaine) ScreenNegative< 150ng/mL
Benzoylecgonine (Cocaine) Confirmation GCMSNot Detected< 100ng/mL
Extended Opiate ScreenNegative< 300ng/mL
Morphine Confirmation LCMSMSNot Detected< 50ng/mL
Oxymorphone Confirmation LCMSMSNot Detected< 50ng/mL
Hydromorphone Confirmation LCMSMSNot Detected< 50ng/mL
Noroxycodone Confirmation LCMSMSNot Detected< 50ng/mL
Norhydrocodone Confirmation LCMSMSNot Detected< 50ng/mL
Oxycodone Confirmation LCMSMSNot Detected< 50ng/mL
Codeine Confirmation LCMSMSNot Detected< 50ng/mL
6MAM Confirmation LCMSMSNot Detected< 10ng/mL
Hydrocodone Confirmation LCMSMSNot Detected< 50ng/mL
Cannabinoid ScreenNegative< 50ng/mL
THC Confirmation GCMSNot Detected< 15ng/mL
PCP ScreenNegative< 25ng/mL
PCP Confirmation GCMSNot Detected< 25ng/mL
Barbiturates ScreenNegative< 200ng/mL
Amobarbital Confirmation GCMSNot Detected< 200ng/mL
Butalbital Confirmation GCMSNot Detected< 200ng/mL
Pentobarbital Confirmation GCMSNot Detected< 200ng/mL
Phenobarbital Confirmation GCMSNot Detected< 200ng/mL
Secobarbital Confirmation GCMSNot Detected< 200ng/mL
Benzodiazepines ScreenNegative< 200ng/mL
Clonazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoclonazepam Confirmation LCMSMSNot Detected< 10ng/mL
Flunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoflunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
Diazepam Confirmation LCMSMSNot Detected< 10ng/mL
Temazepam Confirmation LCMSMSNot Detected< 25ng/mL
Nordiazepam Confirmation LCMSMSNot Detected< 25ng/mL
Oxazepam Confirmation LCMSMSNot Detected< 25ng/mL
Lorazepam Confirmation LCMSMSNot Detected< 25ng/mL
Alprazolam Confirmation LCMSMSNot Detected< 10ng/mL
Alpha-Hydroxyalprazolam Confirmation LCMSMSNot Detected< 25ng/mL
Flurazepam Confirmation LCMSMSNot Detected< 10ng/mL
Midazolam Confirmation LCMSMSNot Detected< 25ng/mL
Alpha-Hydroxytriazolam Confirmation LCMSMSNot Detected< 25ng/mL
Fentanyl ScreenNegative< 5ng/mL
Fentanyl Confirmation LCMSMSNot Detected< 2ng/mL
Norfentanyl Confirmation LCMSMSNot Detected< 4ng/mL
Meperidine ScreenNegative< 200ng/mL
Meperidine Confirmation GCMSNot Detected< 100ng/mL
Normeperidine Confirmation GCMSNot Detected< 100ng/mL
Tramadol ScreenNegative< 200ng/mL
Tramadol Confirmation GCMSNot Detected< 100ng/mL
Methadone ScreenNegative< 300ng/mL
Methadone Confirmation GCMSNot Detected< 100ng/mL
Methadone Metabolite Confirmation GCMSNot Detected< 100ng/mL
Propoxyphene ScreenNegative< 300ng/mL
Norpropoxyphene Confirmation GCMSNot Detected< 150ng/mL
Carisoprodol ScreenNegative< 100ng/mL
Carisoprodol Confirmation GCMSNot Detected< 2.5ug/mL
Meprobamate Confirmation GCMSNot Detected< 2.5ug/mL
Specimen ValidityUrine Creatinine
Urine pH
Urine Specific Gravity
HEALTHCARE WORKER PANEL (HWP4) URINE SCREEN RFLXHWP4HWP4Enzyme Immunoassay
TitleDescriptorRangesUnits
Extended Amphetamines ScreenNegative< 500ng/mL
Amphetamines Confirmation GCMSNot Detected< 250ng/mL
Methamphetamine Confirmation GCMSNot Detected< 250ng/mL
MDMA2 Confirmation GCMSNot Detected< 250ng/mL
MDA2 Confirmation GCMSNot Detected< 250ng/mL
MDEA2 Confirmation GCMSNot Detected< 250ng/mL
Benzoylecgonine (Cocaine) ScreenNegative< 150ng/mL
Benzoylecgonine (Cocaine) Confirmation GCMSNot Detected< 100ng/mL
Extended Opiate ScreenNegative< 300ng/mL
Morphine Confirmation LCMSMSNot Detected< 50ng/mL
Oxymorphone Confirmation LCMSMSNot Detected< 50ng/mL
Hydromorphone Confirmation LCMSMSNot Detected< 50ng/mL
Noroxycodone Confirmation LCMSMSNot Detected< 50ng/mL
Norhydrocodone Confirmation LCMSMSNot Detected< 50ng/mL
Oxycodone Confirmation LCMSMSNot Detected< 50ng/mL
Codeine Confirmation LCMSMSNot Detected< 50ng/mL
6MAM Confirmation LCMSMSNot Detected< 10ng/mL
Hydrocodone Confirmation LCMSMSNot Detected< 50ng/mL
Cannabinoid ScreenNegative< 50ng/mL
THC Confirmation GCMSNot Detected< 15ng/mL
PCP ScreenNegative< 25ng/mL
PCP Confirmation GCMSNot Detected< 25ng/mL
Barbiturates ScreenNegative< 200ng/mL
Amobarbital Confirmation GCMSNot Detected< 200ng/mL
Butalbital Confirmation GCMSNot Detected< 200ng/mL
Pentobarbital Confirmation GCMSNot Detected< 200ng/mL
Phenobarbital Confirmation GCMSNot Detected< 200ng/mL
Secobarbital Confirmation GCMSNot Detected< 200ng/mL
Benzodiazepines ScreenNegative< 200ng/mL
Clonazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoclonazepam Confirmation LCMSMSNot Detected< 10ng/mL
Flunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoflunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
Diazepam Confirmation LCMSMSNot Detected< 10ng/mL
Temazepam Confirmation LCMSMSNot Detected< 25ng/mL
Nordiazepam Confirmation LCMSMSNot Detected< 25ng/mL
Oxazepam Confirmation LCMSMSNot Detected< 25ng/mL
Lorazepam Confirmation LCMSMSNot Detected< 25ng/mL
Alprazolam Confirmation LCMSMSNot Detected< 10ng/mL
Alpha-Hydroxyalprazolam Confirmation LCMSMSNot Detected< 25ng/mL
Flurazepam Confirmation LCMSMSNot Detected< 10ng/mL
Midazolam Confirmation LCMSMSNot Detected< 25ng/mL
Alpha-Hydroxytriazolam Confirmation LCMSMSNot Detected< 25ng/mL
Fentanyl ScreenNegative< 5ng/mL
Fentanyl Confirmation LCMSMSNot Detected< 2ng/mL
Norfentanyl Confirmation LCMSMSNot Detected< 4ng/mL
Meperidine ScreenNegative< 200ng/mL
Meperidine Confirmation GCMSNot Detected< 100ng/mL
Normeperidine Confirmation GCMSNot Detected< 100ng/mL
Tramadol ScreenNegative< 200ng/mL
Tramadol Confirmation GCMSNot Detected< 100ng/mL
Methadone ScreenNegative< 300ng/mL
Methadone Confirmation GCMSNot Detected< 100ng/mL
Methadone Metabolite Confirmation GCMSNot Detected< 100ng/mL
Propoxyphene ScreenNegative< 300ng/mL
Norpropoxyphene Confirmation GCMSNot Detected< 150ng/mL
Carisoprodol ScreenNegative< 100ng/mL
Carisoprodol Confirmation GCMSNot Detected< 2.5ug/mL
Meprobamate Confirmation GCMSNot Detected< 2.5ug/mL
Buprenorphine ScreenNegative< 5ng/mL
Buprenorphine Confirmation GCMSNot Detected< 5ng/mL
Norbuprenorphine Confirmation GCMSNot Detected< 5ng/mL
Specimen ValidityUrine Creatinine
Urine pH
Urine Specific Gravity
HEALTHCARE WORKER PANEL (HWP4A) URINE SCREEN RFLXHWP4AHWP4AEnzyme Immunoassay
TitleDescriptorRangesUnits
Extended Amphetamines ScreenNegative< 500ng/mL
Amphetamines Confirmation GCMSNot Detected< 250ng/mL
Methamphetamine Confirmation GCMSNot Detected< 250ng/mL
MDMA2 Confirmation GCMSNot Detected< 250ng/mL
MDA2 Confirmation GCMSNot Detected< 250ng/mL
MDEA2 Confirmation GCMSNot Detected< 250ng/mL
Benzoylecgonine (Cocaine) ScreenNegative< 150ng/mL
Benzoylecgonine (Cocaine) Confirmation GCMSNot Detected< 100ng/mL
Extended Opiate ScreenNegative< 300ng/mL
Morphine Confirmation LCMSMSNot Detected< 50ng/mL
Oxymorphone Confirmation LCMSMSNot Detected< 50ng/mL
Hydromorphone Confirmation LCMSMSNot Detected< 50ng/mL
Noroxycodone Confirmation LCMSMSNot Detected< 50ng/mL
Norhydrocodone Confirmation LCMSMSNot Detected< 50ng/mL
Oxycodone Confirmation LCMSMSNot Detected< 50ng/mL
Codeine Confirmation LCMSMSNot Detected< 50ng/mL
6MAM Confirmation LCMSMSNot Detected< 10ng/mL
Hydrocodone Confirmation LCMSMSNot Detected< 50ng/mL
Cannabinoid ScreenNegative< 50ng/mL
THC Confirmation GCMSNot Detected< 15ng/mL
PCP ScreenNegative< 25ng/mL
PCP Confirmation GCMSNot Detected< 25ng/mL
Barbiturates ScreenNegative< 200ng/mL
Amobarbital Confirmation GCMSNot Detected< 200ng/mL
Butalbital Confirmation GCMSNot Detected< 200ng/mL
Pentobarbital Confirmation GCMSNot Detected< 200ng/mL
Phenobarbital Confirmation GCMSNot Detected< 200ng/mL
Secobarbital Confirmation GCMSNot Detected< 200ng/mL
Benzodiazepines ScreenNegative< 200ng/mL
Clonazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoclonazepam Confirmation LCMSMSNot Detected< 10ng/mL
Flunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoflunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
Diazepam Confirmation LCMSMSNot Detected< 10ng/mL
Temazepam Confirmation LCMSMSNot Detected< 25ng/mL
Nordiazepam Confirmation LCMSMSNot Detected< 25ng/mL
Oxazepam Confirmation LCMSMSNot Detected< 25ng/mL
Lorazepam Confirmation LCMSMSNot Detected< 25ng/mL
Alprazolam Confirmation LCMSMSNot Detected< 10ng/mL
Alpha-Hydroxyalprazolam Confirmation LCMSMSNot Detected< 25ng/mL
Flurazepam Confirmation LCMSMSNot Detected< 10ng/mL
Midazolam Confirmation LCMSMSNot Detected< 25ng/mL
Alpha-Hydroxytriazolam Confirmation LCMSMSNot Detected< 25ng/mL
Fentanyl ScreenNegative< 5ng/mL
Fentanyl Confirmation LCMSMSNot Detected< 2ng/mL
Norfentanyl Confirmation LCMSMSNot Detected< 4ng/mL
Meperidine ScreenNegative< 200ng/mL
Meperidine Confirmation GCMSNot Detected< 100ng/mL
Normeperidine Confirmation GCMSNot Detected< 100ng/mL
Tramadol ScreenNegative< 200ng/mL
Tramadol Confirmation GCMSNot Detected< 100ng/mL
Methadone ScreenNegative< 300ng/mL
Methadone Confirmation GCMSNot Detected< 100ng/mL
Methadone Metabolite Confirmation GCMSNot Detected< 100ng/mL
Propoxyphene ScreenNegative< 300ng/mL
Norpropoxyphene Confirmation GCMSNot Detected< 150ng/mL
Carisoprodol ScreenNegative< 100ng/mL
Carisoprodol Confirmation GCMSNot Detected< 2.5ug/mL
Meprobamate Confirmation GCMSNot Detected< 2.5ug/mL
Buprenorphine ScreenNegative< 5ng/mL
Buprenorphine Confirmation GCMSNot Detected< 5ng/mL
Norbuprenorphine Confirmation GCMSNot Detected< 5ng/mL
Ethyl Glucuronide ScreenNegative< 250ng/mL
Ethyl Glucuronide Confirmation GCMSNot Detected< 250ng/mL
Ethyl Sulfate Confirmation GCMSNot Detected< 150ng/mL
ETOH (Ethyl Alcohol) ScreenNegative< 20ng/mL
ETOH (Ethyl Alcohol) Confirmation GCFIDNot Detected< 20ng/mL
Specimen ValidityUrine Creatinine
Urine pH
Urine Specific Gravity
HEALTHCARE WORKER PANEL (HWP5A) URINE SCREEN RFLXHWP5AHWP5AEnzyme Immunoassay
TitleDescriptorRangesUnits
Extended Amphetamines ScreenNegative< 500ng/mL
Amphetamines Confirmation GCMSNot Detected< 250ng/mL
Methamphetamine Confirmation GCMSNot Detected< 250ng/mL
MDMA2 Confirmation GCMSNot Detected< 250ng/mL
MDA2 Confirmation GCMSNot Detected< 250ng/mL
MDEA2 Confirmation GCMSNot Detected< 250ng/mL
Benzoylecgonine (Cocaine) ScreenNegative< 150ng/mL
Benzoylecgonine (Cocaine) Confirmation GCMSNot Detected< 100ng/mL
Extended Opiate ScreenNegative< 300ng/mL
Morphine Confirmation LCMSMSNot Detected< 50ng/mL
Oxymorphone Confirmation LCMSMSNot Detected< 50ng/mL
Hydromorphone Confirmation LCMSMSNot Detected< 50ng/mL
Noroxycodone Confirmation LCMSMSNot Detected< 50ng/mL
Norhydrocodone Confirmation LCMSMSNot Detected< 50ng/mL
Oxycodone Confirmation LCMSMSNot Detected< 50ng/mL
Codeine Confirmation LCMSMSNot Detected< 50ng/mL
6MAM Confirmation LCMSMSNot Detected< 10ng/mL
Hydrocodone Confirmation LCMSMSNot Detected< 50ng/mL
Cannabinoid ScreenNegative< 50ng/mL
THC Confirmation GCMSNot Detected< 15ng/mL
PCP ScreenNegative< 25ng/mL
PCP Confirmation GCMSNot Detected< 25ng/mL
Barbiturates ScreenNegative< 200ng/mL
Amobarbital Confirmation GCMSNot Detected< 200ng/mL
Butalbital Confirmation GCMSNot Detected< 200ng/mL
Pentobarbital Confirmation GCMSNot Detected< 200ng/mL
Phenobarbital Confirmation GCMSNot Detected< 200ng/mL
Secobarbital Confirmation GCMSNot Detected< 200ng/mL
Benzodiazepines ScreenNegative< 200ng/mL
Clonazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoclonazepam Confirmation LCMSMSNot Detected< 10ng/mL
Flunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
7 Aminoflunitrazepam Confirmation LCMSMSNot Detected< 10ng/mL
Diazepam Confirmation LCMSMSNot Detected< 10ng/mL
Temazepam Confirmation LCMSMSNot Detected< 25ng/mL
Nordiazepam Confirmation LCMSMSNot Detected< 25ng/mL
Oxazepam Confirmation LCMSMSNot Detected< 25ng/mL
Lorazepam Confirmation LCMSMSNot Detected< 25ng/mL
Alprazolam Confirmation LCMSMSNot Detected< 10ng/mL
Alpha-Hydroxyalprazolam Confirmation LCMSMSNot Detected< 25ng/mL
Flurazepam Confirmation LCMSMSNot Detected< 10ng/mL
Midazolam Confirmation LCMSMSNot Detected< 25ng/mL
Alpha-Hydroxytriazolam Confirmation LCMSMSNot Detected< 25ng/mL
Fentanyl ScreenNegative< 5ng/mL
Fentanyl Confirmation LCMSMSNot Detected< 2ng/mL
Norfentanyl Confirmation LCMSMSNot Detected< 4ng/mL
Meperidine ScreenNegative< 200ng/mL
Meperidine Confirmation GCMSNot Detected< 100ng/mL
Normeperidine Confirmation GCMSNot Detected< 100ng/mL
Tramadol ScreenNegative< 200ng/mL
Tramadol Confirmation GCMSNot Detected< 100ng/mL
Methadone ScreenNegative< 300ng/mL
Methadone Confirmation GCMSNot Detected< 100ng/mL
Methadone Metabolite Confirmation GCMSNot Detected< 100ng/mL
Propoxyphene ScreenNegative< 300ng/mL
Norpropoxyphene Confirmation GCMSNot Detected< 150ng/mL
Carisoprodol ScreenNegative< 100ng/mL
Carisoprodol Confirmation GCMSNot Detected< 2.5ug/mL
Meprobamate Confirmation GCMSNot Detected< 2.5ug/mL
Buprenorphine ScreenNegative< 5ng/mL
Buprenorphine Confirmation GCMSNot Detected< 5ng/mL
Norbuprenorphine Confirmation GCMSNot Detected< 5ng/mL
Cotinine ScreenNegative< 300ng/mL
Cotinine Confirmation GCMSNot Detected< 50ng/mL
Ethyl Glucuronide ScreenNegative< 250ng/mL
Ethyl Glucuronide Confirmation GCMSNot Detected< 250ng/mL
Ethyl Sulfate Confirmation GCMSNot Detected< 150ng/mL
ETOH (Ethyl Alcohol) ScreenNegative< 20ng/mL
ETOH (Ethyl Alcohol) Confirmation GCFIDNot Detected< 20ng/mL
Specimen ValidityUrine Creatinine
Urine pH
Urine Specific Gravity
FACTOR II/PROTHROMBIN ACTIVITYFAC2F02ACTElectromechanical
TitleDescriptorRangesUnits
Factor II1 day46-66%
3 days56-69
1 month-1 year69-98
1-5 years78-103
6-10 years75-104
11-16 years68-102
16+ years87-131
FACTOR IX ACTIVITYFAC9F09ACTElectromechanical
TitleDescriptorRangesUnits
Factor IX1 day31-36%
3 days45-53
1 month-1 year44-67
1-5 years45-70
6-10 years49-80
11-16 years65-119
16+ years60-140
COAG CONSULTATION FOR VONPVONPCCVONPCCElectromechanical, Immuno-turbidimetric, Platelet Aggregation
TitleDescriptorRangesUnits
Factor VIII Coagulant Activity1 day111-200%
3 days88-200
1 month-1 year57-200
1-5 years38-200
6-10 years55-200
11-16 years62-200
16+ years55-150
Factor VIII Related Antigen0-5 years50-165%
6-10 years60-200
11-16 years56-200
16+ years50-165
Normal individuals of blood group "O" may have vonWillebrand factor antigen levels as low as 40%.
Children: Neonates, infants, and children have normal or mildly increased plasma VWF antigen, with respect to the adult reference range.
Von Willebrand Factor Activity> 40%
VON WILLEBRAND PANELVONPVONPElectromechanical, Immuno-turbidimetric, Platelet Aggregation
TitleDescriptorRangesUnits
Factor VIII Coagulant Activity1 day111-200%
3 days88-200
1 month-1 year57-200
1-5 years38-200
6-10 years55-200
11-16 years62-200
16+ years55-150
Factor VIII Related Antigen0-5 years50-165%
6-10 years60-200
11-16 years56-200
16+ years50-165
Normal individuals of blood group "O" may have vonWillebrand factor antigen levels as low as 40%.
Children: Neonates, infants, and children have normal or mildly increased plasma VWF antigen, with respect to the adult reference range.
Von Willebrand Factor Activity> 40%
FACTOR VIII COAGULANT ACTIVITYFAC8ASF08ACTElectromechanical
TitleDescriptorRangesUnits
Factor VIII Coagulant Activity1 day111-200%
3 days88-200
1 month-1 year57-200
1-5 years38-200
6-10 years55-200
11-16 years62-200
16+ years55-150
VON WILLEBRAND FACTOR AGFAC8AGF08RAImmuno-turbidimetric Assay
TitleDescriptorRangesUnits
Factor VIII Related Antigen0-5 years50-165%
6-10 years60-200
11-16 years56-200
16+ years50-165
Normal individuals of blood group "O" may have vonWillebrand factor antigen levels as low as 40%.
Children: Neonates, infants, and children have normal or mildly increased plasma VWF antigen, with respect to the adult reference range.
FACTOR VII ACTIVITYFAC7F07ACTElectromechanical
TitleDescriptorRangesUnits
Factor VII1 day57-80%
3 days74-98
1 month-1 year79-137
1-5 years79-137
6-10 years77-143
11-16 years76-183
16+ years67-182
FACTOR V ACTIVITYFAC5F05ACTElectromechanical
TitleDescriptorRangesUnits
Factor V1 day57-83%
3 days83-124
1 month-1 year84-113
1-5 years60-102
6-10 years50-113
11-16 years60-113
16+ years70-122
FACTOR XII/HAGEMAN ACTIVITYFAC12F12ACTElectromechanical
TitleDescriptorRangesUnits
Factor XII1 day43-80%
3 days19-70
1 month-1 year29-98
1-5 years50-98
6-10 years50-99
11-16 years50-85
16+ years50-150
FACTOR XI ACTIVITYFAC11F11ACTElectromechanical
TitleDescriptorRangesUnits
Factor XI1 day7-28%
3 days23-54
1 month-1 year60-86
1-5 years63-112
6-10 years63-112
11-16 years63-96
16+ years65-135
FACTOR X ACTIVITYFAC10F10ACTElectromechanical
TitleDescriptorRangesUnits
Factor X1 day41-60%
3 days41-67
1 month-1 year68-108
1-5 years64-111
6-10 years60-111
11-16 years47-108
16+ years85-152
PAIN MANAGEMENT FENTANYL RFLXPMFENPMFENEnzyme Immunoassay
TitleDescriptorRangesUnits
Fentanyl ScreenNegative< 2ng/mL
Fentanyl by LC-MS/MSng/mL
Norfentanyl by LC-MS/MSng/mL
FENTANYL SCREEN, URINE, RFLXFENTURFENTUREnzyme Immunoassay
TitleDescriptorRangesUnits
Fentanyl ScreenNegative< 2ng/mL
Fentanyl ScreenPositive> 2ng/mL
FENTANYL/NORFENTANYL (LCMSMS)FENTUFENTULiquid Chromatography Tandem Mass Spectrometry
TitleDescriptorRangesUnits
FentanylPositive Cutoff2.0ng/mL
NorfentanylPositive Cutoff4.0ng/mL
PAIN MANAGEMENT FENTANYL CONFPFENTPFENTLiquid Chromatography Tandem Mass Spectrometry
TitleDescriptorRangesUnits
FentanylPositive cutoff2ng/mL
NorfentanylPositive cutoff4ng/mL
PROTOPORPHYRIN, FREE ERYTHROCYTE, AND ZINC PROTOPORPHYRINEPWBALEPWBALFluorometry
TitleDescriptorRangesUnits
FEP, bloodAdults0-34ug/dL
ZPP, bloodAdults0-38ug/dL
Occupational exposure: BEI® (sampling time is after one month's exposure): 100 ug/dL
FIBRINOGENXFIBXFIBElectromechanical
TitleDescriptorRangesUnits
Fibrinogen1 day213-364mg/dL
3 days314-391
1 month-1 year91-373
1-5 years180-391
6-10 years221-399
11-16 years235-422
16+ years211-419
Abnormalities of fibrinogen function may result in low reported levels. Additional testing, including thrombin times, may be useful in interpreting low fribrinogen levels.
FIBRINOGEN RFLX TTQFIBQFIBElectromechanical
TitleDescriptorRangesUnits
Fibrinogen1 day213-364mg/dL
3 days314-391
1 month-1 year91-373
1-5 years180-391
6-10 years221-399
11-16 years235-422
16+ years211-419
Thrombin Time Patient15.6-20.0sec
Thrombin Time Control15.6-20.0sec
Thrombin Time PT/CT Mixsec
Thrombin Time PT/PSO4 Mixsec
FLUCONAZOLE, QUANTITATIVEFLUCON.LCAFLUCONQuantitative High Performance Liquid Chromatography/Tandem Mass Spectrometry
TitleDescriptorRangesUnits
Fluconazole, Quantitative by LCMSMSTherapeutic Range5.0-20.0ug/mL
CONSULT/REVIEW, FLUIDREVFLREVFLVisual Microscopic
Fluid, Interpretation
Fluid, Reviewed by
FLUPHENAZINEFLUPH.LCAFLUPHQuantitative Liquid Chromatography-Tandem Mass Spectrometry
TitleDescriptorRangesUnits
FluphenazineTherapeutic0.5-2.0ng/mL
ToxicNot well established
FOLATEFOLATEFOLElectrochemiluminescence Immunoassay
TitleDescriptorRangesUnits
FolateNormal4.8-24.2ng/mL
FRAGILE X SYNDROME RFLXFRAGXA.LCAFRAGXAPolymerase Chain Reaction/Capillary Electrophoresis
Fragile X PCR
Fragile X SB
T4, FREE (EQUIL DIALYSIS)FT4TMS.LCAFT4TMSQuantitative Equilibrium Dialysis/High Performance Liquid Chromatography-Tandem Mass Spectrometry
TitleDescriptorRangesUnits
Free T4 by Equilibrium Dialysis-TMSPremature (0-4 weeks)0.86-4.46ng/dL
0-2 weeks0.84-4.97
2 weeks-12 months0.81-2.12
1-11 years0.65-1.9
12+ years0.8-1.7
Pregnant Female
1st Trimester (0-13.3 weeks)0.65-1.4
2nd Trimester (13.4-23.3 weeks)0.5-1.3
3rd Trimester (> 26.6 weeks)0.85-1.1
CARNITINE, FREE AND TOT, PANELCARNPL.LCACARNPLLiquid Chromatography/Tandem Mass Spectrometry
TitleDescriptorRangesUnits
Free/Total Carnitine Ratio0-29 days0.6-0.9umol/L
30-364 days0.4-0.9
1-99 years0.7-0.9
Total L-carnitine0-29 days12-68umol/L
30-364 days27-74
1-99 years27-66
Free L-carnitine0-29 days7-54umol/L
30-364 days16-58
1-99 years22-52
GAMMA-HYDROXUBUTYRIC ACID SCRGHBMSGHBMSGas Chromatography Mass Spectrometry
TitleDescriptorRangesUnits
Gamma-Hydroxubutyric Acid ScreenNot Detected< 10ug/mL
ANTI MULLERIAN HORMONEAMUHPAMUHPICMA
GenderDescriptorRangesUnits
Females< 14 years0.49-3.15ng/mL
14-19 years1.28-16.37
20-29 years0.76-11.34
30-39 years< 9.24
40-49 years< 4.50
50+ years, post menopause< 0.45
Males< 1 year37.20-345.67ng/mL
1-6 years59.54-320.65
7-11 years40.99-203.67
12-17 years< 128.29
17+ years1.15-15.23
INSULIN-LIKE GROWTH FACTOR 1IGFIL1IGFIL1Chemiluminescent Immunoassay (CLIA)
GenderDescriptorRangesUnits
Male1-2 years30-122ng/mL
3 years20-141
4 years25-157
5 years30-174
6 years37-192
7 years44-211
8-18 yearsRefer to Tanner Stages
19-20 years281-510
21-30 years155-432
31-40 years132-333
41-50 years121-237
51-60 years68-245
61-70 years60-220
71-80 years36-215
Tanner Stage I (8-15 years)52-391
Tanner Stage II & III (8-16 years)39-648
Tanner Stage IV & V (11-18 years)277-434
Female1-2 years56-144ng/mL
3 years26-162
4 years32-179
5 years39-198
6 years55-238
7 years55-268
8-18 yearsRefer to Tanner Stages
19-20 years217-475
21-30 years87-368
31-40 years106-368
41-50 years118-298
51-60 years53-287
61-70 years75-263
71-80 years54-205
Tanner Stage I (8-12 years)64-358
Tanner Stage II (8-14 years)89-566
Tanner Stage III (9-15 years)192-568
Tanner Stage IV & V (11-18 years)268-430
GENTAMICIN, PEAKGENT.PKGENPKEnzyme Immunoassay
TitleDescriptorRangesUnits
Gentamicin, Time of last dose
Gentamicin, Peak5.0-10.0ug/mL
ToxicGT 12.0
GENTAMICIN, TROUGHGENT.TRGENTREnzyme Immunoassay
TitleDescriptorRangesUnits
Gentamicin, Trough1.0-2.0ug/mL
ToxicGT 2.0
GENTAMICIN, INFUSIONGENT2GENTINEnzyme Immunoassay
TitleDescriptorRangesUnits
Gentamicin, Troughug/mL
1.0-2.0
ToxicGT 2.0
Gentamicin Time, Troughh
Gentamicin, Peakug/mL
5.0-10.0
ToxicGT 12.0
Gentamicin Time, Peakh
GENTAMICIN, RANDOMGENTGENREnzyme Immunoassay
TitleDescriptorRangesUnits
GentamicinTrough1.0-2.0ug/mL
Toxic> 2.0
Peak5.0-10.0
Toxic> 12.0
LIVER HEALTH PANELLHPANLHPAN
GGT
HFPA
GLIADIN ABS, IGA, IGGGLIGAGLIGAMultiplex Bead Immunoassay
TitleDescriptorRangesUnits
Gliadin Ab, IgANegative< 15U/mL
Positive> or = 15
This test was performed using a deamidated gliadin peptide (DGP) assay.
Gliadin Ab, IgGNegative< 15U/mL
Positive> or = 15
This test was performed using a deamidated gliadin peptide (DGP) assay.
GLOMERULAR BASEMENT MEMBRANEGLBMABGLBMABMultiplex Bead Immunoassay
TitleDescriptorRangesUnits
Glomerular Basement Membrane AntibodyNegative< 1.0AI (Antibody Index)
Positive> or = 1.0
This test is designed for the in-vitro measurement of specific IgG auto-antibodies against the Glomerular Basement Membrane (GBM). It is intended as an aid in the diagnosis of Good-pasture's syndrome. Some patients with other renal diseases may exhibit positive results. Glomerular Basement Membrane antibodies are not found in normal healthy individuals.
Results were obtained with the BioRad Bioplex Multiplex assay. Values obtained from different manufacturers assays cannot be used interchangeably. The magnitude of the reported IgG levels cannot be correlated to an endpoint titer.
ESTIMATED GFR (CALC)GFRGFRCalculation
TitleDescriptorRangesUnits
Glomerular Filtration Rate EstimatedmL/min/1.73m2
Chronic kidney disease, if found over a 3-month period.LT 60
Kidney failureLT 15
For African Americans, multiply the calculated GFR by 1.21.
HEART METABOLIC SYNDROME RFLXHRTMTBHRTMTB
GLU
GLYCO
HRTLIP
ADIPO 
CYSTCG
OXLDL
GLUCOSE CHALLENGEGCT.PGGCTPGHexokinase
TitleDescriptorRangesUnits
Glucose, 1 hr (Pregnant)50-129mg/dL
Presumptive Gestational Diabetes Mellitus
130 mg/dL or greater (identifies 90% of patients with GDM)
140 mg/dL or greater (identifies 80% of patients with GDM)
These threshold values apply to a blood glucose drawn 1 hour after a 50 gram oral glucose load. An abnormal result must be verified by either a 3-hour (100 gram) or a 2-hour (75 gram) glucose tolerance test for gestational diabetes.
GLUCOSE, CSFGLU-CGLUSFEnzymatic
TitleDescriptorRangesUnits
Glucose, CSF0-10 years60-80mg/dL
10+ years40-70
GLUCOSEGLUGLUHexokinase
TitleDescriptorRangesUnits
Glucose, Fasting or Random0-2 day premature30-80mg/dL
0-2 day full-term40-90
2 days-1 months60-105
Adult65-99
Pregnant Female65-94
ADA Diagnostic Categories for non-pregnant adults
Impaired fasting glucose: 100-125 mg/dL.
A fasting glucose result of 126 mg/dL or greater indicates diabetes if the abnormality is confirmed on a subsequent day.
A random glucose result of GT 200 mg/dL indicates diabetes if the abnormality is confirmed on a subsequent day.
GLUCOSE TOLERANCE, 2HR-F/2HGTOL2GTOL2Hexokinase
TitleDescriptorRangesUnits
Glucose, Fastingmg/dL
0-2 days premature30-80
0-2 days full-term40-90
2 days-1 month60-105
Adult65-99
Glucose, 2 hrmg/dL
NormoglycemiaLT 140
Impaired glucose tolerance140-199 mg/dL
Indicates diabetes if confirmed on a subsequent day.200 or more
These criteria apply to the 2 hour (75 gram) ADA glucose tolerance testing protocol for non-pregnant adults.
GLUCOSE, FLUIDGLU-FLDGLUFLEnzymatic
TitleDescriptorRangesUnits
Glucose, FluidSerous FluidEqual to the serum glucose valuemg/dL
Synovial Fluid< 10 mg/dL when compared to the serum glucose value.
Method not validated for body fluid. Clinical correlation necessary.
GLUCOSE TOLERANCE, GEST 3 HRGTPGGTPGHexokinase
TitleDescriptorRangesUnits
Glucose, Pregnantmg/dL
Two or more of the following threshold values must be met or exceeded to confirm gestational diabetes
Fasting95
1 hour180
2 hour155
3 hour140
These criteria apply to the 3-hour (100 gram) ACOG glucose tolerance testing protocol for gestational diabetes.
METABOLIC HEALTH PANELMHPANMHPAN
GLYCO   
MCUC   
GLU
HADDOCK IGEICHDAR.LCAICHDARImmunocap
TitleDescriptorRangesUnits
Haddock IgENo significant level detected< 0.10kU/L
Clinical relevance undetermined0.10-0.34
Low0.35-0.70
Moderate0.71-3.50
High3.51-17.50
Very high> 17.51
HALOPERIDOL, SERUM OR PLASMAHALPHALPTandem Mass Spectrometry
TitleDescriptorRangesUnits
HaloperidolTherapeutic Range5-20ng/mL
Toxic> 42
HBV PROGNOSIS PANEL RFLXHBCHRHBCHRElectrochemiluminescence Immunoassay, Enzyme Immunoassay
TitleDescriptorRangesUnits
HBsAg ScreenNonreactive
HBsAg ConfirmationNonreactive
Hepatitis B Surface AbNon-Immune< 8.5mIU/mL
Indeterminate8.5-11.4
Indicates vaccine response or HBV infection> 11.4
Samples with a calculated value of 10 mIU/mL or greater are considered reactive (protective) in accordance with the CDC guidelines
Hepatitis Be AgNonreactive
Hepatitis Be AbNonreactive
BETA HCG, QUANTHCG-QUANTBHCGQElectrochemiluminescence Immunoassay
TitleDescriptorRangesUnits
HCG-Quant Beta SubunitNon-pregnant females< 5.4mIU/mL
Postmenopausal females< 7.1
Minimum detectable concentration of HCG is 0.6 mIU/mL.
**Representative Reference Intervals**
Weeks of gestationmIU/mL
3 weeks5.8-71.2
4 weeks9.5-750
5 weeks217-7138
6 weeks158-31795
7 weeks3697-163563
8 weeks32065-149571
9 weeks63803-151410
10 weeks46509-186977
12 weeks27832-210612
14 weeks13950-62530
15 weeks12039-70971
16 weeks9040-56451
17 weeks8175-55868
18 weeks8099-58176
HCG values in early normal pregnancy double every 48 hours.
HEART INFLAMMATION PANELHRTINFHRTINF
HCRP   
PLACA2   
MCUC   
FISOP   
MPOENZ   
OXLDL
HDL CHOLESTEROLHDLHDLHomogeneous Enzymatic Colorimetric
TitleDescriptorRangesUnits
HDLLow< 40mg/dL
Within normal limits40-59
High> = 60
HDL Cholesterol greater than or equal to 60 mg/dL is considered to be a 'negative' risk factor, serving to remove one risk factor from the total count.
HEMOGLOBIN A2 QUANTITATIONA2A2QTHPLC
TitleDescriptorRangesUnits
Hemoglobin A20-3 months0.0-3.6%
4+ months1.0-3.8
HGB/THALASSEMIA PANEL RFLXHGB.THAL.PANELHGTHALIon Exchange/HPLC
TitleDescriptorRangesUnits
Hemoglobin A20-3 mo0.0-3.6%
4+ mo1.0-3.8
Hemoglobin F0-30 days61.0-88.5%
1 mo45.7-67.3
2 mo29.4-60.8
3 mo14.8-55.9
4 mo9.4-28.5
5 mo2.3-22.4
6-11 mo2.3-13.0
1 yr1.3-5.0
13 mo+0.0-2.0
Hgb Other
Hgb S (Relative)LT 1.0%
Brilliant Cresyl Blue (No longer performed)
ZPP/Heme Ratio23-78umol/mol
Kleinhauer Betke Stain
Hemoglobin S SolubilityNegative
Monoclonal C
Citrate Gel Electro
Monoclonal E
Cellulose Electro
Unstable Hgb
Slide Interpretation
Interpretation
Reviewed By
HEMOGLOBIN F QUANTITATIONHGBFFQTHPLC
TitleDescriptorRangesUnits
Hemoglobin F%
0-30 days61.0-88.5
1 months45.7-67.3
2 months29.4-60.8
3 months14.8-55.9
4 months9.4-28.5
5 months2.3-22.4
6-11 months2.3-13.0
1 year1.3-5.0
13+ months0.0-2.0
HEPARIN ASSAYHEPARINHEPASYAnti-Xa Chromogenic
TitleDescriptorRangesUnits
Heparin LevelTherapeutic Range0.30-0.70IU/mL
HEPATITIS PANEL, CHRONIC RFLXHEPCHRHEPCHRElectrochemiluminescence Immunoassay
TitleDescriptorRangesUnits
Hepatitis A Virus TotalNonreactive
Hepatitis B Surface AntigenNonreactive
Confirmation
Hepatitis B Core AntibodyNonreactive
Hepatitis C Antibody ScreenNonreactive
Hepatitis B Surface AbNon-Immune< 8.5mIU/mL
Indeterminate8.5-11.4
Indicates vaccine response or HBV infection> 11.4
Samples with a calculated value of 10 mIU/mL or greater are considered reactive (protective) in accordance with the CDC guidelines.
HEPATITIS B SURFACE AB, QUANTANTI-HBSHBSABElectrochemiluminescence Immunoassay
TitleDescriptorRangesUnits
Hepatitis B Surface AbNon-Immune< 8.5mIU/mL
Indeterminate8.5-11.4
Indicates vaccine response or HBV infection> 11.4
Samples with a calculated value of 10 mIU/mL or greater are considered reactive (protective) in accordance with the CDC guidelines.
HEXPHOSPHOLIPID NEUTRALIZATIONHPNTHPNTElectromechanical (clot based)
TitleDescriptorRangesUnits
Hexagonal Phospholipid Neutralizationseconds
Negative< = 9.1
A Lupus Inhibitor is not ruled out by a negative Hexagonal Phospholipid Neutralization alone. Additional tests,such as DRVVT may be necessary to rule out a Lupus Inhibitor.
Positive for the Lupus Inhibitor> = 9.2
Repeat evaluation after at least 12 weeks is suggested, as consensus guidelines suggest clinically significant lupus anticoagulants are persistent.
HGB/THALASSEMIA SCREENHGSCRNHGSCRNHPLC
TitleDescriptorRangesUnits
Hgb A
Hgb A20-3 months0.0-3.6%
4+ months1.0-3.8
Hgb F0-30 days61.0-88.5%
1 month45.7-67.3
2 months29.4-60.8
3 months14.8-55.9
4 months9.4-28.5
5 months2.3-22.4
6-11 months2.3-13.0
1 year1.3-5.0
13+ months0.0-2.0
Other Hemoglobins SeenNo variant hemoglobins detected
Comment
HSCRP AND CHOLESTEROL PROFILEHCRPPHCRPPEnzymatic, Nephelometry
TitleDescriptorRangesUnits
High Sensitivity CRPLow risk< 1.0mg/L
Average risk1.0-3.0
High risk> 3.0
Relative risk categories follow the recommendations of the American Heart Association and the CDC. Measurement of hsCRP should be done twice (averaging results), optimally two weeks apart, in metabolically stable patients. If the hsCRP level is GT 10 mg/L, the test should be repeated and the patient examined for non-cardiovascular sources of inflammation, such as infection.
CholesterolDesirable< 200mg/dL
Borderline high200-239
High> = 240
HDLLow< 40mg/dL
Within normal limits40-59
High> = 60
HDL Cholesterol greater than or equal to 60 mg/dL is considered to be a 'negative' risk factor, serving to remove one risk factor from the total count.
CRP, HIGH SENSITIVITYHCRPHCRPNephelometry
TitleDescriptorRangesUnits
High Sensitivity CRPLow risk< 1.0mg/L
Average risk1.0-3.0
High risk> 3.0
Relative risk categories follow the recommendations of the American Heart Association and the CDC. Measurement of hsCRP should be done twice (averaging results), optimally two weeks apart, in metabolically stable patients. If the hsCRP level is GT 10 mg/L, the test should be repeated and the patient examined for non-cardiovascular sources of inflammation, such as infection.
CHRONIC URTICARIA PANELCURTPCURTPImmunochemiluminometric Assay by ADVIA Centaur, Cell Culture, Immunoassay
TitleDescriptorRangesUnits
Histamine ReleaseLT 16%
Thyroid Peroxidase AntibodyLT 9IU/mL
Thyroglobulin AntibodyLT 2IU/mL
If the sample contains anti-thyroglobuin antibodies of greater than 19 IU/mL, the presence of these antibodies may cause falsely low thyroglobulin values.
TSH, 3rd GenerationmIU/L
Premature Infants, 28-36 weeks
1st week of life0.20-27.90mIU/L
Term infants, (GT 37 weeks)
Serum or Cord Blood1.00-39.00mIU/L
LT or = 4 days3.20-35.00mIU/L
5-6 daysNot Established
1-4 weeks1.70-9.10mIU/L
1-11 months0.80-8.20mIU/L
1-19 years0.50-4.30mIU/L
20+ years0.40-4.50mIU/L
Pregnancy Ranges
First Trimester0.26-2.66
Second Trimester0.55-2.73
Third Trimester0.43-2.91
TSH levels decline rapidly during the first week of life in most children, but may remain transiently elevated in a few individuals despite normal free T4 levels. For confirmatory testing following a positive newborn thyroid screen, a free (or total) T4 level is usually required for proper interpretation of TSH levels in this group.
HISTONE AB, IGGHISTOG.LCAHISTOGELISA
TitleDescriptorRangesUnits
Histone Antibody (Hrana)Negative0.9 or lessUnits
Weak Positive1.0-1.5
Moderate Positive1.6-2.5
Strong Positive2.6 or greater
HIV 1 QUANT PCR RFLX GENOTYPEHIVPGTHIVPGTQuantitative PCR/Sequencing
TitleDescriptorRangesUnits
HIV-1 Viral Load ResultNot Detectedlog Copies/mL
HIV-1 Viral Load ResultNot DetectedCopies/mL
HIV-1 Viral Load Comment
Reportable Range HIV-1 RNA 1.3 to 7.0 log copies/mL (20 to 10,000,000 copies/mL)
This assay was performed using the FDA approved Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 test. This test is intended for use in conjunction with other laboratory markers as a prognostic indicator for patients with HIV-1 infection. It may also be used to aid in the assessment of viral response to an antiretroviral treatment as measured by changes in plasma HIV-1 RNA levels. A threefold (0.5 log) change in copies/mL is usually considered to be clinically significant. This test is performed pursuant to an agreement with Roche Molecular Systems, Inc.
Drug ResistanceEvidence of Resistance
NRTI Class(free text mutations)
Emtricitabine (FTC)None
Lamivudine (3TC)None
Zidovudine (ZDV)None
Didanosine (ddl)None
Tenofovir (TDF)None
Stavudine (d4T)None
Abacavir (ABC)None
NNRTI Class(free text mutations)
Rilpivirine (RPV)None
Etravirine (ETR)None
Efavirenz (EFV)None
Nevirapine (NVP)None
PI Class(free text mutations)
Tipranavir (TPV)None
Indinavir (IDV)None
Saquinavir (SQV)None
Lopinavir + Ritonavir (LPV)None
Fosamprenavir (FPV)None
Darunavir (DRV)None
Atanzanavir (ATV)None
Nelfinavir (NFV)None
Comment: [HIVGC2+HIVGC3]: All HIV 1 Genotype results must be interpreted in the context of both clinical and laboratory findings. This information is protected by various state laws to client location and, in such cases, cannot be further disclosed without the patient's specific written consent, or as otherwise permitted by law. [New code HIVGC4]: The protease inhibitor (PI) evidence of resistance interpretations were developed to estimate the expected virological response to standard doses of protease inhibitors with pharmacokinetic boosting by Ritonavir. This has become the most common method of administering each of the protease inhibitors, except Nelfinavir, to ensure adequate drug levels in all patients. Boosted PIs are more active in the presence of resistance than non-boosted PIs.
HUMAN ANTI-MOUSE ABHAMAF.LCAHAMAFEnzyme Immunoassay
TitleDescriptorRangesUnits
Human Anti-Mouse Abng/mL
Normal level< 75
Increased level75 or more
CELIAC PROFILE PEDS, EXTENDEDCELPROCELPROMultiplex Bead Immunoassay, Nephelometry
TitleDescriptorRangesUnits
IgA0-30 days1-7mg/dL
1 month1-56
2 months3-49
3 months5-48
4 months4-76
5 months8-87
6 months8-70
7-8 months12-93
9-11 months17-87
1 year15-110
2 years15-128
3 years23-164
4 years26-474
5-7 years35-210
8-9 years47-245
10+ years71-397
Tissue Transglutaminase Ab, IgANegative< 15.0U/mL
Positive> = 15.0
Gliadin Ab, IgANegative< 15.0U/mL
Positive> = 15.0
This test was performed using a deamidated gliadin peptide (DGP) assay.
Gliadin Ab, IgGNegative< 15.0U/mL
Positive> = 15.0
This test was performed using a deamidated gliadin peptide (DGP) assay.
tTG antibody, especially IgA, is sensitive and specific for untreated celiac disease. Levels can decrease significantly in response to a gluten-free diet. The IgG assay is used mainly to detect celiac patients who are IgA-deficient.
CELIAC PROFILE PEDIATRIC BASICCELPEDCELPEDMultiplex Bead Immunoassay, Nephelometry
TitleDescriptorRangesUnits
IgA0-30 days1-7mg/dL
1 month1-56
2 months3-49
3 months5-48
4 months4-76
5 months8-87
6 months8-70
7-8 months12-93
9-11 months17-87
1 year15-110
2 years15-128
3 years23-164
4 years26-474
5-7 years35-210
8-9 years47-245
10+ years71-397
Tissue Transglutaminase Ab, IgANegative< 15.0U/mL
Positive> or = 15.0
tTG antibody, especially IgA, is sensitive and specific for untreated celiac disease. Levels can decrease significantly in response to a gluten-free diet. The IgG assay is used mainly to detect celiac patients who are IgA-deficient.
IGAIGAIGANephelometry
TitleDescriptorRangesUnits
IgA0-30 days1-7mg/dL
1 month1-56
2 months3-49
3 months5-48
4 months4-76
5 months8-87
6 months8-70
7-8 months12-93
9-11 months17-87
1 year15-110
2 years15-128
3 years23-164
4 years26-474
5-7 years35-210
8-9 years47-245
10+ years71-397
IMMUNOGLOBULIN EIGECIGECFEIA
TitleDescriptorRangesUnits
IgE0-11 months1.4-52.3kU/L
1-4 years0.4-351.6
5-10 years0.5-393.0
11-15 years1.9-170.0
16+ years0.0-158.0
Minimum detectable concentration is 2.0 kU/L.
BIRD FANCIERS PROFILE PNL IIIICBFP3.LCAICBFP3ImmunoCAP® FEIA - IgE, Gel Diffusion (Ouchterlony)
TitleDescriptorRangesUnits
IgE1-11 months0-12IU/mL
1 year0-15
2 years1-29
3 years4-35
4 years2-33
5 years8-56
6 years3-95
7 years2-88
8 years5-71
9 years3-88
10 years7-110
11-14 years7-111
15-19 years6-96
20-30 years4-59
31-51 years5-79
51-80 years3-48
Chicken Feathers IgE< 0.35kU/L
Parrot Australian (Budgerigar) Droppings IgE< 0.35kU/L
Parrot Australian (Budgerigar) Feathers IgE< 0.35kU/L
Canary Droppings Gel DiffusionNegative
Chicken Serum Gel DiffusionNegative
Cockatiel Droppings Gel DiffusionNegative
Finch Droppings Gel DiffusionNegative
Parakeet Droppings Gel DiffusionNegative
Parakeet Serum Gel DiffusionNegative
Parrot Droppings Gel DiffusionNegative
Parrot Serum Gel DiffusionNegative
Pigeon/Dove Droppings Gel DiffusionNegative
Pigeon/Dove Serum Gel DiffusionNegative
Aspergillus fumigatus Mix Gel DiffusionNegative
Aureobasidium pullulans Gel DiffusionNegative
IGF BINDING PROTEIN 1IGFP1IGFP1Radioimmunoassay
TitleDescriptorRangesUnits
IGF Binding Protein-1Adult5-34ng/mL
5-9 years15-95
10-14 years8-64
15-18 years5-40
IGG SUBCLASS 1IGGSB1IGGSB1Nephelometry
TitleDescriptorRangesUnits
IgG Subclass 10-1 years151-792mg/dL
1-3 years265-938
3-6 years362-1228
6-12 years377-1131
12-18 years362-1027
18+ years405-1011
IMMUNOGLOBULIN G SUBCLASSESIGGSBIGGSBNephelometry
TitleDescriptorRangesUnits
IgG Subclass 1mg/dL
0-1 years151-792
1-3 years265-938
3-6 years362-1228
6-12 years377-1131
12-18 years362-1027
18+ years405-1011
IgG Subclass 2mg/dL
0-1 years26-136
1-3 years28-216
3-6 years57-290
6-12 years68-388
12-18 years81-472
18+ years169-786
IgG Subclass 3mg/dL
0-1 years9-92
1-3 years9-86
3-6 years13-79
6-12 years16-89
12-18 years14-106
18+ years11-85
IgG Subclass 4mg/dL
0-1 years0-46
1-3 years1-74
3-6 years1-145
6-12 years1-170
12-18 years5-199
18+ years3-201
The total IgG (mg/dL) can be derived from the sum of the subclass IgG1, IgG2, IgG3, and IgG4 values. However, a confirmatory and more precise total IgG is available by the nephelometric method for quantitative total IgG.
IGG SUBCLASS 2IGGSB2IGGSB2Nephelometry
TitleDescriptorRangesUnits
IgG Subclass 20-1 years26-136mg/dL
1-3 years28-216
3-6 years57-290
6-12 years68-388
12-18 years81-472
18+ years169-786
IGG SUBCLASS 3IGGSB3IGGSB3Nephelometry
TitleDescriptorRangesUnits
IgG Subclass 30-1 years9-92mg/dL
1-3 years9-86
3-6 years13-79
6-12 years16-89
12-18 years14-106
18+ years11-85
IGG SUBCLASS 4IGGSB4IGGSB4Nephelometry
TitleDescriptorRangesUnits
IgG Subclass 40-1 year0-46mg/dL
1-3 years1-74
3-6 years1-145
6-12 years1-170
12-18 years5-199
18+ years3-201
IGG INDEX, CSF AND SERUMIGG INDEXIGGINephelometry
TitleDescriptorRangesUnits
IgG, CSF0.5-7.7mg/dL
Albumin, CSF5-30mg/dL
IgG, Serum0-30 days603-1523mg/dL
1 month238-860
2 months195-570
3 months166-551
4 months185-530
5 months163-772
6 months204-668
7-8 months206-857
9-11 months279-1014
1 year327-1150
2 years402-997
3 years417-1077
4 years438-1173
5-7 years600-1214
8-9 years576-1490
10+ years758-1612
Albumin, Serum0-4 days2900-4600mg/dL
4 days-14 years3900-5600
14-18 years3300-4700
18-60 years3500-5000
60-90 years3300-4800
90+ years3000-4700
CSF/Serum Index0.25-0.75
OLIGOCLONAL BANDINGOLBNLOLBNLIsoelectric Focusing on Agarose Gel
TitleDescriptorRangesUnits
IgG, Quant, CSF0.0-8.6mg/dL
Albumin, CSF11-48mg/dL
Immunoglobulin G, Qn, Serum700-1600mg/dL
Albumin, Serum0-2 years3.4-4.2g/dL
3-59 years3.5-5.5
60-69 years3.6-4.8
70-79 years3.5-4.8
80-89 years3.5-4.7
89+ years3.2-4.6
IgG/Alb Ratio, CSF0.00-0.25
CSF IgG Index0.0-0.7
IgG, Syn Rate, CSF-9.9-+3.3mg/day
CSF/Serum Alb. IndexRelationship to blood-brain barrier:
Consistent with an intact barrier< 9
Slight impairment9-14
Moderate impairment14-30
Severe impairment30-100
Complete breakdown> 100
IGGIGGIGGNephelometry
TitleDescriptorRangesUnits
IgG0-30 days603-1523mg/dL
1 month238-860
2 months195-570
3 months166-551
4 months185-530
5 months163-772
6 months204-668
7-8 months206-857
9-11 months279-1014
1 year327-1150
2 years402-997
3 years417-1077
4 years438-1173
5-7 years600-1214
8-9 years576-1490
10+ years758-1612
IMIPRAMINE/CLOMIPRAMINELCIMILCIMILiquid Chromatography Tandem Mass Spectrometry
TitleDescriptorRangesUnits
ImipramineNot Detected< 350ng/mL
ClomipramineNot Detected< 350ng/mL
IMIPRAMINE AND METABOLITEIMIIMDESTandem Mass Spectrometry
TitleDescriptorRangesUnits
ImipramineNo reference range established for parent drug. See Total for reference range, which takes into account all metabolites. ng/mL
DesipramineTherapeutic100-300ng/mL
Toxic> 500
Total (Imipramine + Desipramine)Therapeutic100-300ng/mL
Toxic> 500
ALLERGIC BRONCH ASPERGIL PANELICABAPICABAPQuantitative ImmunoCAP® Fluorescent Enzyme Immunoassay/Qualitative Immunodiffusion
TitleDescriptorRangesUnits
Immunoglobulin E0-5 months2-13IU/mL
6-12 months2-34IU/mL
1-2 years2-97IU/mL
3 years2-199IU/mL
4-6 years2-307IU/mL
7-8 years2-403IU/mL
9-12 years2-696IU/mL
13-15 years2-629IU/mL
16-17 years2-537IU/mL
18+ years2-214IU/mL
A. fumigatus #1 AB, PrecipitinNone Detected
A. fumigatus #6 AB, PrecipitinNone Detected
Allergen, Fungi/Mold, A. fumigatusNo significant level detectedLT 0.10kU/L
Clinical revelance undetermined0.10-0.34kU/L
Low0.35-0.70kU/L
Moderate0.71-3.50kU/L
High3.51-17.50kU/L
Very High17.51 or greaterkU/L
Allergen, Interp, Immunocap Score IgE See below
IMMUNOPHENOTYPE SCREEN RFLXIPSCRNIPSCRNFlow Cytometry
Immunophenotyping Result
IMMUNOPHENOTYPE SCRN TISS RFLXIPTISSIPTISSFlow Cytometry
Immunophenotyping Result
FRAGILE X SYNDROME MUTATION ANALYSISFRGXGFRGXGPCR & SB
Indication
Results
Comments
Method
Signed
INSULIN, FREE AND TOTALINSFT.LCAINSFTChemiluminescent Immunometric Assay
TitleDescriptorRangesUnits
Insulin Free0-8 years0-13uIU/mL
8+ years0-17
Insulin Total2.6-24.9uIU/mL
This test reacts on a nearly equimolar basis with the analogs insulin aspart, insulin glargine, and insulin lispro. Insulin detemir exhibits approximately 50 percent cross-reactivity. Test reactivity with insulin glulisine is negligible (< 3 percent). To convert to pmol/L, multiply µIU/mL by 6.0.
ISOPROPYL ALCOHOLIALCIALCGas Chromatography/FID
TitleDescriptorRangesUnits
Isopropyl AlcoholNot Detected< 8mg/dL
JO-1 AUTOANTIBODY, IGGJO1MPJO1MPMultiplex Luminex
TitleDescriptorRangesUnits
JO-1 Autoantibody, IgGNegative< 1.0AI
Positive> = 1.0
JUNIPER WESTERN IGEICJWEIICJWEIRIA
TitleDescriptorRangesUnits
Juniper Western IgE< 0.35kU/L
Juniper Western Class
FREE LIGHT CHAINS PANELGAMPANGAMPANNephelometry/Agarose Gel ELP, IFE
TitleDescriptorRangesUnits
Kappa FLC0.33-1.94mg/dL
Lambda FLC0.57-2.63
Kappa/Lambda FLC Ratio0.26-1.65
Results obtained by using The Binding Site reagents on a Siemens' BN II analyzer.
Protein, Total0-12 months4.3-6.9g/dL
1-3 years5.2-7.4
3-6 years5.6-7.7
6-10 years6.5-8.3
10-18 years6.1-8.0
18-60 years6.3-8.0
60+ years6.1-7.8
Albumin0-4 days2.9-4.6g/dL
4 days-14 years3.9-5.6
14-18 years3.3-4.7
18-60 years3.5-5.0
60-90 years3.3-4.8
90+ years3.0-4.7
Alpha-10.1-0.4g/dL
Alpha-20.5-1.1g/dL
Beta-10.4-0.8g/dL
Beta-20.2-0.6g/dL
Gamma0.6-1.5g/dL
Albumin45.0-80.0%
Alpha-11.0-6.0%
Alpha-26.0-17.0%
Beta-15.0-13.0%
Beta-22.0-8.5%
Gamma7.5-24.0%
Interpretation
Monoclonal Peak
If Positive
Monoclonal Proteing/dL
Monoclonal Protein %%
Monoclonal Protein (2)g/dL
Monoclonal Protein (2)%%
Immunofixation Interpretation
CONFIRM KETAMINE (GCMS)KETAMSKETAMSGas Chromatography Mass Spectrometry
TitleDescriptorRangesUnits
Ketamine ConfirmationNot Detected< 7ng/mL
LACOSAMIDELACOS.LCALACOSLiquid Chromatography/Tandem Mass Spectrometry
TitleDescriptorRangesUnits
Lacosamidemcg/mL
Following a single 200 mg dose administered as a 30-minute infusion, a 60-minute infusion, or orally as a tablet to 24 male subjects, mean maximum plasma lacosamide concentrations were 5.95 +/- 1.49, 5.38 +/- 1.10 and 5.15 +/- 1.4 mcg/mL, respectively.
Mean plasma concentrations following maintenance doses
200 mg/day4.99 +/-2.51mcg/mL
400 mg/day9.35 +/-4.22mcg/mL
600 mg/day12.46 +/-5.60mcg/mL
NMS Labs derived data
5th - 95th Percentile Data1.8 - 13.0mcg/mL
Mean5.3mcg/mL
(N = 14900)
DISACCHARIDASE ANALYSISDISAC.LCADISACEnzymatic Assay
TitleDescriptorRangesUnits
LactaseNormal16.5-32.5uM/min/gram protein
AbnormalLT 15.0
SucraseNormal29.0-79.8uM/min/gram protein
AbnormalLT 25.0
MaltaseNormal98.0-223.6uM/min/gram protein
AbnormalLT 100.0
PalatinaseNormal4.6-17.6uM/min/gram protein
AbnormalLT 5.0
Interpretation
LAMELLAR BODY COUNTLBCLBCAutomated Cell Count
TitleDescriptorRangesUnits
Lamellar Body CountsMatureGT 50000Lamellar bodies/uL
Transitional35000-50000
ImmatureLT 35000
LD, FLUIDLDH.FLDLDFLEnzymatic
TitleDescriptorRangesUnits
LD, FluidExudate> or = 200U/L
Transudate< 200
Method not validated for body fluid.
Clinical correlation necessary.
DIRECT LDLDLDLDLDLHomogeneous Enzymatic Colorimetric
TitleDescriptorRangesUnits
LDL Cholesterol, DirectOptimal< 100mg/dL
Near or above optimal100-129
Borderline high130-159
High160-189
Very high190 or more
LDLDHLDEnzymatic
TitleDescriptorRangesUnits
LD0-4 days290-816U/L
4-10 days545-2105
10 days-24 months180-453
24 months-12 years110-311
12-60 years115-225
60-90 years110-221
90+ years99-299
LEAD AND ZPP WITH DEMOOSHAPODEMOSHInductively Coupled Plasma-Mass Spectrometry (ICP-MS)
TitleDescriptorRangesUnits
Lead, Blood0-15 years0.0-5.0ug/dL
15+ years0.0-10.0
Critical High> 70.0
Zinc Protoporphyrin23-78umol/mol
ZPP-OSHA Calculation13-46ug/dL
Note
Number of TestsAction Requiredug/dL Lead
1Notification of greater workers in writing; medical examination of workers and consultation40.0 or greater
3 (average)Removal of worker greater job with potential lead exposure50.0 or greater
1Removal of worker greater from job with potential lead exposure60.0 or greater
2Reinstatement of worker less in job with potential lead exposure is based on symptoms and medical evaluation40.0 or less
Federal lead construction standards require workers to be notified and removed from job at lead levels of 50 ug/dL and higher until a physician authorizes return. OSHA requirements in effect since 1978 call for the measurement of whole blood lead and zinc protoporphyrin (ZPP NCCLS document C42-A, Nov. 1996) to evaluate the occupational exposure to lead. OSHA requires ZPP whole blood testing in units of ug/dL. For adults, conversion of ZPP units to ug/dL whole blood assumes a hematocrit of 45%. Conversion factor: mol/mol heme x 0.584 = ug/dL.
LEAD AND ZPP OSHA PROFILEOSHAPOOSHAPOInductively Coupled Plasma-Mass Spectrometry (ICP-MS)
TitleDescriptorRangesUnits
Lead, Bloodug/dL
0-15 years0.0-5.0
15+ years0.0-10.0
Critical high> 70.0
Zinc Protoporphyrinumol/mol
23-78
ZPP-OSHA Calculationug/dL
13-46
Note
Number of TestsAction Requiredug/dL Lead
1Notification of greater workers in writing; medical examination of workers and consultation40.0 or greater
3 (average)Removal of worker greater job with potential lead exposure50.0 or greater
1Removal of worker greater from job with potential lead exposure60.0 or greater
2Reinstatement of worker less in job with potential lead exposure is based on symptoms and medical evaluation40.0 or less
Federal lead construction standards require workers to be notified and removed from job at lead levels of 50 ug/dL and higher until a physician authorizes return. OSHA requirements in effect since 1978 call for the measurement of whole blood lead and zinc protoporphyrin (ZPP NCCLS document C42-A, Nov. 1996) to evaluate the occupational exposure to lead. OSHA requires ZPP whole blood testing in units of ug/dL. For adults, conversion of ZPP units to ug/dL whole blood assumes a hematocrit of 45%. Conversion factor: mol/mol heme x 0.584 = ug/dL.
LEAD, QUANT, SERUMSERPBSERPBInductively Coupled Plasma-Mass Spectrometry (ICP-MS)
TitleDescriptorRangesUnits
Lead, SerumNormal< 0.5ug/dL
LEAD WITH DEMOGRAPHICSLEADDEMOPBInductively Coupled Plasma-Mass Spectrometry (ICP-MS)
TitleDescriptorRangesUnits
Lead, Whole Blood0-15 years0.0-5.0ug/dL
15+ years0.0-10.0
Critical High> 70.0
LEAD, WHOLE BLOODPBWBPBWBInductively Coupled Plasma-Mass Spectrometry (ICP-MS)
TitleDescriptorRangesUnits
Lead, Whole Blood0-15 years0.0-5.0ug/dL
15+ years0.0-10.0
Critical High> 70.0
LEGIONELLA AB IGG, IGM, IGALEGLEGABEIA
TitleDescriptorRangesUnits
Legionella Ab, IgG/IgM/IgANegative - Antibodies to Legionella pneumophila serogroups 1-6 not detectedLT 0.91ODR
Equivocal - Testing of a second specimen in 3 to 9 weeks suggested0.91-1.09
Positive - Suggestive of Legionella pneumophila infectionGT 1.09
LEISHMANIA ANTIBODY, IGGLEISHA.LCALEISHASemi-Quantitative Immunoassay
TitleDescriptorRangesUnits
Leishmania Antibody, IgGNegative-No significant level of Leishmania Antibody, IgG detected0Units
Positive-IgG antibody to Leishmania detected, which may suggest current or past infection1-15Units
LEMON IGEICFLEMICFLEMImmunoCap FEIA
TitleDescriptorRangesUnits
Lemon IgE< 0.35kU/L
LIBRIUM AND NORDIAZEPAMLIBNOLIBNOQuantitative Liquid Chromatography-Tandem Mass Spectrometry
TitleDescriptorRangesUnits
LibriumDose (Adult): 5-100 mg500-3000ng/mL
Toxic> 5000
NordiazepamBased on normal dosages100-1500ng/mL
Toxic> 2500
Interpretive Data: Adverse effects may include drowsiness, ataxia, nausea, and constipation.
LIDOCAINE, URINELCLIDLCLIDLiquid Chromatography Tandem Mass Spectrometry
TitleDescriptorRangesUnits
LidocaineNot Detected< 350ng/mL
LIDOCAINELIDOCNLIDOCNEIA
TitleDescriptorRangesUnits
LidocaineTherapeutic1.5-5.0ug/mL
ToxicGT 6.0
LIPOPROTEIN (A)LPALPARate Nephelometry
TitleDescriptorRangesUnits
Lipoprotein (a)2-72mg/dL
African-American4-109
LITHIUMLILIColorimetric
TitleDescriptorRangesUnits
LithiumTherapeutic0.6-1.2mmol/L
Toxic> 2.0
LORAZEPAMLOR.LCALORQuantitative Liquid Chromatography/Tandem Mass Spectrometry
TitleDescriptorRangesUnits
LorazepamTherapeutic (Adult) dose 1-10 mg/d50-240ng/mL
Toxic> 300
B. BURGDORFERI AB (LYME), CSFLYMECF.LCALYMECFSemi-Quantitative Enzyme-Linked Immunosorbent Assay
TitleDescriptorRangesUnits
Lyme (B. burgdorferi) Ab, CSFNegative-Antibody to B. burgdorferi not detected0.99 or lessLIV
Equivocal-Repeat testing in 10-14 days may be helpful1.00-1.20
Positive-Probable presence of antibody to B. burgdorferi detected1.21 or more
Interpretive Data: The detection of antibodies to B. burgdorferi in cerebrospinal fluid may indicate central nervous system infection. However, consideration must be given to possible contamination by blood or transfer of serum antibodies across the blood-brain barrier.
Current CDC recommendations for the serologic diagnosis of Lyme disease are to screen with a polyvalent ELISA test and confirm equivocal and positive results with immunoblot. Both IgM and IgG immunoblots should be performed on samples less than 4 weeks after appearance of erythema migrans. Only IgG immunoblot should be performed on samples greater than 4 weeks after the disease onset. IgM immunoblot in the chronic stage is not recommended and does not aid in the diagnosis of neuroborreliosis or chronic Lyme disease. Please submit requests for appropriate immunoblot testing within 10 days.
LYMPH AG MITOGEN PROLIF PANELLAMALAMACell Culture
Lymphocyte Antigen & Mitogen Proliferation Panel
MAGNESIUMMAGMGColorimetric
TitleDescriptorRangesUnits
Magnesium0-20 days1.9-4.6mg/dL
21 days-12 months1.7-3.2
1-3 years2.2-3.2
4-18 years2.1-2.9
19+ years1.7-2.4
RUBEOLA/MUMPS/RUBELLA ABS, IGGMMRGMMRGElectrochemiluminescence Immunoassay (ECLIA), Chemiluminescent Immunoassay (CLIA)
TitleDescriptorRangesUnits
Measles (Rubeola) Ab, IgGNegative: No detectable IgG antibodies to measles virus.
Equivocal: Questionable presence of IgG antibodies to measles virus. Retesting of a second sample in 2 weeks may be helpful.
Positive: IgG antibodies to measles virus detected. This may indicate exposure to measles virus or previous vaccination.
Mumps Ab, IgGNegative: No detectable IgG antibodies to mumps virus.
Equivocal: Questionable presence of IgG antibodies to mumps virus. Retesting of a second sample in 2 weeks may be helpful.
Positive: IgG antibodies to mumps virus detected. This may indicate exposure to mumps virus or previous vaccination.
Rubella Ab, IgGPresumed Immune> 9IU/mL
Presumed Non-Immune< 10
Result flagging will be based on presumed immune status
MEPERIDINE (GCMS)MSMEPMSMEPGas Chromatography Mass Spectrometry
TitleDescriptorRangesUnits
Meperidine Confirmation by GC/MSNot Detected< 40ng/mL
Normeperidine Confirmation by GC/MSNot Detected< 40ng/mL
PAIN MANAGEMENT MEPERIDINE RFLXPMMEPPMMEPEnzyme Immunoassay
TitleDescriptorRangesUnits
Meperidine ScreenNegative< 200ng/mL
Meperidine by GC/MSng/mL
Nor-Meperidine by GC/MSng/mL
MEPERIDINE SCREEN RFLXMEPUMEPUEnzyme Immunoassay
TitleDescriptorRangesUnits
Meperidine ScreenNegative< 200ng/mL
MEPROBAMATE, URINEMEPROBMEPROBGas Chromatography Mass Spectrometry
TitleDescriptorRangesUnits
Meprobamate, UrineNot Detected< 500ng/mL
MERCURY, QUANT, SERUMSERHGSERHGInductively Coupled Plasma-Mass Spectrometry (ICP-MS)
TitleDescriptorRangesUnits
Mercury, Serum, QuantitativeNormal< 6.0ug/L
HEAVY METAL 3, URINE RANDOMUHMR3UHMR3Inductively Coupled Plasma-Mass Spectrometry (ICP-MS)
TitleDescriptorRangesUnits
Mercury, Urine0.0-10.0ug/L
Mercury: Creatinine Ratio< = 35.0ug/gCR
Arsenic, Urine0.0-35.0 (based on biological exposure index)ug/L
Arsenic: Creatinine Ratio< = 30.0ug/gCR
Lead, Urine0.0-23.0ug/L
Lead: Creatinine Ratio< = 5.0ug/gCR
Creatinine, UrineMale39-259mg/dL
Female28-217
HEAVY METAL 4, URINE RANDOMUHMR4UHMR4Inductively Coupled Plasma-Mass Spectrometry (ICP-MS)
TitleDescriptorRangesUnits
Mercury, Urine0.0-10.0ug/L
Mercury: Creatinine Ratio< = 35.0ug/gCR
Arsenic, Urine0.0-35.0 (based on biological exposure index)ug/L
Arsenic: Creatinine Ratio< = 30.0ug/gCR
Lead, Urine0.0-23.0ug/L
Lead: Creatinine Ratio< = 5.0ug/gCR
Creatinine, UrineMale39-259mg/dL
Female28-217
Cadmium, Urine0.0-2.6ug/L
Cadmium, Urine0.0-3.0ug/gCR
PAIN MANAGEMENT METHADONE RFLXPMMETHPMMETHEnzyme Immunoassay
TitleDescriptorRangesUnits
Methadone & Metabolite ScreenNegative< 300ng/mL
Methadone Metabolite (EDDP) by GC/MSng/mL
PAIN MANAGEMENT METHADONE CONFPMETCPMETCGas Chromatography Mass Spectrometry
TitleDescriptorRangesUnits
Methadone (EDDP) Confirmation by GC/MSNot Detected< 90ng/mL
METHADONE RFLXMETHMETDEnzyme Immunoassay
TitleDescriptorRangesUnits
Methadone (EDDP) ScreenNegative< 300ng/mL
METHADONE METAB (GCMS)MSMETMSMETGas Chromatography Mass Spectrometry
TitleDescriptorRangesUnits
Methadone Metabolite (EDDP)Not Detected< 90ng/mL
METHOCARBAMOLLCMCBLCMCBLiquid Chromatography Tandem Mass Spectrometry
TitleDescriptorRangesUnits
MethocarbamolNot Detected< 350ng/mL
VOLATILESVOLVOLATGas Chromatography/FID
TitleDescriptorRangesUnits
Methyl AlcoholNot Detected< 10mg/dL
Isopropyl AlcoholNot Detected< 10mg/dL
AcetoneNot Detected< 10mg/dL
METHYL ALCOHOLMALCMALCGas Chromatography/FID
TitleDescriptorRangesUnits
Methyl AlcoholNot Detected< 8mg/dL
PAIN MGMT ALT AMP CONFIRMPALTAPPALTAPGas Chromatography Mass Spectrometry
TitleDescriptorRangesUnits
Methylenedioxymethamphetamine (MDMA) Confirmation by GC/MSNot Detected< 40ng/mL
Methylenedioxyethylamphetamine (MDEA) Confirmation by GC/MSNot Detected< 40ng/mL
Methylenedioxyamphetamine (MDA) Confirmation by GC/MSNot Detected< 40ng/mL
METHYLMALONIC ACID URINE RANDOMRANMMARANMMATandem Mass Spectrometry
TitleDescriptorRangesUnits
Methylmalonic Acid, UrineNo reference range establishedumol/L
Methylmalonic Acid, Urineratio to CRT0.0-3.6mmol/molCRT
Creatinine, Urine19-311mg/dL
METOPROLOL LCMPRLCMPRLiquid Chromatography Tandem Mass Spectrometry
TitleDescriptorRangesUnits
MetoprololNot Detected< 350ng/mL
MEXILETINEMEXI.LCAMEXIQuantitative Liquid Chromatography-Tandem Mass Spectrometry
TitleDescriptorRangesUnits
MexiletineTherapeutic Range1.0-2.0ug/mL
Toxic Level> 2.0
Toxic concentrations may cause hypotension, tremor, and cardiac abnormalities.
MICROSOMAL AB, LIVER/KIDNEYMICROLKLKMIFA
TitleDescriptorRangesUnits
Microsomal Ab Liver/KidneyNegativeLT 1:20Titer
MIRTAZEPINELCMIRLCMIRLiquid Chromatography Tandem Mass Spectrometry
TitleDescriptorRangesUnits
MirtazepineNot Detected< 350ng/mL
MITOCHONDRIAL M2 AB, IGGMM2AB.LCAMM2ABELISA
TitleDescriptorRangesUnits
Mitochondrial M2 Antibody, IgGNegative< = 20.0Units
Equivocal20.1-24.0
Positive> = 25.0
PAIN MANAGEMENT OPIATES PMOPIPMOPILiquid Chromatography Tandem Mass Spectrometry
TitleDescriptorRangesUnits
Morphine by LC-MS/MSNot Detected< 50ng/mL
Oxymorphone by LC-MS/MSNot Detected< 50ng/mL
Noroxcodone by LC-MS/MSNot Detected< 50ng/mL
Hydromorphone by LC-MS/MSNot Detected< 50ng/mL
Codeine by LC-MS/MSNot Detected< 50ng/mL
Oxycodone by LC-MS/MSNot Detected< 50ng/mL
Hydrocodone by LC-MS/MSNot Detected< 50ng/mL
Norhydrocodone by LC-MS/MSNot Detected< 50ng/mL
6MAM by LC-MS/MSNot Detected< 10ng/mL
CONFIRM OPIATES 9 DRUGS (LCMS)LCOP9LCOP9Liquid Chromatography Tandem Mass Spectrometry
TitleDescriptorRangesUnits
Morphine Confirmation by LC-MS/MSNot Detected< 50ng/mL
Oxymorphone Confirmation by LC-MS/MSNot Detected< 50ng/mL
Noroxcodone Confirmation by LC-MS/MSNot Detected< 50ng/mL
Hydromorphone Confirmation by LC-MS/MSNot Detected< 50ng/mL
Codeine Confirmation by LC-MS/MSNot Detected< 50ng/mL
Oxycodone Confirmation by LC-MS/MSNot Detected< 50ng/mL
Hydrocodone Confirmation by LC-MS/MSNot Detected< 50ng/mL
Norhydrocodone Confirmation by LC-MS/MSNot Detected< 50ng/mL
6MAM Confirmation by LC-MS/MSNot Detected< 10ng/mL
MUMPS VIRUS AB, IGMMUMPSM.LCAMUMPSMEnzyme Immunoassay
TitleDescriptorRangesUnits
Mumps Virus Antibody, IgMNegative< 0.80AU
Borderline0.80-1.20
Positive> 1.20
M. PNEUMONIAE AB, IGGMPABGMPABGEIA
TitleDescriptorRangesUnits
Mycoplasma Pneumoniae Antibody, IgGNegative-No detectable IgG antibody, suggests no prior exposure to Mycoplasma pneumoniae. Result does not rule out recent exposure.LT 0.100U/L
Equivocal-Borderline antibody result. Testing of a 2nd specimen in 4 to 6 weeks suggested.0.100-0.320
Positive-Indicates recent or past exposure with Mycoplasma pneumoniae.GT 0.320
M. PNEUMONIAE AB, IGG, IGMMPABGMMPABGMEIA
TitleDescriptorRangesUnits
Mycoplasma Pneumoniae Antibody, IgGNegative-No detectable IgG antibody, suggests no prior exposure to Mycoplasma pneumoniae. Result does not rule out recent exposure.LT 0.100U/L
Equivocal-Borderline antibody result. Testing of a 2nd specimen in 4 to 6 weeks suggested.0.100-0.320
Positive-Indicates recent or past exposure with Mycoplasma pneumoniae.GT 0.320
Mycoplasma Pneumoniae Antibody, IgMNegative-No clinically significant amount of Mycoplasma pneumoniae IgM antibody detected.LT 0.770U/L
Low Positive-Mycoplasma pneumoniae IgM antibody presumptively detected. Testing of a 2nd specimen in 1 to 2 weeks suggested.0.770-0.950
Positive-A significant amount of Mycoplasma pneumoniae specific IgM antibody detected.GT 0.950
Low levels of IgM antibodies may persist for more than 12 months post-infection.
M. PNEUMONIAE AB, IGMMPABMMPABMEIA
TitleDescriptorRangesUnits
Mycoplasma Pneumoniae Antibody, IgMNegative-No clinically significant amount of Mycoplasma pneumoniae IgM antibody detected.< 0.770U/L
Low Positive-Mycoplasma pneumoniae IgM antibody presumptively detected. Testing of a 2nd specimen in 1 to 2 weeks suggested.0.770-0.950
Positive-A significant amount of Mycoplasma pneumoniae specific IgM antibody detected. Low levels of IgM antibodies may persist for more than 12 months post-infection.> 0.950
MYELOPEROXIDASE ABMPOMPOMultiplex Bead Immunoassay
TitleDescriptorRangesUnits
Myeloperoxidase AntibodyNegative< 1.0AI (Antibody Index)
Positive> = 1.0
ANCA PANEL NO ANA RFLXANCAPRANCAPRMultiplex Bead Immunoassay, IFA
TitleDescriptorRangesUnits
Myeloperoxidase AntibodyNegative< 1.0AI (Antibody Index)
Positive> or = 1.0
Proteinase 3 AntibodyNegative< 1.0AI (Antibody Index)
Positive> or = 1.0
ANCA Titer, IFANegative< 1:20
ANCA Pattern
ANCA PANEL W/ANA RFLXANCAMEANCAMEMultiplex Bead Immunoassay, IFA
TitleDescriptorRangesUnits
Myeloperoxidase AntibodyNegative< 1.0AI (Antibody Index)
Positive> or = 1.0
Proteinase 3 AntibodyNegative< 1.0AI (Antibody Index)
Positive> or = 1.0
ANANegative
A multiplex screen for 11 autoantibodies (dsDNA, Smith, Ribosomal P, Chromatin, RNP, SmRNP, Scl-70, Centromere B, SSA, SSB and J0-1) was performed and no autoantibodies were detected. A negative multiplex ANA does not rule out all possibility of a connective tissue or autoimmune disease, and further studies should be considered if clinical suspicion is high.
DSDNA AutoantibodyNegative< 5IU/mL
Indeterminate5-9
Positive> or = 10
Smith AutoantibodyNegative< 1.0AI (Antibody Index)
Positive> or = 1.0
Ribosomal P AutoantibodyNegative< 1.0AI (Antibody Index)
Positive> or = 1.0
Chromatin AutoantibodyNegative< 1.0AI (Antibody Index)
Positive> or = 1.0
RNP AutoantibodyNegative< 1.0AI (Antibody Index)
Positive> or = 1.0
SMRNP AutoantibodyNegative< 1.0AI (Antibody Index)
Positive> or = 1.0
SCL-70 AutoantibodyNegative< 1.0AI (Antibody Index)
Positive> or = 1.0
Centromere B AutoantibodyNegative< 1.0AI (Antibody Index)
Positive> or = 1.0
SSA (RO) AutoantibodyNegative< 1.0AI (Antibody Index)
Positive> or = 1.0
SSB (LA) AutoantibodyNegative< 1.0AI (Antibody Index)
Positive> or = 1.0
JO-1 AutoantibodyNegative< 1.0AI (Antibody Index)
Positive> or = 1.0
ANCA Titer, IFANegative< 1:20
ANCA Pattern
N-METHYLHISTAMINE, URINENMHU.LCANMHULiquid Chromatography-Tandem Mass Spectrometry/Enzymatic Colorimetric Assay
TitleDescriptorRangesUnits
N-Methylhistamine, Urine0-5 years120-510mcg/g
6-16 years70-330
16+ years30-200
DIFFERENTIAL, BAL RFLXBALDIFBALDIFMicroscopic
TitleDescriptorRangesUnits
NeutrophilsSmoker0-1%
Non-smokerup to 3
Lymphocytes6-8%
Variant Lymphocytes%
Macrophages/Monocytes%
Phagocytic Monocytes%
Eosinophils0-1%
Basophils0-1%
Squamous EpithelialCells%
Columnar EpithelialCells%
Others%
Fungus
Bacteria
Bal Note
NICOTINE/METAB, SERUM OR PLASMANICMSPNICMSPTandem Mass Spectrometry
TitleDescriptorRangesUnits
NicotineNon-smoker< 2ng/mL
CotinineNon-smoker< 5ng/mL
3-OH-CotinineNon-smoker< 10ng/mL
> 5 ng/mL Nicotine indicates use of tobacco products and or nicotine replacement therapy.
> 100 ng/mL Cotinine indicates use of tobacco products and or nicotine replacement therapy. Cotinine is the major metabolite of nicotine.
> 100 ng/mL of 3-OH Cotinine indicates use of tobacco products and/or nicotine replacement therapy.
NICOTINE AND METABOLITES, URNICMURNICMURTandem Mass Spectrometry
TitleDescriptorRangesUnits
NicotineNon-smoker< 2ng/mL
CotinineNon-smoker< 5ng/mL
3-OH-CotinineNon-smoker< 50ng/mL
NornicotineNon-smoker< 2ng/mL
AnabasineNon-smoker< 10ng/mL
> 100 ng/mL Nicotine indicates use of tobacco products and or nicotine replacement therapy.
> 200 ng/mL Cotinine indicates use of tobacco products and or nicotine replacement therapy. Cotinine is the major metabolite of nicotine.
> 50 ng/mL 3-OH-Cotinine indicates use of tobacco products and or nicotine replacement therapy. 3-OH-Cotinine is a metabolite of Cotinine.
> 30 ng/mL of Nornicotine indicates use of tobacco products and/or nicotine replacement therapy.
> 10 ng/mL Anabasine indicates use of tobacco products. Anabasine is not present in nicotine replacement therapy products such as transdermal patches, gum, nasal sprays and inhalers.
FUNGUS STAIN ONLYFSMFSMMicroscopy
No fungal elements seen
Budding yeast seen
Budding yeast with pseudohyphae seen
Hyphal elements seen
FLUOXETINELCFLXLCFLXLiquid Chromatography Tandem Mass Spectrometry
TitleDescriptorRangesUnits
NorfluoxetineNot Detected< 350ng/mL
PAIN MANAGEMENT PROPOXY CONFPPROCPPROCGas Chromatography Mass Spectrometry
TitleDescriptorRangesUnits
Norproproxyphene Confirmation by GC/MSNot Detected< 80ng/mL
PROPOX/NORPROPOXYPHENE (GCMS)MSPROMSPROGas Chromatography Mass Spectrometry
TitleDescriptorRangesUnits
Norproproxyphene Confirmation by GC/MSNot Detected< 80ng/mL
COMP CONFIRM PROPOXYPHENECPPROPCPPROPGas Chromatography
TitleDescriptorRangesUnits
Norproproxyphene Confirmation by GC/MSNot Detected< 80ng/mL
NORTRIPTYLINELCNORLCNORLiquid Chromatography Tandem Mass Spectrometry
TitleDescriptorRangesUnits
NortriptylineNot Detected< 350ng/mL
NORTRIPTYLINENORNORTTandem Mass Spectrometry
TitleDescriptorRangesUnits
NortriptylineTherapeutic50-150ng/mL
Toxic> 500
NORVENLAFAXINELCVENLCVENLiquid Chromatography Tandem Mass Spectrometry
TitleDescriptorRangesUnits
NorvenlafaxineNot Detected< 350ng/mL
NPM1 MUTATION ANALYSISNPMMUTNPMMUTPCR/Fragment Analysis
NPM1 Result
PROBRAIN NATRIURETIC PEPT, NTPBNPPBNPQuantitative Electrochemiluminescent Immunoassay
TitleDescriptorRangesUnits
NT-ProBrain Natriuretic Pept0-74 years< 125pg/mL
75+ years< 450
OLANZAPINE LCOLALCOLALiquid Chromatography Tandem Mass Spectrometry
TitleDescriptorRangesUnits
OlanzapineNot Detected< 350ng/mL
OLANZAPINE, SERUM OR PLASMAOLANZSOLANZSTandem Mass Spectrometry
TitleDescriptorRangesUnits
OlanzapineTherapeutic range20-80ng/mL
ToxicNot well established
OPIATE SCREEN RFLXOPIATEOPIEnzyme Immunoassay
TitleDescriptorRangesUnits
Opiates ScreenNegative< 300ng/mL
OPIATES RFLXOPISCOOPISCOEnzyme Linked Immunosorbent Assay
TitleDescriptorRangesUnits
Opiatesng/mL
6-Monoacetylmorphine, Freeng/mL
Coedine, FreeTherapeutic range30-120ng/mL
Dihydrocodeine/Hydrocodol, FreeUsual therapeutic range50-100ng/mL
Hydrocodone, FreeFollowing a single 10 mg doseUp to 39ng/mL
Hydromorphone, FreePeak plasma concentrations ranged from 18-27ng/mL (mean 22 ng/mL) one hour after a 4 mg oral dose.ng/mL
Morphine, FreeUsual range following therapeutic doses10-70ng/mL
Oxycodone, FreePeak plasma concentrations 1 hr after a single immediate-release tablet preparation containing 5 mg Oxycodone9-38ng/mL
Peak plasma concentrations within 2.5 hours after 10 mg of an immediate release preparation of Oxycodone13-46ng/mL
Mean peak plasma concentrations following a single dose of a 40 to 80 mg controlled release Oxycodone preparation39-100ng/mL
Toxicity may be significant at greater than 200 ng/mL. However, concentrations associated with toxicity are variable and depend on an individual's tolerance to the drug.
Oxycodone/Oxymorphoneng/mL
CULTURE IV CATHETER TIPIVCCATHCulture - Semiquantitative
Organism name with colony count
OXCARBAZEPINE METABOLITEOXCAROXCARTandem Mass Spectrometry
TitleDescriptorRangesUnits
Oxcarbazepine Metabolite3-35ug/mL
Toxic Alert> 40
OXIDIZED LDLOXLDL.LCAOXLDLEnzyme-Linked Immunosorbent Assay
TitleDescriptorRangesUnits
Oxidized LDLLow Risk< 60U/L
Moderate Risk60-69
High Risk> = 70
OXYCODONE SCREEN RFLXOXYSOXYSEnzyme Immunoassay
TitleDescriptorRangesUnits
Oxycodone ScreenNegative< 100ng/mL
PANCREATIC ELASTASE, FECALPANCEFPANCEFEnzyme-Linked Immunosorbent Assay
TitleDescriptorRangesUnits
Pancreatic Elastase, FecalNormal201 or greaterug/g
Moderate to mild pancreatic insufficiency100-200
Severe exocrine insufficiency99 or less
PANCREATIC POLYPEPTIDEPANPEP.LCAPANPEPRadioimmunoassay
TitleDescriptorRangesUnits
Pancreatic Polypeptide0-3 yearsNot establishedpg/mL
3-9 years< or = 519
10-13 years< or = 361
14-17 years< or = 297
18-29 years67-249
30-39 years53-508
40-49 years82-1016
50-64 years67-1319
64+ yearsNot established
LIQUID-BASED PAP, PAP ONLYPAPLQPAPLQLiquid-based vial
Pap Result
CONVENTIONAL SLIDE, PAP ONLYPAPSMRPAPSMRSlide
Pap result
PAROXETINELCPARLCPARLiquid Chromatography Tandem Mass Spectrometry
TitleDescriptorRangesUnits
ParoxetineNot Detected< 350ng/mL
PARVOVIRUS B19 ANTIBODY, IGG,IGMPRVOGMPRVOGMEIA
TitleDescriptorRangesUnits
Parvovirus B19 Ab, IgGPositiveGT 1.09IV
Equivocal0.91-1.09
NegativeLT 0.91
Parvovirus B19 Ab, IgMPositiveGT 1.09IV
Equivocal0.91-1.09
NegativeLT 0.91
PARVOVIRUS B19 AB, IGGPARVOGPARVOGEIA
TitleDescriptorRangesUnits
Parvovirus B19 Ab, IgGPositiveGT 1.09IV
Equivocal0.91-1.09
NegativeLT 0.91
PARVOVIRUS B19 AB, IGMPARVOMPARVOMEIA
TitleDescriptorRangesUnits
Parvovirus B19 Ab, IgMPositiveGT 1.09IV
Equivocal0.91-1.09
NegativeLT 0.91
PEMPHIGUS PANELPEMPECPEMPABEnzyme-Linked Immunosorbent Assay/Indirect Fluorescent Antibody
Pemphigus Ab Panel
PENTAZOCINE LCPTZLCPTZLiquid Chromatography Tandem Mass Spectrometry
TitleDescriptorRangesUnits
PentazocineNot Detected< 350ng/mL
PENTOBARBITALPENTO.LCAPENTOQuantitative Gas Chromatography/Mass Spectrometry
TitleDescriptorRangesUnits
PentobarbitalTherapeutic RangeSedation: 1-5ug/mL
Intracranial Pressure (ICP) Therapy: 25-35
Coma: 10-50
Toxic Level> 10
Toxic concentrations may cause respiratory depression, hypotension, coma, and death.
PHENCYCLIDINE (GCMS)MSPCPMSPCPGas Chromatography Mass Spectrometry
TitleDescriptorRangesUnits
Phencyclidine (PCP) ConfirmNot Detected< 6ng/mL
PAIN MGMT PHENCYCLIDINEPPCPPPCPGas Chromatography Mass Spectrometry
TitleDescriptorRangesUnits
Phencyclidine (PCP) ConfirmNot Detected< 6ng/mL
PAIN MGMT PHENCYCLIDINE RFLXPMPCPPMPCPEnzyme Immunoassay
TitleDescriptorRangesUnits
Phencyclidine ScreenNegative< 25ng/mL
Phencyclidine by GC/MSng/mL
PHENCYCLIDINE RFLXPCPPCPEnzyme Immunoassay
TitleDescriptorRangesUnits
Phencyclidine ScreenNegative< 25ng/mL
PHENOBARBITALPHNBPHNBKinetic Interaction of Microparticles
TitleDescriptorRangesUnits
PhenobarbitalTherapeutic10.0-30.0ug/mL
Toxic> 40.0
PRIMIDONE AND METABOLITEPRMPHPRMPHEnzymatic, Kinetic Interaction of Microparticles
TitleDescriptorRangesUnits
PhenobarbitalTherapeutic15.0-40.0ug/mL
Toxic> 50.0
PrimidoneTherapeutic5.0-12.0ug/mL
Toxic> 15.0
PHENTERMINE LCPTMLCPTMLiquid Chromatography Tandem Mass Spectrometry
TitleDescriptorRangesUnits
PhentermineNot Detected< 350ng/mL
PHENYLPROPANOLAMINELCPPALCPPALiquid Chromatography Tandem Mass Spectrometry
TitleDescriptorRangesUnits
PhenylpropanolamineNot Detected< 350ng/mL
PHENYTOINLCPHYLCPHYLiquid Chromatography Tandem Mass Spectrometry
TitleDescriptorRangesUnits
PhenytoinNot Detected< 650ng/mL
ANTI CONVULSANT PROFILECONVULCONVULKinetic Interaction of Microparticles
TitleDescriptorRangesUnits
PhenytoinTherapeutic10.0-20.0ug/mL
Toxic> 25.0
PhenobarbitalTherapeutic10.0-30.0ug/mL
Toxic> 40.0
PHENYTOINPHTNPHTNKinetic Interaction of Microparticles
TitleDescriptorRangesUnits
PhenytoinTherapeutic10.0-20.0ug/mL
Toxic> 25.0
HEMOGLOBIN, PLASMA QUANTHGB.PLASMAPHGBQTSpectrophotometry
TitleDescriptorRangesUnits
Plasma Hgbquantitative0-10mg/dL
90% of population LT 10 mg/dL, 10% of population LT 20 mg/dL. Reference values are difficult to define, since hemoglobin concentration depends heavily on the care by which the sample was obtained and processed.
PLATELET ASPIRIN TESTPLTASAPLTASAVerifyNow Aspirin Test
Platelet Aspirin Test          ARU (Aspirin Reaction Units)

  < 550 ARU = Aspirin effect present.  Results can be affected by NSAID interference, 
  P2Y12 Inhibitors, GPIIb/IIIa inhibitors, inherited platelet disorders, low HCT or 
  low PLT counts.  

  > or = 550 ARU = Aspirin effect absent
PLATELET COUNT, BLOODPLTPLTCNTAutomated
TitleDescriptorRangesUnits
Platelet Count0-3 days250-450K/uL
3-9 days200-400
9-30 days250-450
1-6 months300-750
6 months-2 years250-600
2-8 years250-550
8-12 years200-450
12-18 years150-450
18+ years150-400
PNH PANELPNHPANPNHPANFlow Cytometry
PNH Panel Result
PORPHOBILINOGEN DEAMINASE, RBCPBGAR.LCAPBGARQuantitative Enzymatic/Fluorometry
TitleDescriptorRangesUnits
Porphobilinogen Deaminase, RBCAdult2.10-4.30mU/g Hb
Interpretive Data: Porphobilinogen (PBG) deaminase (hydroxymethylbilane synthase or urophorphyrinogen I synthase) is expressed in units of mU per gram hemoglobin at 37C. In persons genetically susceptible to acute intermittent porphyria (AIP), PBG deaminase concentrations are approximately half of reference values. Normal concentrations of erythrocyte PBG deaminase may include abnormal forms of hepatic PBG deaminase.
PORPHYRINS, TOTAL SERUMPORPHSPORPHSFluorometry
TitleDescriptorRangesUnits
Porphyrins, Total SerumNormal0.1-1.0ug/dL
POTASSIUM, FLUIDPOTFLDKFLISE
TitleDescriptorRangesUnits
Potassium, FluidCSF70% of plasma levelmmol/L
GastricAbout 10
Other fluidNo reference range established
Method not validated for body fluid
Clinical correlation necessary
POTASSIUMPOTKISE
TitleDescriptorRangesUnits
Potassium0-30 days3.9-6.9mmol/L
1-12 months3.6-6.8
1-5 years3.2-5.7
5-10 years3.4-5.4
10+ years3.5-5.3
PW/AS METHYLATION ANALYSISPWASMAPWASMACapillary Electrophoresis, Polymerase Chain Reaction
Prader-Willi DNA Methylation Analysis
PREGNANCY TEST (HCG), SERUMHCGPRGElectrochemiluminescence Immunoassay
TitleDescriptorRangesUnits
Pregnancy Test Beta HCGNegative< 5.4mIU/mL
Indeterminate5.4-25.0
Positive> 25.0
PREGNANCY TEST, URINEPRGPRGUEIA
TitleDescriptorRangesUnits
Pregnancy TestNegativeLT 25mIU/mL
Positive25 or greater
The following comment will be appended to all negative pregnancy results.
Levels of hCG greater than 300,000 mIU/mL (about 4-12 weeks gestation) may cause false-negative results. Consider quantitative serum hCG
test to confirm negative screening result if clinical picture suggests pregnancy.
PROCAINAMIDE, SERUMPRNCALPRCNALImmunoassay
TitleDescriptorRangesUnits
Procainamide, Serum4.0-10.0ug/mL
Detection limit0.6
None detected< 0.6
NAPA, Serum6.0-20.0ug/mL
Detection limit0.9
None detected< 0.9
Total PA+NAPA10.0-30.0ug/mL
PROPAFENONEPROPAFENONEPROPAFQuantitative Liquid Chromatography-Tandem Mass Spectrometry
TitleDescriptorRangesUnits
PropafenoneTherapeutic Range0.50-2.00ug/mL
Toxic Level> 2.00
Toxic concentrations may cause hypotension, seizures, and cardiac abnormalities.
PAIN MANAGEMENT PROPOXY RFLXPMPROPPMPROPEnzyme Immunoassay
TitleDescriptorRangesUnits
Propoxyphene ScreenNegative< 300ng/mL
Norpropoxyphene by GC/MSng/mL
PROPOXYPHENE RFLXPROPOXPROPEnzyme Immunoassay
TitleDescriptorRangesUnits
Propoxyphene ScreenNegative< 300ng/mL
PROPRANOLOLLCPPLLCPPLLiquid Chromatography Tandem Mass Spectrometry
TitleDescriptorRangesUnits
PropranololNot Detected< 350ng/mL
PROTEIN C ACTIVITYPROCFACTPCClotting Assay
TitleDescriptorRangesUnits
Protein C Activity1 day31-35%
3 days31-45
1 month-1 year36-108
1-5 years65-117
6-10 years83-109
11-16 years76-98
16+ years70-145
PROTEIN, CSFPRO-CTPSFColorimetric
TitleDescriptorRangesUnits
Protein, CSFLT 1 day40-120mg/dL
1-30 days20-80
1 month-adult15-45
PROTEIN, FLUIDPRO-FLDTPFLColorimetric
TitleDescriptorRangesUnits
Protein, FluidExudate> or = 3.0g/dL
Transudate< 3.0
Synovial< 3.0
Method not validated for body fluid.
Clinical correlation necessary.
SPEP, SERUMELPPELPAgarose Gel ELP (high resolution), Colormetric
TitleDescriptorRangesUnits
Protein, Total0-12 months4.3-6.9g/dL
1-3 years5.2-7.4
3-6 years5.6-7.7
6-10 years6.5-8.3
10-18 years6.1-8.0
18-60 years6.2-8.2
60+ years6.1-7.8
Albumin0-4 days2.9-4.6g/dL
4 days-14 years3.9-5.6
14-18 years3.3-4.7
18-60 years3.5-5.0
60-90 years3.3-4.8
90+ years3.0-4.7
Alpha-10.1-0.4g/dL
Alpha-20.5-1.1g/dL
Beta-10.4-0.8g/dL
Beta-20.2-0.6g/dL
Gamma 0.6-1.5g/dL
Albumin45.0-80.0%
Alpha-11.0-6.0%
Alpha-26.0-17.0%
Beta-15.0-13.0%
Beta-22.0-8.5%
Gamma7.5-24.0%
Interpretation
Monoclonal Peak
If Positive
Monoclonal Proteing/dL
Monoclonal Protein %%
Monoclonal Protein (2)g/dL
Monoclonal Protein (2)%%
PROTEIN, TOTALPROTPColorimetric (Biuret)
TitleDescriptorRangesUnits
Protein, Total0-12 months4.3-6.9g/dL
1-3 years5.2-7.4
3-6 years5.6-7.7
6-10 years6.5-8.3
10-18 years6.1-8.0
18-60 years6.2-8.2
60+ years6.1-7.8
IMMUNOFIXATION, SERUMIEPIEPImmunofixation ELP/High Resolution
TitleDescriptorRangesUnits
Protein, Total0-12 months4.3-6.9g/dL
1-3 years5.2-7.4
3-6 years5.6-7.7
6-10 years6.5-8.3
10-18 years6.1-8.0
18-60 years6.3-8.0
60+ years6.1-7.8
Albumin0-4 days2.9-4.6g/dL
4 days-14 years3.9-5.6
14-18 years3.3-4.7
18-60 years3.5-5.0
60-90 years3.3-4.8
90+ years3.0-4.7
Alpha-10.1-0.4g/dL
Alpha-20.5-1.1g/dL
Beta-10.4-0.8g/dL
Beta-20.2-0.6g/dL
Gamma0.6-1.5g/dL
Albumin45.0-80.0%
Alpha-11.0-6.0%
Alpha-26.0-17.0%
Beta-15.0-13.0%
Beta-22.0-8.5%
Gamma7.5-24.0%
Interpretation
Monoclonal Peak
If Positive
Monoclonal Proteing/dL
Monoclonal Protein %%
Monoclonal Protein (2)g/dL
Monoclonal Protein (2)%%
Immunofixation Interpretation
SPEP, SERUM RFLXPELPIFPELPIFAgarose Gel ELP (high resolution), Colormetric
TitleDescriptorRangesUnits
Protein, Total0-12 months4.3-6.9g/dL
1-3 years5.2-7.4
3-6 years5.6-7.7
6-10 years6.5-8.3
10-18 years6.1-8.0
18-60 years6.3-8.0
60+ years6.1-7.8
Albumin0-4 days2.9-4.6g/dL
4 days-14 years3.9-5.6
14-18 years3.3-4.7
18-60 years3.5-5.0
60-90 years3.3-4.8
90+ years3.0-4.7
Alpha-10.1-0.4g/dL
Alpha-20.5-1.1g/dL
Beta-10.4-0.8g/dL
Beta-20.2-0.6g/dL
Gamma0.6-1.5g/dL
Albumin45.0-80.0%
Alpha-11.0-6.0%
Alpha-26.0-17.0%
Beta-15.0-13.0%
Beta-22.0-8.5%
Gamma7.5-24.0%
Monoclonal Peak
If Positive
Monoclonal Proteing/dL
Monoclonal Protein %%
Monoclonal Protein (2)g/dL
Monoclonal Protein (2)%%
Interpretation
Immunofixation Interpretation
PROTEINASE 3 ABPR3ABPR3ABMultiplex Bead Immunoassay
TitleDescriptorRangesUnits
Proteinase 3 AntibodyNegative< 1.0AI (Antibody Index)
Positive> or = 1.0
PROTHROMBIN TIMEPTPTElectromechanical
TitleDescriptorRangesUnits
Protime1 day15.0-16.1sec
3 days14.1-16.1
1 month-1 year12.0-15.1
1-5 years12.6-14.2
6-10 years12.2-14.8
11-16 years13.3-15.8
16+ years12.0-14.2
Protime Population MeanNo longer reported
INR1 day1.2-1.3
3 days1.1-1.3
1 month-1 year0.9-1.2
1-5 years0.9-1.1
6-10 years0.9-1.1
11-16 years1.0-1.2
16+ years0.9-1.1
Usual oral anticoagulation range2.0-3.0
High level oral anticoagulation range2.5-3.5
COAGULATION BATTERYCOAG-BATCOAGB
TitleDescriptorRangesUnits
Protime1 day15.0-16.1sec
3 days14.1-16.1
1 month-1 year12.0-15.1
1-5 years12.6-14.2
6-10 years12.2-14.8
11-16 years13.3-15.8
16+ years12.0-14.2
Protime Population MeanNo longer reportedsec
INR1 day1.2-1.3
3 days1.1-1.3
1 month-1 year0.9-1.2
1-5 years0.9-1.1
6-10 years0.9-1.1
11-16 years1.0-1.2
16+ years0.9-1.1
Usual oral anticoagulation range2.0-3.0
High level oral anticoagulation range2.5-3.5
PTT1 day31-42sec
3 days27-40
1 month-1 year32-44
1-5 years31-41
6-10 years29-41
11-16 years31-43
16+ years26-36
Deep venous thrombosis or pulmonary embolism therapeutic heparin levels of 0.3-0.7 Units/mL anti FactorXa usually correspond to an aPTT of 65-99 seconds. Acute cardiac syndrome therapeutic range based on heparin levels of 0.2 to 0.5 usually correspond to an aPTT of 57 to 76 seconds. Pediatric guidelines suggested heparin levels of 0.35-0.7 usually correspond to an aPTT of 69 to 99 seconds.
Platelet Count0-3 days250-450K/uL
3-9 days200-400
9-30 days250-450
1-6 months300-750
6 months-2 years250-600
2-8 years250-550
8-12 years200-450
12-18 years150-450
18+ years150-400
Interpretation
Reviewed by
MENORRHAGIA EVALUATION RFLXMENEVLMENEVLElectromechanical, Immuno-turbidimetric, Platelet Aggregation
TitleDescriptorRangesUnits
Protime1 day15.0-16.1sec
3 days14.1-16.1
1 month-1 year12.0-15.1
1-5 years12.6-14.2
6-10 years12.2-14.8
11-16 years13.3-15.8
16+ years12.0-14.2
Protime Population MeanNo longer reportedsec
INR0.9-1.2
Usual oral anticoagulation range2.0-3.0
High level oral anticoagulation range2.5-3.5
PTT1 day31-42sec
3 days27-40
1 month-1 year32-44
1-5 years31-41
6-10 years29-41
11-16 years31-43
16+ years26-36
Deep venous thrombosis or pulmonary embolism therapeutic heparin levels of 0.3-0.7 Units/mL anti FactorXa usually correspond to an aPTT of 65-99 seconds. Acute cardiac syndrome therapeutic range based on heparin levels of 0.2 to 0.5 usually correspond to an aPTT of 57 to 76 seconds. Pediatric guidelines suggested heparin levels of 0.35-0.7 usually correspond to an aPTT of 69 to 99 seconds.
PT 1/1 Mixsec
PT Control Plasmasec
PTT 1/1 Mixsec
PTT Control Plasmasec
von Willebrand Factor ActivityGT 40%
Factor VIII Related Antigen0-5 years50-165%
6-10 years60-200
11-16 years56-200
16+ years50-165
Normal individuals of blood group "O" may have vonWillebrand factor antigen levels as low as 40%.
Children: Neonates, infants, and children have normal or mildly increased plasma VWF antigen, with respect to the adult reference range.
Factor VIII Coagulant Activity1 day111-200%
3 days88-200
1 month-1 year57-200
1-5 years38-200
6-10 years55-200
11-16 years62-200
16+ years55-150
Factor XI1 day7-28%
3 days23-54
1 month-1 year60-86
1-5 years63-112
6-10 years63-112
11-16 years63-96
16+ years65-135
DIC SCREEN RFLXDICBDICElectromechanical, Immuno-turbidimetric Microscopy
TitleDescriptorRangesUnits
Protime1 day15.0-16.1sec
3 days14.1-16.1
1 month-1 year12.0-15.1
1-5 years12.6-14.2
6-10 years12.2-14.8
11-16 years13.3-15.8
16+ years12.0-14.2
Protime Population MeanNo longer reportedsec
INR1 day1.2-1.3
3 days1.1-1.3
1 month-1 year0.9-1.2
1-5 years0.9-1.1
6-10 years0.9-1.1
11-16 years1.0-1.2
16+ years0.9-1.1
Usual oral anitcoagulation range2.0-3.0
High-level oral anticoagulation range2.5-3.5
PTT1 day31-42sec
3 days27-40
1 month-1 year32-44
1-5 years31-41
6-10 years29-41
11-16 years31-43
16+ years26-36
Deep venous thrombosis or pulmonary embolism therapeutic heparin levels of 0.3-0.7 Units/mL anti Factor Xa usually correspond to an aPTT of 65-99 seconds. Acute cardiac syndrome therapeutic range based on heparin levels of 0.2 to 0.5 usually correspond to an aPTT of 57 to 76 seconds. Pediatric guidelines suggested heparin levels of 0.35-0.7 usually correspond to an aPTT of 69 to 99 seconds.
Fibrinogen1 day213-364mg/dL
3 days314-391
1 month-1 year91-373
1-5 years180-391
6-10 years221-399
11-16 years235-422
16+ years211-419
Thrombin Time Patient15.6-20.0sec
Thrombin Time Control15.6-20.0sec
Thrombin Time PT/CT Mixsec
Thrombin Time PT/SO4 Mixsec
D-dimer, QuantitativeLT 0.50ug/mL FEU
Platelet Count0-3 days250-450K/uL
3-9 days200-400
9-30 days250-450
1-6 months300-750
6 months-2 years250-600
2-8 years250-550
8-12 years200-450
12-18 years150-450
18+ years150-400
RBC Morphology
DIC Comment
FACTOR IX INHIB, QUANT RFLXF09INHF09INHElectromechanical
TitleDescriptorRangesUnits
Protime1 day15.0-16.1sec
3 days14.1-16.1
1 month-1 year12.0-15.1
1-5 years12.6-14.2
6-10 years12.2-14.8
11-16 years13.3-15.8
16+ years12.0-14.2
Protime Population MeanNo longer reportedsec
PTT1 day31-42sec
3 days27-40
1 month-1 year32-44
1-5 years31-41
6-10 years29-41
11-16 years31-43
16+ years26-36
Deep venous thrombosis or pulmonary embolism therapeutic heparin levels of 0.3-0.7 Units/mL anti Factor Xa usually correspond to an aPTT of 65-99 seconds. Acute cardiac syndrome therapeutic range based on heparin levels of 0.2 to 0.5 usually correspond to an aPTT of 57 to 76 seconds. Pediatric guidelines suggested heparin levels of 0.35-0.7 usually correspond to an aPTT of 69 to 99 seconds.
Protime 1/1 Mixsec
Protime Control Plasmasec
PTT 1/1 Mixsec
PTT Control Plasmasec
Factor IX1 day31-36%
3 days45-53
1 month-1 year44-67
1-5 years45-70
6-10 years49-80
11-16 years65-119
16+ years60-140
Factor 9 InhibitorsNegative Inhibitor Units
FACTOR X INHIB, QUANT RFLXF10INHF10INHElectromechanical
TitleDescriptorRangesUnits
Protime1 day15.0-16.1sec
3 days14.1-16.1
1 month-1 year12.0-15.1
1-5 years12.6-14.2
6-10 years12.2-14.8
11-16 years13.3-15.8
16+ years12.0-14.2
Protime Population MeanNo longer reportedsec
PTT1 day31-42sec
3 days27-40
1 month-1 year32-44
1-5 years31-41
6-10 years29-41
11-16 years31-43
16+ years26-36
Deep venous thrombosis or pulmonary embolism therapeutic heparin levels of 0.3-0.7 Units/mL anti Factor Xa usually correspond to an aPTT of 65-99 seconds. Acute cardiac syndrome therapeutic range based on heparin levels of 0.2 to 0.5 usually correspond to an aPTT of 57 to 76 seconds. Pediatric guidelines suggested heparin levels of 0.35-0.7 usually correspond to an aPTT of 69 to 99 seconds.
Protime 1/1 Mixsec
Protime Control Plasmasec
PTT 1/1 Mixsec
PTT Control Plasmasec
Factor X1 day41-60%
3 days41-67
1 month-1 year68-108
1-5 years64-111
6-10 years60-111
11-16 years47-108
16+ years85-152
Factor 10 InhibitorsNegative Inhibitor Units
FACTOR XII INHIB, QUANT RFLXF12INHF12INHElectromechanical
TitleDescriptorRangesUnits
Protime1 day15.0-16.1sec
3 days14.1-16.1
1 month-1 year12.0-15.1
1-5 years12.6-14.2
6-10 years12.2-14.8
11-16 years13.3-15.8
16+ years12.0-14.2
Protime Population MeanNo longer reportedsec
PTT1 day31-42sec
3 days27-40
1 month-1 year32-44
1-5 years31-41
6-10 years29-41
11-16 years31-43
16+ years26-36
Deep venous thrombosis or pulmonary embolism therapeutic heparin levels of 0.3-0.7 Units/mL anti Factor Xa usually correspond to an aPTT of 65-99 seconds. Acute cardiac syndrome therapeutic range based on heparin levels of 0.2 to 0.5 usually correspond to an aPTT of 57 to 76 seconds. Pediatric guidelines suggested heparin levels of 0.35-0.7 usually correspond to an aPTT of 69 to 99 seconds.
Protime 1/1 Mixsec
PT Control Plasmasec
PTT 1/1 Mixsec
PTT Control Plasmasec
Factor XII1 day43-80%
3 days19-70
1 month-1 year29-98
1-5 years50-98
6-10 years50-99
11-16 years50-85
16+ years50-150
Factor 12 InhibitorsNegative Inhibitor Units
FACTOR V INHIB, QUANT RFLXF05INHF05INHElectromechanical
TitleDescriptorRangesUnits
Protime1 day15.0-16.1sec
3 days14.1-16.1
1 month-1 year12.0-15.1
1-5 years12.6-14.2
6-10 years12.2-14.8
11-16 years13.3-15.8
16+ years12.0-14.2
Protime Population MeanNo longer reportedsec
PTT1 day31-42sec
3 days27-40
1 month-1 year32-44
1-5 years31-41
6-10 years29-41
11-16 years31-43
16+ years26-36
Deep venous thrombosis or pulmonary embolism therapeutic heparin levels of 0.3-0.7 Units/mL anti FactorXa usually correspond to an aPTT of 65-99 seconds. Acute cardiac syndrome therapeutic range based on heparin levels of 0.2 to 0.5 usually correspond to an aPTT of 57 to 76 seconds. Pediatric guidelines suggested heparin levels of 0.35-0.7 usually correspond to an aPTT of 69 to 99 seconds.
Protime 1/1 Mixsec
Protime Control Plasmasec
PTT 1/1 Mixsec
PTT Control Plasmasec
Factor V1 day57-83%
3 days83-124
1 month-1 year84-113
1-5 years60-102
6-10 years50-113
11-16 years60-113
16+ years70-122
Factor 5 InhibitorsNegative Inhibitor Units
FACTOR II INHIB, QUANT RFLXF02INHF02INHElectromechanical
TitleDescriptorRangesUnits
Protime1 day15.0-16.1sec
3 days14.1-16.1
1 month-1 year12.0-15.1
1-5 years12.6-14.2
6-10 years12.2-14.8
11-16 years13.3-15.8
16+ years12.0-14.2
Protime Population MeanNo longer reportedsec
PTT1 day31-42sec
3 days27-40
1 month-1 year32-44
1-5 years31-41
6-10 years29-41
11-16 years31-43
16+ years26-36
Deep venous thrombosis or pulmonary embolism therapeutic heparin levels of 0.3-0.7 Units/mL anti FactorXa usually correspond to an aPTT of 65-99 seconds. Acute cardiac syndrome therapeutic range based on heparin levels of 0.2 to 0.5 usually correspond to an aPTT of 57 to 76 seconds. Pediatric guidelines suggested heparin levels of 0.35-0.7 usually correspond to an aPTT of 69 to 99 seconds.
Protime 1/1 Mixsec
Protime Control Plasmasec
PTT 1/1 Mixsec
PTT Control Plasmasec
Factor II1 day46-66%
3 days56-69
1 month-1 year69-98
1-5 years78-103
6-10 years75-104
11-16 years68-102
16+ years87-131
Factor 2 InhibitorsNegative Inhibitor Units
FACTOR VII INHIB, QUANT RFLXF07INHF07INHElectromechanical
TitleDescriptorRangesUnits
Protime1 day15.0-16.1sec
3 days14.1-16.1
1 month-1 year12.0-15.1
1-5 years12.6-14.2
6-10 years12.2-14.8
11-16 years13.3-15.8
16+ years12.0-14.2
Protime Population MeanNo longer reportedsec
PTT1 day31-42sec
3 days27-40
1 month-1 year32-44
1-5 years31-41
6-10 years29-41
11-16 years31-43
16+ years26-36
Deep venous thrombosis or pulmonary embolism therapeutic heparin levels of 0.3-0.7 Units/mL anti FactorXa usually correspond to an aPTT of 65-99 seconds. Acute cardiac syndrome therapeutic range based on heparin levels of 0.2 to 0.5 usually correspond to an aPTT of 57 to 76 seconds. Pediatric guidelines suggested heparin levels of 0.35-0.7 usually correspond to an aPTT of 69 to 99 seconds.
Protime 1/1 Mixsec
Protime Control Plasmasec
PTT 1/1 Mixsec
PTT Control Plasmasec
Factor VII1 day57-80%
3 days74-98
1 month-1 year79-137
1-5 years